Region,Subregion,Country,Drug Type,Source,Notes,Year,Lifetime,Past Month,Past Year
Americas,Central America,El Salvador,Cannabis,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",Resin,2018,0.8,,
Americas,Central America,Guatemala,Cannabis,ARQ,-,2004,2,,1
Americas,Central America,Guatemala,Cannabis,ARQ,Herb,2014,11.31,3.08,5.69
Americas,Central America,Guatemala,Cannabis,ARQ,Resin,2014,0.88,,
Americas,Central America,Honduras,Cannabis,ARQ,Select Regions (Central  District),2008,3.4,,
Americas,Central America,Honduras,Cannabis,ARQ,"Herb, Secondary Schools",2014,16.8,4.4,9.6
Americas,Central America,Honduras,Cannabis,ARQ,"Herb, Secondary Schools",2015,14.7,1.1,6.8
Americas,Central America,Honduras,Cannabis,ARQ,Herb,2016,12,5.2,7.2
Americas,Central America,Nicaragua,Cannabis,Govt.,-,2003,4.8,,
Americas,Central America,Panama,Cannabis,CICAD/ OAS,-,2008,6.2,1.8,2.9
Americas,Central America,Panama,Cannabis,ARQ,Herb,2013,8.56,1.13,3.33
Americas,Central America,Panama,Cannabis,ARQ,Resin,2013,0.64,0.04,0.21
Americas,North America,Canada,Cannabis,ARQ,-,2008,47.3,,39.4
Americas,North America,Canada,Cannabis,ARQ,-,2010,34.3,13.3,23.7
Americas,North America,Canada,Cannabis,ARQ,-,2010,30,,25.8
Americas,North America,Canada,Cannabis,ARQ,-,2012,28.33,,23.05
Americas,North America,Canada,Cannabis,ARQ,-,2014,24.72,12.54,19.2
Americas,North America,Canada,Cannabis,ARQ,-,2016,25.9,13.86,21.56
Americas,North America,Canada,Cannabis,ARQ,Other types of cannabis,2016,5.34,,4.39
Americas,North America,Greenland,Cannabis,HBSC,-,2010,16.2,4.31,12.17
Americas,North America,Mexico,Cannabis,National Adiction Household Survey,-,2011,2.4,0.73,1.33
Americas,North America,Mexico,Cannabis,National Adiction Household Survey,-,2008,,,1.2
Americas,North America,Mexico,Cannabis,National Adiction Household Survey,-,2002,,,0.5
Americas,North America,Mexico,Cannabis,ARQ,-,2011,2.4,,1.3
Americas,North America,Mexico,Cannabis,ARQ,Herb only,2014,10.6,3.9,7.6
Americas,North America,Mexico,Cannabis,ARQ,Herb,2016,5.3,1.1,2.6
Americas,North America,Mexico,Cannabis,ARQ,Resin,2016,0.7,,
Americas,North America,United States of America,Cannabis,ARQ,Herb,2009,32.3,15.9,26.7
Americas,North America,United States of America,Cannabis,Govt.,Herb,2010,33.4,16.7,27.5
Americas,North America,United States of America,Cannabis,ARQ,Herb,2011,34.5,17.6,28.8
Americas,North America,United States of America,Cannabis,ARQ,Herb,2012,33.8,17,28
Americas,North America,United States of America,Cannabis,ARQ,-,2013,35.8,18,29.8
Americas,North America,United States of America,Cannabis,ARQ,-,2014,33.7,16.6,27.3
Americas,North America,United States of America,Cannabis,ARQ,Monitoring the future,2015,31.1,14.8,25.3
Americas,North America,United States of America,Cannabis,ARQ,-,2016,29.7,14,23.9
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,1991,22.7,8.3,15
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,1992,21.1,7.7,14.3
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,1993,23.4,10.2,17.7
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,1994,27.8,13.9,22.5
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,1995,31.6,15.6,26.1
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,1996,35.6,17.7,29
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,1997,37.8,17.9,30.1
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,1998,36.5,16.9,28.2
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,1999,36.4,16.9,27.9
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2000,35.3,16.3,27.2
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2001,35.3,16.6,27.5
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2002,34,15.3,26.1
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2003,32.4,14.8,24.6
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2004,31.4,13.6,23.8
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2005,30.8,13.4,23.4
Africa,East Africa,Ethiopia,Cannabis,ARQ,Ages not specified,1999,11,,
Africa,East Africa,Kenya,Cannabis,Govt.,Resin,2007,1.1,0.9,
Africa,East Africa,Kenya,Cannabis,ARQ,Herb,2012,3.1,,
Africa,East Africa,Kenya,Cannabis,ARQ,Resin,2012,0.8,,
Africa,East Africa,Kenya,Cannabis,ARQ,Herb,2016,2.8,1.1,1.1
Africa,East Africa,Kenya,Cannabis,ARQ,Herb,2016,7.5,1.8,
Africa,East Africa,Madagascar,Cannabis,ARQ,-,2004,,,18.53
Africa,East Africa,Madagascar,Cannabis,ARQ,Herb,2018,16.67,,16.67
Africa,East Africa,Mauritius,Cannabis,ARQ,-,2004,10.9,,2.2
Africa,East Africa,Seychelles,Cannabis,ARQ,-,2001,,,0.31
Africa,North Africa,Algeria,Cannabis,ARQ,-,2005,,,
Africa,North Africa,Algeria,Cannabis,ARQ,Herb,2010,0.17,0.07,0.07
Africa,North Africa,Algeria,Cannabis,ARQ,Resin,2016,5.44,2.69,3.61
Africa,North Africa,Egypt,Cannabis,ARQ,-,2006,18.9,,
Africa,North Africa,Egypt,Cannabis,ARQ,(general population survey),2013,,,1.4
Africa,North Africa,Egypt,Cannabis,ARQ,Herb (general population survey),2013,,,5.3
Africa,North Africa,Egypt,Cannabis,MedSPAD,-,2016,2.72,1.6,2.56
Africa,North Africa,Morocco,Cannabis,MedSPAD,Select regions (Rabat),2005,6.573,2.9456,4.6228
Africa,North Africa,Morocco,Cannabis,MedSPAD,Resin,2009,7.2,2.6,4.6
Africa,North Africa,Morocco,Cannabis,MedSPAD,-,2009,9.2,4.1,6.2
Africa,North Africa,Morocco,Cannabis,ARQ,-,2013,5,3,3
Africa,North Africa,Morocco,Cannabis,MedSPAD,-,2017,6,3,5
Africa,North Africa,Sudan,Cannabis,ARQ,-,2009,3,,
Africa,North Africa,Tunisia,Cannabis,MedSPAD,-,2013,1.4,0.4,0.7
Africa,North Africa,Tunisia,Cannabis,MedSPAD Survey 2016/2017,-,2016,3.8,1.5,2.5
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2006,28.9,12.5,22.2
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2007,27.9,12.4,21.4
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2008,27.9,12.5,21.5
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2009,29,13.8,22.9
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2010,30.4,14.8,24.5
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2011,31,15.2,25
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2012,30.7,15.1,24.7
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2013,32,15.6,25.8
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2014,30.5,14.4,24.2
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2015,30,14,23.7
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2016,28.6,13.7,22.6
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",Herb and rasin,2017,29.3,14.5,23.9
Americas,North America,United States of America,Cannabis,"Monitoring the future, Adolescent Drug Use",-,2018,32.6,16.7,27.5
Americas,South America,Argentina,Cannabis,ARQ,-,2007,10.9,,7.6
Americas,South America,Argentina,Cannabis,ARQ,Herb,2009,13.2,5.7,9.5
Americas,South America,Argentina,Cannabis,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Herb,2010,3,1.3,2.2
Americas,South America,Argentina,Cannabis,ARQ,Herb,2011,14.7,6.5,11.1
Americas,South America,Argentina,Cannabis,ARQ,Herb,2014,18.3,8.8,13.6
Americas,South America,Argentina,Cannabis,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Herb,2017,8.6,2.8,4.9
Americas,South America,Argentina,Cannabis,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Resin,2017,0.3,,
Americas,South America,Bolivia (Plurinational State of),Cannabis,ARQ,-,2008,6.2,1.9,3.6
Americas,South America,Bolivia (Plurinational State of),Cannabis,ARQ,Herb,2008,1.1,0.34,0.71
Americas,South America,Bolivia (Plurinational State of),Cannabis,ARQ,"Herb, Capitals of departments",2013,1.11,0.34,0.71
Americas,South America,Bolivia (Plurinational State of),Cannabis,ARQ,Herb,2012,11.97,1.45,3.44
Americas,South America,Bolivia (Plurinational State of),Cannabis,ARQ,Resin,2012,1.98,0.2,0.47
Americas,South America,Bolivia (Plurinational State of),Cannabis,Government,Herb,2016,12.15,2.18,4.98
Americas,South America,Bolivia (Plurinational State of),Cannabis,ARQ,Resin,2016,0.61,,
Americas,South America,Bolivia (Plurinational State of),Cannabis,ARQ,Herb,2016,12.15,2.18,4.98
Americas,South America,Bolivia (Plurinational State of),Cannabis,ARQ,Other types of cannabis,2016,0.6,,0.4
Americas,South America,Brazil,Cannabis,Government,-,2005,7.67,4.43,6.29
Africa,North Africa,Tunisia,Cannabis,,-,2018,,,5.07
Africa,Southern Africa,Namibia,Cannabis,Govt.,Herb,2015,9.3,6.2,6.4
Africa,Southern Africa,South Africa,Cannabis,ARQ,Herb,2008,12.7,9.7,
Africa,Southern Africa,South Africa,Cannabis,ARQ,Western Cape Town only,2011,23.6,8.2,12.3
Africa,Southern Africa,South Africa,Cannabis,ARQ,Herb,2011,12.8,9.2,
Africa,Southern Africa,South Africa,Cannabis,ARQ,-,2011,12.8,9.2,
Africa,Southern Africa,Zambia,Cannabis,WHO,GSHS,2004,35.3,,
Africa,West and Central Africa,Cabo Verde,Cannabis,2018 National Survey on Substance Use and Health (NSSUH),-,2018,,,10.4
Africa,West and Central Africa,Central African Republic,Cannabis,ARQ,Resin,2017,5,3,
Africa,West and Central Africa,Central African Republic,Cannabis,ARQ,Herb,2017,30,21,
Africa,West and Central Africa,Côte d'Ivoire,Cannabis,Government,-,2017,2.5,1.5,1.5
Africa,West and Central Africa,Côte d'Ivoire,Cannabis,Government,Spice,2017,1.2,0.4,0.6
Africa,West and Central Africa,Ghana,Cannabis,ARQ,-,2007,,,17.1
Africa,West and Central Africa,Nigeria,Cannabis,UNODC Report,-,2017,,,3.3
Africa,West and Central Africa,Togo,Cannabis,ARQ,-,2009,1.9,,1.2
Americas,Caribbean,Antigua and Barbuda,Cannabis,OAS (MEM),-,2005,24.9,8.4,13.4
Americas,Caribbean,Antigua and Barbuda,Cannabis,CICAD/ OAS,-,2013,32.58,17.96,23.89
Americas,Caribbean,Bahamas,Cannabis,Govt.,-,2008,15.6,,8.5
Americas,Caribbean,Bahamas,Cannabis,CICAD/ OAS,-,2011,12.78,4.29,8.1
Americas,Caribbean,Barbados,Cannabis,OAS (MEM),-,2006,17.4,6,10.6
Americas,Caribbean,Barbados,Cannabis,CICAD/ OAS,-,2013,20.93,10.44,15.96
Americas,Caribbean,Dominica,Cannabis,OAS (MEM),-,2006,29.4,11.8,17.9
Americas,Caribbean,Dominica,Cannabis,CICAD/ OAS,-,2011,32.87,12.47,19.77
Americas,Caribbean,Dominican Republic,Cannabis,ARQ,-,2008,1.7,0.4,1
Americas,Caribbean,Grenada,Cannabis,Govt.,-,2005,29.1,10.4,18.1
Americas,Caribbean,Grenada,Cannabis,CICAD/ OAS,-,2013,19.74,6.99,12.92
Americas,Caribbean,Haiti,Cannabis,ARQ,-,2005,3,,1.7
Americas,Caribbean,Haiti,Cannabis,CICAD/ OAS,-,2014,3.2,1.21,2.36
Americas,Caribbean,Jamaica,Cannabis,OAS,-,2006,25.1,8.5,14.6
Americas,Caribbean,Jamaica,Cannabis,ARQ,-,2010,14.3,,
Americas,Caribbean,Jamaica,Cannabis,CICAD/ OAS,-,2013,21.11,6.29,11.93
Americas,Caribbean,Jamaica,Cannabis,2016 National Drug Prevalence Survey,-,2016,2.3,0.1,2.3
Americas,Caribbean,Jamaica,Cannabis,2016 National Drug Prevalence Survey,-,2016,9.8,6.3,7.9
Americas,Caribbean,Jamaica,Cannabis,2016 National Drug Prevalence Survey,-,2016,6.2,3.3,5.2
Americas,Caribbean,Puerto Rico,Cannabis,Govt.,Youth Risk Behavior Survey,2005,12.5,6.8,
Americas,Caribbean,Saint Kitts and Nevis,Cannabis,Govt.,-,2006,32.4,9.74,18.5
Americas,Caribbean,Saint Kitts and Nevis,Cannabis,CICAD/ OAS,-,2013,24.24,11.61,16.07
Americas,Caribbean,Saint Lucia,Cannabis,OAS (MEM),-,2005,25.5,8.8,15.9
Americas,Caribbean,Saint Lucia,Cannabis,CICAD/ OAS,-,2013,28.77,10.71,17.22
Americas,Caribbean,Saint Vincent and the Grenadines,Cannabis,OAS (MEM),-,2006,17.76,5.17,11.72
Americas,Caribbean,Saint Vincent and the Grenadines,Cannabis,CICAD/ OAS,-,2013,26.7,14.11,19.39
Americas,Caribbean,Trinidad and Tobago,Cannabis,OAS (MEM),-,2006,11.97,2.75,6.55
Americas,Caribbean,Trinidad and Tobago,Cannabis,CICAD/ OAS,-,2013,16.6,6.23,10.7
Americas,Caribbean,Turks and Caicos Islands,Cannabis,ARQ,-,2002,21.4,,14.5
Americas,Central America,Belize,Cannabis,OAS (MEM),-,2002,20.5,6.7,13.4
Americas,Central America,Belize,Cannabis,CICAD/ OAS,-,2013,24.27,10.64,15.84
Americas,Central America,Costa Rica,Cannabis,ARQ,Herb,2009,9.97,3.56,6.82
Americas,Central America,Costa Rica,Cannabis,ARQ,Herb,2012,16.83,5.65,11.74
Americas,Central America,Costa Rica,Cannabis,ARQ,Herb,2015,13.309,1.795,7.3
Americas,Central America,Costa Rica,Cannabis,ARQ,Herb,2018,9.38,3.01,5.12
Americas,Central America,El Salvador,Cannabis,ARQ,-,2008,5.5,1.8,3.5
Americas,Central America,El Salvador,Cannabis,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",-,2012,12.7,0.7,3.4
Americas,Central America,El Salvador,Cannabis,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Resin,2012,0.9,0,0.1
Americas,Central America,El Salvador,Cannabis,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Herb,2012,11.8,0.7,3.3
Americas,Central America,El Salvador,Cannabis,ARQ,-,2016,15.4,4,7.3
Americas,Central America,El Salvador,Cannabis,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",-,2018,15.9,3.6,6.6
Americas,Central America,El Salvador,Cannabis,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",Herb,2018,15.1,3.6,6.6
Americas,South America,Brazil,Cannabis,ARQ,-,2010,5.7,2,3.7
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,1994,,,5.6
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,1996,,,6.7
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,1998,,,7.6
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,2000,,,8.1
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,2002,,,6.2
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,2004,,,6.2
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,2006,,,7.4
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,2008,,,9.1
Americas,South America,Chile,Cannabis,ARQ,Herb,2009,25.9,8.15,16.2
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,2010,,,5.3
Americas,South America,Chile,Cannabis,ARQ,Herb,2011,26.9,12.35,20.5
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,2012,,,6.7
Americas,South America,Chile,Cannabis,ARQ,Herb,2013,38.96,19.98,32.87
Americas,South America,Chile,Cannabis,Government,Herb,2013,34.89,17.13,28.35
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,2014,,,13.5
Americas,South America,Chile,Cannabis,ARQ,Herb only,2015,43.83,20,34.79
Americas,South America,Chile,Cannabis,Chile XII study 2017,Herb,2016,,,12.6
Americas,South America,Chile,Cannabis,ARQ,Herb only,2017,42.73,18.21,33.22
Americas,South America,Colombia,Cannabis,CICAD/ OAS,-,2005,9.58,3.01,8.36
Americas,South America,Colombia,Cannabis,ARQ,Herb,2011,7,2.83,5.22
Americas,South America,Colombia,Cannabis,ARQ,Herb,2012,31.16,7.14,15.01
Americas,South America,Colombia,Cannabis,Government,-,2016,36.31,9.74,20.77
Americas,South America,Colombia,Cannabis,ARQ,Herb,2016,14.18,5.01,9.65
Americas,South America,Ecuador,Cannabis,ARQ,-,2008,6.4,2.2,4.2
Americas,South America,Ecuador,Cannabis,ARQ,-,2009,11.41,1.68,4.43
Americas,South America,Ecuador,Cannabis,ARQ,Herb,2012,6.7,1.3,2.9
Americas,South America,Ecuador,Cannabis,ARQ,Resin,2012,0.5,0.1,0.2
Americas,South America,Ecuador,Cannabis,ARQ,-,2012,7.19,1.37,3.1
Americas,South America,Ecuador,Cannabis,Government,Herb,2016,26.93,5.06,11.57
Americas,South America,Ecuador,Cannabis,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",-,2016,11.56,1.93,9.57
Americas,South America,Guyana,Cannabis,ARQ,-,2002,6.8,1.8,3.5
Americas,South America,Guyana,Cannabis,CICAD/ OAS,-,2013,6.6,2.2,3.8
Americas,South America,Paraguay,Cannabis,CICAD/ OAS,-,2005,4.2,1.6,3
Americas,South America,Paraguay,Cannabis,ARQ,"Herb, School in cities of at least 30000",2014,5.7,2.3,3.7
Americas,South America,Paraguay,Cannabis,ARQ,"Resin, School in cities of at least 30000",2014,1,0,0
Americas,South America,Peru,Cannabis,DEVIDA,-,2006,2,0.6,1.2
Americas,South America,Peru,Cannabis,ARQ,Herb,2006,2.366,0.837,1.642
Americas,South America,Peru,Cannabis,DEVIDA,-,2007,3.1,0.9,1.9
Americas,South America,Peru,Cannabis,ARQ,Herb,2010,3.3,2.4,2.9
Americas,South America,Peru,Cannabis,DEVIDA,Herb,2012,4.3,1.4,2.2
Americas,South America,Peru,Cannabis,Government,Herb,2012,5.02,1.55,2.53
Americas,South America,Peru,Cannabis,ARQ,Resin,2012,4.97,1.67,2.63
Americas,South America,Peru,Cannabis,Government,Herb,2016,14.77,1.55,5.17
Americas,South America,Peru,Cannabis,OAS / DEVIDA,Herb,2017,5.6,1.2,2.6
Americas,South America,Suriname,Cannabis,CICAD/ OAS,-,2006,7.71,2.73,4.8
Americas,South America,Suriname,Cannabis,Suriname National Household Drug Prevalence Survey,-,2013,0.3,0.3,0.3
Americas,South America,Uruguay,Cannabis,ARQ,Herb,2009,16.2,6.8,12.5
Americas,South America,Uruguay,Cannabis,ARQ,Herb,2011,16.4,7.5,12
Americas,South America,Uruguay,Cannabis,ARQ,Resin,2011,0.6,,
Americas,South America,Uruguay,Cannabis,ARQ,-,2014,20.1,9.5,17
Americas,South America,Uruguay,Cannabis,ARQ,Herb,2014,20.1,9.5,17
Americas,South America,Uruguay,Cannabis,ARQ,Resin,2014,0.8,0.2,0.6
Americas,South America,Uruguay,Cannabis,ARQ,Herb,2014,25.3,12.1,19.8
Americas,South America,Uruguay,Cannabis,ARQ,Resin,2014,1.4,0.3,1
Americas,South America,Uruguay,Cannabis,ARQ,Herb,2016,25.3,12.1,19.8
Americas,South America,Uruguay,Cannabis,ARQ,Resin,2016,1.4,0.3,1
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis,ARQ,Herb,2009,1.746839645,0.595073346,0.882812824
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis,ARQ,Herb,2011,3.16,1.09,1.84
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis,ARQ,Herb,2014,6.1,1.1,3.1
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis,ARQ,Herb,2016,3.44,1.19,2.05
Asia,Central Asia and Transcaucasia,Armenia,Cannabis,ESPAD,-,2007,3,,
Asia,Central Asia and Transcaucasia,Armenia,Cannabis,HBSC,-,2010,2.82,3.21,2.73
Asia,Central Asia and Transcaucasia,Georgia,Cannabis,Research,Select regions (capital);  Georgian Medical News No3 (180) 2010,2010,16.9,3.6,9.6
Asia,Central Asia and Transcaucasia,Georgia,Cannabis, ESPAD,-,2015,11,4,4
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis,ARQ,-,2007,4.6,,2.7
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis,ARQ,-,2012,11.2,3.6,6.5
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis,ARQ,-,2001,0.3,,
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis,ARQ,Herb,2018,0.01,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis,Govt.,-,2008,1.53,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis,ARQ,-,2011,,,0.02
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis,ARQ,Central Registry,2014,,,0.01
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis,ARQ,Central Registry,2015,,,0.01
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis,ARQ,Central Registry,2016,,,0.01
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis,ARQ,Central Registry,2018,,0.03,
Asia,East and South-East Asia,"China, Macao SAR",Cannabis,ARQ,-,2002,2.8,,
Asia,East and South-East Asia,"China, Macao SAR",Cannabis,ARQ,Central Registry,2018,,60,
Asia,East and South-East Asia,"China, Taiwan Province of China",Cannabis,Govt.,-,2006,0.1,,
Asia,East and South-East Asia,Indonesia,Cannabis,ARQ,Herb,2010,0.57,0.19,0.3
Asia,East and South-East Asia,Indonesia,Cannabis,ARQ,Resin,2011,1.3,0.1,1.3
Asia,East and South-East Asia,Indonesia,Cannabis,ARQ,Herb,2011,1.9,0.07,1.3
Asia,East and South-East Asia,Indonesia,Cannabis,ARQ,"Herb only, 20 provinces",2015,0.59,,0.21
Asia,East and South-East Asia,Indonesia,Cannabis,ARQ,"Herb only, 13 out of 34 Provinces",2018,,,9.6
Asia,East and South-East Asia,Japan,Cannabis,ARQ,-,2010,0.3,,
Asia,East and South-East Asia,Japan,Cannabis,ARQ,-,2011,0.2,,
Asia,East and South-East Asia,Japan,Cannabis,ARQ,-,2013,0.2,,
Asia,East and South-East Asia,Japan,Cannabis,ARQ,-,2014,0.2,,
Asia,East and South-East Asia,Japan,Cannabis,ARQ,-,2016,0.3,,
Asia,East and South-East Asia,Japan,Cannabis,ARQ,-,2018,0.3,,
Asia,East and South-East Asia,Malaysia,Cannabis,ARQ,Herb,2018,,,100
Asia,East and South-East Asia,Myanmar,Cannabis,ARQ,-,2004,0.9,,0.5
Asia,East and South-East Asia,Thailand,Cannabis,ARQ,Ages not specified,2003,4.4,,
Asia,Near and Middle East / South-West Asia,Israel,Cannabis,ARQ,-,2009,,,4.2
Asia,Near and Middle East / South-West Asia,Israel,Cannabis,ARQ,-,2009,7.08,4.44,5.66
Asia,Near and Middle East / South-West Asia,Israel,Cannabis,ARQ,Resin,2009,5.73,3.63,4.66
Asia,Near and Middle East / South-West Asia,Israel,Cannabis,ARQ,Herb,2009,5.16,3.51,4.15
Asia,Near and Middle East / South-West Asia,Israel,Cannabis,ARQ,-,2010,6.6,3.9,6.4
Asia,Near and Middle East / South-West Asia,Israel,Cannabis,ARQ,Schools -except private schools,2014,8.5,5.5,6
Asia,Near and Middle East / South-West Asia,Jordan,Cannabis,ARQ,-,2001,,,2.5
Asia,Near and Middle East / South-West Asia,Lebanon,Cannabis,MedSPAD,Cannabis Resin,2009,6.1,,
Asia,Near and Middle East / South-West Asia,Oman,Cannabis,,Resin,2017,,,17
Asia,Near and Middle East / South-West Asia,Oman,Cannabis,,Herb,2017,,,12
Asia,Near and Middle East / South-West Asia,Pakistan,Cannabis,ARQ,-,2013,3.6,,
Asia,South Asia,Bangladesh,Cannabis,ARQ,-,2001,5,,3
Asia,South Asia,Bhutan,Cannabis,ARQ,"Herb, General population survey",2010,,,0.093
Asia,South Asia,India,Cannabis,ARQ,-,2001,,3,
Asia,South Asia,India,Cannabis,ARQ,-,2018,,,0.92
Europe,Eastern Europe,Belarus,Cannabis,ARQ,-,2010,5.3,0.6,2.4
Europe,Eastern Europe,Republic of Moldova,Cannabis,ESPAD,-,2008,4.8,1.3,2.8
Europe,Eastern Europe,Republic of Moldova,Cannabis,Govt.,-,2010,4.9,1.1,2.3
Europe,Eastern Europe,Republic of Moldova,Cannabis,ARQ,-,2012,3.5,0.3,1.2
Europe,Eastern Europe,Republic of Moldova,Cannabis,ESPAD,-,2015,4,2,
Europe,Eastern Europe,Russian Federation,Cannabis,ARQ/ ESPAD,-,2007,18.6,,17
Europe,Eastern Europe,Russian Federation,Cannabis,HBSC,-,2010,7.11,4.76,5.21
Europe,Eastern Europe,Russian Federation,Cannabis,ARQ,-,2011,14.8,4,9.5
Europe,Eastern Europe,Russian Federation,Cannabis,ARQ,-,2013,0.001,,
Europe,Eastern Europe,Ukraine,Cannabis,ESPAD,-,2007,14,,
Europe,Eastern Europe,Ukraine,Cannabis,ARQ,Registered users,2010,9,2,3
Europe,Eastern Europe,Ukraine,Cannabis,ARQ,Registered users,2011,12.4,3,7.3
Europe,Eastern Europe,Ukraine,Cannabis,ARQ,Registered users,2013,,,0.15
Europe,Eastern Europe,Ukraine,Cannabis,ARQ,Registered users,2014,,,2.1
Europe,Eastern Europe,Ukraine,Cannabis,ESPAD,-,2015,9,2,
Europe,South-Eastern Europe,Albania,Cannabis,ARQ,-,2004,5.5,,
Europe,South-Eastern Europe,Albania,Cannabis,ARQ / ESPAD,Herb,2015,6.6,3.5,5
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis,ARQ,-,2008,,,10
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis,ARQ,-,2011,4.5,1.4,3.3
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis,ARQ,Resin,2011,,1,
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis,ARQ,-,2012,1,,
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis,ARQ,Herb,2012,0.8,,
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis,ARQ,Resin,2012,0.2,,
Europe,South-Eastern Europe,Bulgaria,Cannabis,ARQ,-,2008,26,9.4,17
Europe,South-Eastern Europe,Bulgaria,Cannabis,ARQ,Resin,2008,11.4,3.7,6.8
Europe,South-Eastern Europe,Bulgaria,Cannabis,ARQ,Herb,2008,24.5,8.7,15.7
Europe,South-Eastern Europe,Bulgaria,Cannabis,ESPAD,-,2011,25.6,11.3,20.5
Europe,South-Eastern Europe,Bulgaria,Cannabis,ARQ,-,2013,26.2,11.1,19.6
Europe,South-Eastern Europe,Bulgaria,Cannabis,ARQ,Herb,2013,25.5,10.8,19
Europe,South-Eastern Europe,Bulgaria,Cannabis,ARQ,Resin,2013,8.1,3.3,6
Europe,South-Eastern Europe,Bulgaria,Cannabis,ARQ \ ESPAD,-,2015,26.9,12.2,21.4
Europe,South-Eastern Europe,Croatia,Cannabis,ARQ,-,2007,18.3,,13.4
Europe,South-Eastern Europe,Croatia,Cannabis,ARQ,Herb,2010,13.4,5.5,10.2
Europe,South-Eastern Europe,Croatia,Cannabis,ESPAD,-,2015,21,8,
Europe,South-Eastern Europe,Montenegro,Cannabis,ESPAD,-,2011,5.5,2.8,3.9
Europe,South-Eastern Europe,Montenegro,Cannabis,ESPAD,-,2008,4,1.6,2.4
Europe,South-Eastern Europe,Montenegro,Cannabis,ARQ,-,2015,8,3,6
Europe,South-Eastern Europe,North Macedonia,Cannabis,ESPAD,-,2008,5.5,2.2,4.3
Europe,South-Eastern Europe,North Macedonia,Cannabis,HBSC,-,2010,2.75,1.77,2.31
Europe,South-Eastern Europe,North Macedonia,Cannabis,ESPAD,-,2015,5,2,
Europe,South-Eastern Europe,North Macedonia,Cannabis,ARQ,-,2015,5,2.2,3.9
Europe,South-Eastern Europe,North Macedonia,Cannabis,ARQ,Herb,2015,,,3.5
Europe,South-Eastern Europe,Romania,Cannabis,ESPAD,-,2007,3.5,,1.9
Europe,South-Eastern Europe,Romania,Cannabis,ARQ,-,2011,7.1,2.2,5.5
Europe,South-Eastern Europe,Romania,Cannabis,ARQ,-,2015,8.1,2.9,6.1
Europe,South-Eastern Europe,Serbia,Cannabis,ARQ,-,2008,6.7,,4.9
Europe,South-Eastern Europe,Serbia,Cannabis,ESPAD,-,2011,6.7,2.6,5
Europe,South-Eastern Europe,Turkey,Cannabis,ARQ,-,2003,4.3,,3.31
Europe,Western and Central Europe,Andorra,Cannabis,ARQ,-,2008,,8.4,
Europe,Western and Central Europe,Andorra,Cannabis,ARQ,-,2014,28.1,9.9,13.2
Europe,Western and Central Europe,Austria,Cannabis,ESPAD,-,2007,18,6.7,
Europe,Western and Central Europe,Austria,Cannabis,ARQ,-,2007,19,7,15
Europe,Western and Central Europe,Austria,Cannabis,ARQ / ESPAD,-,2015,19.9,9,16
Europe,Western and Central Europe,Belgium,Cannabis,ARQ,-,2010,24.04,9.22,15.36
Europe,Western and Central Europe,Belgium,Cannabis,ARQ,-,2011,21.5,12,15
Europe,Western and Central Europe,Belgium,Cannabis,ARQ,-,2012,20.9,11.2,13.6
Europe,Western and Central Europe,Belgium,Cannabis,ARQ,Flemish part,2012,21.2,11,13.7
Europe,Western and Central Europe,Belgium,Cannabis,ARQ,Flemish part,2013,17.5,6.3,13.7
Europe,Western and Central Europe,Belgium,Cannabis,ARQ,Flemish part,2014,15.3,4.6,11.3
Europe,Western and Central Europe,Belgium,Cannabis,ESPAD,Flemish part,2014,16,8,11
Europe,Western and Central Europe,Belgium,Cannabis,ESPAD,Flemish part,2015,17,8,
Europe,Western and Central Europe,Belgium,Cannabis,ARQ / ESPAD,Flemish part,2016,17.9,6.3,13.5
Europe,Western and Central Europe,Belgium,Cannabis,ARQ / ESPAD,Flemish part,2016,14.6,5.2,10.8
Europe,Western and Central Europe,Belgium,Cannabis,ARQ,Other types of cannabis,2017,17.9,6.3,13.5
Europe,Western and Central Europe,Cyprus,Cannabis,ESPAD,-,2007,5,,
Europe,Western and Central Europe,Cyprus,Cannabis,ARQ,-,2007,5,3,4
Europe,Western and Central Europe,Cyprus,Cannabis,ESPAD,-,2011,7,5,7
Europe,Western and Central Europe,Cyprus,Cannabis,ARQ,-,2012,10.9,2,4.3
Europe,Western and Central Europe,Cyprus,Cannabis,ESPAD,-,2015,7,5,
Europe,Western and Central Europe,Cyprus,Cannabis,ESPAD,-,2016,17.2,2.2,2.2
Europe,Western and Central Europe,Czechia,Cannabis,ARQ./ ESPAD,-,2007,45.1,,35.4
Europe,Western and Central Europe,Czechia,Cannabis,ARQ,-,2007,45.1,18.1,34.8
Europe,Western and Central Europe,Czechia,Cannabis,ARQ,-,2011,42.3,14.6,29.7
Europe,Western and Central Europe,Czechia,Cannabis,ARQ,Male,2014,24,8,
Europe,Western and Central Europe,Czechia,Cannabis,ARQ,Female,2014,24,10,
Europe,Western and Central Europe,Czechia,Cannabis,ARQ / ESPAD,-,2015,36.8,12.8,27
Europe,Western and Central Europe,Czechia,Cannabis,ARQ / ESPAD,-,2016,32,10.2,23.9
Europe,Western and Central Europe,Denmark,Cannabis,ARQ,-,2007,25.5,,
Europe,Western and Central Europe,Denmark,Cannabis,ARQ / ESPAD,-,2011,18.1,6.2,
Europe,Western and Central Europe,Denmark,Cannabis,ARQ / ESPAD,-,2015,12.4,4.9,
Europe,Western and Central Europe,Estonia,Cannabis,ARQ,-,2007,26.2,6.2,19.2
Europe,Western and Central Europe,Estonia,Cannabis,HBSC,-,2010,14.3,2.66,8.7
Europe,Western and Central Europe,Estonia,Cannabis,ARQ,-,2011,24.2,,
Europe,Western and Central Europe,Estonia,Cannabis,ESPAD,-,2015,25,8,
Europe,Western and Central Europe,Estonia,Cannabis,ARQ,-,2013,15,,
Europe,Western and Central Europe,Estonia,Cannabis,ARQ / ESPAD,-,2015,25,,
Europe,Western and Central Europe,Faroe Islands,Cannabis,ESPAD,-,2007,6,,
Europe,Western and Central Europe,Faroe Islands,Cannabis,ESPAD,-,2015,6,1,
Europe,Western and Central Europe,Finland,Cannabis,ARQ,-,2007,8,2,6
Europe,Western and Central Europe,Finland,Cannabis,ARQ,-,2011,11,3,9
Europe,Western and Central Europe,Finland,Cannabis,ARQ,-,2013,0.708333333,,
Europe,Western and Central Europe,Finland,Cannabis,ARQ,Herb,2013,8,,
Europe,Western and Central Europe,Finland,Cannabis,ARQ,Resin,2013,5.5,,
Europe,Western and Central Europe,Finland,Cannabis,ARQ (ESPAD),-,2015,8,2,7
Europe,Western and Central Europe,France,Cannabis,ESPAD,-,2007,31,,
Europe,Western and Central Europe,France,Cannabis,ARQ,-,2011,41.5,6.5,34.6
Europe,Western and Central Europe,France,Cannabis,ARQ,Urban areas (excluding overseas departments),2014,47.8,25.5,38.2
Europe,Western and Central Europe,France,Cannabis,ESPAD,-,2015,31,17,
Europe,Western and Central Europe,France,Cannabis,ARQ,-,2017,39.1,21,31.3
Europe,Western and Central Europe,Germany,Cannabis,ARQ,Select regions,2007,25.2,,17.2
Europe,Western and Central Europe,Germany,Cannabis,Die Drogenaffinität Jugendlicher in der Bundesrepublik Deutschland 2008.,-,2008,28.3,3.7,9.6
Europe,Western and Central Europe,Germany,Cannabis,ARQ/ESPAD,Select regions,2011,22.2,,
Europe,Western and Central Europe,Germany,Cannabis,ARQ,-,2011,6.7,1.9,4.6
Europe,Western and Central Europe,Germany,Cannabis,ARQ / DAS Data,-,2015,8.7,3.4,6.9
Europe,Western and Central Europe,Gibraltar,Cannabis,ARQ,-,2008,,,13.2
Europe,Western and Central Europe,Gibraltar,Cannabis,ARQ,-,2019,,2.36,3.54
Europe,Western and Central Europe,Greece,Cannabis,ARQ,-,2010,7.2,4.1,6.3
Europe,Western and Central Europe,Greece,Cannabis,ARQ,-,2011,8.4,4,6.9
Europe,Western and Central Europe,Greece,Cannabis,ESPAD,-,2015,9.08,4.15,7.44
Europe,Western and Central Europe,Greece,Cannabis,ARQ,Other types of cannabis,2015,2.51,,
Europe,Western and Central Europe,Hungary,Cannabis,ESPAD,-,2007,5.3,,
Europe,Western and Central Europe,Hungary,Cannabis,ESPAD,-,2015,18.6,5.7,12.5
Europe,Western and Central Europe,Iceland,Cannabis,ESPAD,-,2007,9,,
Europe,Western and Central Europe,Iceland,Cannabis,HBSC,-,2010,8.75,3.64,6.9
Europe,Western and Central Europe,Iceland,Cannabis,ARQ,-,2011,4,4,
Europe,Western and Central Europe,Iceland,Cannabis,ESPAD,-,2015,7,2,
Europe,Western and Central Europe,Iceland,Cannabis,ARQ,Resin,2017,1.3,,
Europe,Western and Central Europe,Iceland,Cannabis,ARQ,Herb,2017,3.4,,
Europe,Western and Central Europe,Ireland,Cannabis,ESPAD,-,2007,20,,
Europe,Western and Central Europe,Ireland,Cannabis,ARQ,-,2011,18,7,14
Europe,Western and Central Europe,Ireland,Cannabis,ARQ,-,2014,,8.17,13.5
Europe,Western and Central Europe,Ireland,Cannabis,ARQ / ESPAD,-,2015,19,9.8,16.8
Europe,Western and Central Europe,Italy,Cannabis,ARQ,-,2010,12.3,7.2,10.8
Europe,Western and Central Europe,Italy,Cannabis,ARQ,-,2012,12.55,7.66,11.1
Europe,Western and Central Europe,Italy,Cannabis,ARQ,-,2013,14.41,9.39,13.2
Europe,Western and Central Europe,Italy,Cannabis,ARQ,Male,2014,29,16.1,24.5
Europe,Western and Central Europe,Italy,Cannabis,ARQ,Female,2014,21,10.3,17.2
Europe,Western and Central Europe,Italy,Cannabis,ARQ,-,2015,33.1,16.6,26.5
Europe,Western and Central Europe,Italy,Cannabis,ARQ,-,2016,32.42,16.15,25.79
Europe,Western and Central Europe,Italy,Cannabis,ARQ,-,2018,33.18,15.29,25.54
Europe,Western and Central Europe,Italy,Cannabis,ARQ,Spice,2018,8.55,2.04,5.34
Europe,Western and Central Europe,Latvia,Cannabis,ARQ,Riga City,2010,22.7,7.9,15.8
Europe,Western and Central Europe,Latvia,Cannabis,ESPAD,-,2011,24.5,6.3,16.4
Europe,Western and Central Europe,Latvia,Cannabis,ARQ,-,2013,21.34,5.77,14.24
Europe,Western and Central Europe,Latvia,Cannabis,ARQ,-,2015,16.6,4.2,10.8
Europe,Western and Central Europe,Liechtenstein,Cannabis,ARQ,-,2005,16.2,,11.2
Europe,Western and Central Europe,Liechtenstein,Cannabis,ARQ,-,2005,24.4,,16.2
Europe,Western and Central Europe,Liechtenstein,Cannabis,ARQ,-,2011,21,8,16
Europe,Western and Central Europe,Liechtenstein,Cannabis,ARQ,-,2015,30.8,11.6,26.2
Europe,Western and Central Europe,Lithuania,Cannabis,ESPAD,-,2007,18.2,4.7,11.7
Europe,Western and Central Europe,Lithuania,Cannabis,ARQ,-,2011,19.6,4.8,12.5
Europe,Western and Central Europe,Lithuania,Cannabis,ARQ,Herb,2015,18.7,4.3,11.3
Europe,Western and Central Europe,Lithuania,Cannabis,ARQ,Resin,2015,4,,
Europe,Western and Central Europe,Luxembourg,Cannabis,ARQ,-,1999,27.4,,22.4
Europe,Western and Central Europe,Luxembourg,Cannabis,National Drug Report 2017,-,1999,24.3,,20.6
Europe,Western and Central Europe,Luxembourg,Cannabis,National Drug Report 2017,-,1999,27.7,,
Europe,Western and Central Europe,Luxembourg,Cannabis,National Drug Report 2017,-,1999,10.5,,
Europe,Western and Central Europe,Luxembourg,Cannabis,National Drug Report 2017,-,2006,19.15,7.27,13.81
Europe,Western and Central Europe,Luxembourg,Cannabis,ARQ,-,2010,15.5,6.3,12.1
Europe,Western and Central Europe,Luxembourg,Cannabis,HBSC,-,2010,8.49,4.19,6.75
Europe,Western and Central Europe,Luxembourg,Cannabis,National Drug Report 2017,-,2010,20.5,,
Europe,Western and Central Europe,Luxembourg,Cannabis,National Drug Report 2017,-,2010,5.6,,
Europe,Western and Central Europe,Luxembourg,Cannabis,National Drug Report 2017,-,2015,16.4,4.7,11.1
Europe,Western and Central Europe,Malta,Cannabis,ARQ,-,2007,12.9,5.3,10.6
Europe,Western and Central Europe,Malta,Cannabis,ESPAD,-,2011,9.8,4,8
Europe,Western and Central Europe,Malta,Cannabis,ARQ / ESPAD,-,2015,12.6,5.4,10.4
Europe,Western and Central Europe,Monaco,Cannabis,ESPAD,-,2007,28,,
Europe,Western and Central Europe,Monaco,Cannabis,ESPAD,-,2015,31,12,
Europe,Western and Central Europe,Netherlands,Cannabis,ESPAD,-,2007,28,,15
Europe,Western and Central Europe,Netherlands,Cannabis,ARQ,-,2007,11.8,5.3,9.3
Europe,Western and Central Europe,Netherlands,Cannabis,ARQ,-,2010,17.4,7.7,
Europe,Western and Central Europe,Netherlands,Cannabis,ARQ,-,2014,9.2,4.6,7.9
Europe,Western and Central Europe,Netherlands,Cannabis,ESPAD,-,2015,22,12,
Europe,Western and Central Europe,Netherlands,Cannabis,ARQ / ESPAD,-,2015,9.7,4.9,8.2
Europe,Western and Central Europe,Norway,Cannabis,ESPAD,-,2007,6,,6
Europe,Western and Central Europe,Norway,Cannabis,ESPAD,-,2011,5,2,4
Europe,Western and Central Europe,Norway,Cannabis,ESPAD,-,2015,7,2,5
Europe,Western and Central Europe,Poland,Cannabis,ARQ,-,2010,36,8,18
Europe,Western and Central Europe,Poland,Cannabis,ARQ,-,2012,24.3,10.5,20.1
Europe,Western and Central Europe,Poland,Cannabis,ARQ,-,2013,40.2,9,23.4
Europe,Western and Central Europe,Poland,Cannabis,ESPAD,-,2015,24,9,
Europe,Western and Central Europe,Poland,Cannabis,ARQ,-,2016,42,9.9,21
Europe,Western and Central Europe,Poland,Cannabis,ARQ,-,2018,37.5,9.3,20.2
Europe,Western and Central Europe,Portugal,Cannabis,ESPAD,-,2007,13,6,10
Europe,Western and Central Europe,Portugal,Cannabis,ESPAD,-,2011,16,9,16
Europe,Western and Central Europe,Portugal,Cannabis,ARQ,-,2015,15,8,13
Europe,Western and Central Europe,Slovakia,Cannabis,ARQ,-,2010,18.8,6.1,14.3
Europe,Western and Central Europe,Slovakia,Cannabis,ARQ,-,2015,38.5,11.9,25.7
Europe,Western and Central Europe,Slovakia,Cannabis,ARQ,-,2018,18.3,,
Europe,Western and Central Europe,Slovenia,Cannabis,ESPAD,-,2007,24,,17.6
Europe,Western and Central Europe,Slovenia,Cannabis,ARQ,-,2007,22,9.5,17.6
Europe,Western and Central Europe,Slovenia,Cannabis,ARQ,-,2011,23,10,19
Europe,Western and Central Europe,Slovenia,Cannabis,ESPAD,-,2015,25,12,
Europe,Western and Central Europe,Spain,Cannabis,ARQ,-,2010,33,17.2,26.4
Europe,Western and Central Europe,Spain,Cannabis,ARQ,-,2012,33.6,16.1,26.6
Europe,Western and Central Europe,Spain,Cannabis,ARQ,-,2014,29.1,18.6,25.4
Europe,Western and Central Europe,Spain,Cannabis, ARQ,-,2016,31.1,18.3,26.3
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,-,2009,7,,5
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,Male,2014,7.4,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,Female,2014,5.9,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,"Herb, male",2014,6.7,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,"Herb, female",2014,4.8,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,"Resin, male",2014,4.7,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,"Resin, female",2014,3.7,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,Male,2015,7.1,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,Female,2015,4,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,"Herb, male",2015,6.6,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,"Herb, female",2015,3.5,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,"Resin, male",2015,4.5,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,"Resin, female",2015,2.7,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,-,2016,4.7,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,-,2018,6.45,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,Herb,2018,4.9,,
Europe,Western and Central Europe,Sweden,Cannabis,ARQ,Resin,2018,5.01,,
Europe,Western and Central Europe,Spain,Cannabis,HBSC,-,2010,25.79,12.19,21.07
Europe,Western and Central Europe,Switzerland,Cannabis,ARQ,Male,2014,30,14.2,
Europe,Western and Central Europe,Switzerland,Cannabis,ARQ,Female,2014,19.2,10.2,
Europe,Western and Central Europe,Switzerland,Cannabis,"Addiction Monitoring in Switzerland, July 2017",-,2016,29.5,9.4,20.8
Europe,Western and Central Europe,Switzerland,Cannabis,ESPAD,-,2007,33,,
Europe,Western and Central Europe,United Kingdom (England),Cannabis,ARQ,-,2010,24.3,11.3,21.2
Europe,Western and Central Europe,United Kingdom (England),Cannabis,ARQ,-,2011,21.1,10.1,18.8
Europe,Western and Central Europe,United Kingdom (England),Cannabis,ARQ,-,2012,22.5,10.2,18.6
Europe,Western and Central Europe,United Kingdom (England),Cannabis,ARQ,-,2013,21.9,10.7,18.7
Europe,Western and Central Europe,United Kingdom (England),Cannabis,ARQ,-,2014,18.7,9.7,15.8
Europe,Western and Central Europe,United Kingdom (England),Cannabis,Government,-,2016,22.1,10.5,18.5
Europe,Western and Central Europe,United Kingdom (Scotland),Cannabis,Government,-,2013,17,9,15
Europe,Western and Central Europe,United Kingdom (Scotland),Cannabis,Government,-,2015,16.5,9.5,14.7
Europe,Western and Central Europe,United Kingdom (Wales),Cannabis,HBSC,-,2010,21.58,10.06,18.77
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 1996,-,1996,39.1,16.1,25.83876189
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 1998,-,1998,45.4,18,28.19272545
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government  2000,-,2000,46.2,17.4,27.01243032
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government  2001/2002,-,2001,44.5,17.6,27.33382692
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government  2002/2003,-,2002,43.6,16.6,26.21215292
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government  2003/2004,-,2003,42.2,15.8,25.31991101
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2004/2005,-,2004,41.1,14.1,23.63990235
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2005/2006,-,2005,40.1,13,21.44768672
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2006/2007,-,2006,39.7,11.93782796,20.94721757
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2007/2008,-,2007,36.9,9.72622577,17.94381662
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government  2008/2009,-,2008,36.8,10.26669963,18.58597834
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2009/2010,-,2009,34.5,9.13744269,16.03968529
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government  2010/2011,-,2010,34.3,8.98763353,17.09804375
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government  2011/2012,-,2011,32.3,9.3,15.66707749
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government  2012/2013,-,2012,30.8,,13.5295034
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2013/2014,-,2013,30.8,,15.07469024
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2014/2015,-,2014,30.9,8.45280553,16.35273651
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2015/2016,-,2015,30.2,7.71160564,15.7
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2016/2017,-,2016,31.3,7.5,16.44152103
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2017/2018,-,2017,30.8,7.3,16.7
Europe,Western and Central Europe,United Kingdom (England and Wales),Cannabis,Government 2018/2019,-,2018,30.3,9.5,17.3
Oceania,Australia and New Zealand,Australia,Cannabis,ARQ,-,2007,9.3,,6.8
Oceania,Australia and New Zealand,Australia,Cannabis,ARQ,-,2010,21.5,7.8,15.7
Oceania,Australia and New Zealand,Australia,Cannabis,ARQ,-,2013,18,7.6,14.8
Oceania,Australia and New Zealand,Australia,Cannabis,ARQ,-,2013,18,7.6,
Oceania,Australia and New Zealand,Australia,Cannabis,ARQ,-,2016,16.6,,12.2
Oceania,Australia and New Zealand,Australia,Cannabis,ARQ,Other types of cannabis,2016,1.4,,0.5
Oceania,Australia and New Zealand,Australia,Cannabis,ARQ,-,2017,17,8,15
Oceania,Australia and New Zealand,Australia,Cannabis,ARQ,Other types of cannabis,2017,2,,
Oceania,Australia and New Zealand,New Zealand,Cannabis,New Zealand Health Survey,-,2011,,,14.9
Oceania,Australia and New Zealand,New Zealand,Cannabis,New Zealand Health Survey,-,2012,,,19.2
Oceania,Australia and New Zealand,New Zealand,Cannabis,New Zealand Health Survey,-,2013,,,21.4
Oceania,Australia and New Zealand,New Zealand,Cannabis,New Zealand Health Survey,-,2014,,,21.2
Oceania,Australia and New Zealand,New Zealand,Cannabis,New Zealand Health Survey,-,2015,,,24.6
Oceania,Australia and New Zealand,New Zealand,Cannabis,New Zealand Health Survey,-,2016,,,22.2
Oceania,Australia and New Zealand,New Zealand,Cannabis,New Zealand Health Survey,-,2017,,,24.2
Oceania,Australia and New Zealand,New Zealand,Cannabis,Govt,Household survey,2013,,,23.7
Oceania,Australia and New Zealand,New Zealand,Cannabis,Govt.,Household survey,2008,37.3,,24.8
Oceania,Australia and New Zealand,New Zealand,Cannabis,ARQ,Herb,2007,27,,
Oceania,Melanesia,Fiji,Cannabis,Govt.,-,2004,13,,
Oceania,Melanesia,Vanuatu,Cannabis,UNICEF,-,2000,5.6,,
Oceania,Micronesia,Guam,Cannabis,Govt.,Youth Risk Behavior Survey,2007,45.5,23.3,
Oceania,Micronesia,Marshall Islands,Cannabis,Govt.,Youth Risk Behavior Survey,2007,13.9,8.5,
Oceania,Micronesia,Micronesia (Federated States of),Cannabis,UNICEF,-,2001,1.4,,
Oceania,Micronesia,Northern Mariana Islands,Cannabis,Govt.,Youth Risk Behavior Survey,2007,54.9,31.9,
Oceania,Micronesia,Palau,Cannabis,Govt.,Youth Risk Behavior Survey,2007,59.8,38.5,
Oceania,Micronesia,Palau,Cannabis,Youth Risk Behavior Survey,-,2011,64.2,,
Oceania,Polynesia,American Samoa,Cannabis,Govt.,Youth Risk Behavior Survey,2007,17.6,10.2,
Oceania,Polynesia,Tonga,Cannabis,UNICEF,-,2001,31.8,,
Africa,East Africa,Kenya,Opioids,ARQ,-,2017,0.5,,
Africa,East Africa,Kenya,Opioids,ARQ,Heroin,2016,1.2,0.2,
Africa,East Africa,Mauritius,Opioids,ARQ,-,2004,1.2,,
Africa,North Africa,Algeria,Opioids,ARQ,Heroin,2016,0.45,0.34,0.38
Africa,North Africa,Egypt,Opioids,ARQ,Pharmaceutical opioids,2013,,,3
Africa,North Africa,Egypt,Opioids,ARQ,-,2013,,,2
Africa,North Africa,Egypt,Opioids,MedSPAD,Tramadol,2016,1.64,0.74,1.38
Africa,North Africa,Egypt,Opioids,MedSPAD,Heroin,2016,1.06,0.44,0.74
Africa,North Africa,Egypt,Opioids,MedSPAD,Opium/Morphine,2016,1.78,0.71,1.37
Africa,North Africa,Morocco,Opioids,ARQ,-,2013,1,,
Africa,North Africa,Morocco,Opioids,MedSPAD,Heroin,2017,0.8,0.2,0.7
Africa,North Africa,Tunisia,Opioids,MedSPAD Survey 2016/2017,Subutex,2016,0.2,0.1,0.1
Africa,Southern Africa,South Africa,Opioids,ARQ,Heroin,2008,6.2,,
Africa,Southern Africa,South Africa,Opioids,ARQ,"Heroin, Western Cape Town only",2011,0.8,,
Africa,Southern Africa,South Africa,Opioids,ARQ,Heroin,2011,5.3,,
Africa,West and Central Africa,Central African Republic,Opioids,ARQ,Heroin,2017,5,,
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Government,Heroin,2017,1.7,0.4,0.6
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Government,Opium,2017,1.1,0.2,0.4
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Government,Morphine,2017,1.8,0.4,0.7
Africa,West and Central Africa,Nigeria,Opioids,UNODC Report,Pharmaceutical opioids,2017,,,2.4
Africa,West and Central Africa,Nigeria,Opioids,UNODC Report,Heroin,2017,,,0.1
Americas,Caribbean,Antigua and Barbuda,Opioids,OAS (MEM),-,2005,0.9,,
Americas,Caribbean,Bahamas,Opioids,Govt.,-,2008,0.3,,
Americas,Caribbean,Barbados,Opioids,ARQ,-,2002,1.3,,0.7
Americas,Caribbean,Barbados,Opioids,OAS (MEM),-,2006,1,,
Americas,Caribbean,Dominica,Opioids,OAS (MEM),-,2006,0.3,,
Americas,Caribbean,Dominican Republic,Opioids,ARQ,-,2008,0.2,,
Americas,Caribbean,Grenada,Opioids,Govt.,-,2005,0.7,0.2,0.4
Americas,Caribbean,Haiti,Opioids,ARQ,-,2005,3,,1.9
Americas,Caribbean,Jamaica,Opioids,OAS,-,2006,1.7,,
Americas,Caribbean,Puerto Rico,Opioids,Govt.,Youth Risk Behavior Survey,2005,1.6,,
Americas,Caribbean,Saint Vincent and the Grenadines,Opioids,OAS (MEM),-,2006,0.2,,
Americas,Caribbean,Trinidad and Tobago,Opioids,ARQ,-,2002,0.6,,0.3
Americas,Central America,Belize,Opioids,OAS (MEM),-,2002,1.2,0.3,0.6
Americas,Central America,Costa Rica,Opioids,ARQ,Heroin,2012,0.28,0.08,0.12
Americas,Central America,Costa Rica,Opioids,ARQ,-,2012,0.28,0.08,0.12
Americas,Central America,Costa Rica,Opioids,ARQ,Heroin,2015,0.37,0.17,0.17
Americas,Central America,Costa Rica,Opioids,ARQ,-,2015,0.2,,0.2
Americas,Central America,Costa Rica,Opioids,ARQ,Pharmaceutical opioids,2015,0.93,0.54,0.93
Americas,Central America,Costa Rica,Opioids,Government provided CICAD university population data for 2018.,Heroin,2018,0.2,0.1,0.1
Americas,Central America,Costa Rica,Opioids,ARQ,Heroin,2018,0.65,0.3,0.43
Americas,Central America,Costa Rica,Opioids,ARQ,Pharmaceutical opioids,2018,8.61,6.28,7.81
Americas,Central America,El Salvador,Opioids,ARQ,-,2008,0.51,,
Americas,Central America,El Salvador,Opioids,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",-,2012,0.7,0,0.4
Americas,Central America,El Salvador,Opioids,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Morphine,2012,0.1,,
Americas,Central America,El Salvador,Opioids,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Opium,2012,0.6,0,0.4
Americas,Central America,El Salvador,Opioids,ARQ,-,2016,0.8,,
Americas,Central America,El Salvador,Opioids,ARQ,Heroin,2016,0.8,,
Americas,Central America,El Salvador,Opioids,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",Heroin,2018,1,,
Americas,Central America,Guatemala,Opioids,ARQ,-,2004,0.28,,0.08
Americas,Central America,Guatemala,Opioids,ARQ,Heroin,2014,0.8,,
Americas,Central America,Honduras,Opioids,ARQ,-,2005,,,0.18
Americas,Central America,Panama,Opioids,ARQ,Heroin,2013,0.04,,
Americas,North America,Canada,Opioids,ARQ,Heroin,2008,2.3,,1.4
Americas,North America,Canada,Opioids,ARQ,Heroin,2010,1.6,,0.9
Americas,North America,Canada,Opioids,ARQ,-,2010,6.9,,4.4
Americas,North America,Canada,Opioids,ARQ,Prescription opioids,2010,6.2,,4.1
Americas,North America,Canada,Opioids,ARQ,Heroin,2012,1.23,,
Americas,North America,Canada,Opioids,ARQ,Pharmaceutical opioids,2012,4.66,,2.65
Americas,North America,Canada,Opioids,ARQ,-,2012,5.03,,2.9
Americas,North America,Canada,Opioids,ARQ,-,2014,3.77,,3.08
Americas,North America,Canada,Opioids,ARQ,Heroin,2014,0.98,,0.57
Americas,North America,Canada,Opioids,ARQ,Pharmaceutical opioids,2014,3.31,,2.87
Americas,North America,Canada,Opioids,ARQ,Heroin,2016,0.85,,0.4
Americas,North America,Canada,Opioids,ARQ,Pharmaceutical opioids,2016,4.61,,3.67
Americas,North America,Canada,Opioids,ARQ,-,2016,5.03,,3.82
Americas,North America,Mexico,Opioids,National Addiction Household Survey,-,2011,0.1,0,0.04
Americas,North America,Mexico,Opioids,National Addiction Household Survey,-,2008,0.1,,
Americas,North America,Mexico,Opioids,ARQ,-,2011,0.1,,0.001
Americas,North America,Mexico,Opioids,ARQ,Opium,2011,0.1,,0.001
Americas,North America,Mexico,Opioids,ARQ,Heroin,2011,0.001,,0.001
Americas,North America,Mexico,Opioids,ARQ,Heroin,2014,0.9,0.3,0.5
Americas,North America,Mexico,Opioids,ARQ,Opium,2016,0.03,,
Americas,North America,Mexico,Opioids,ARQ,Pharmaceutical opioids,2016,0.1,0.01,0.03
Americas,North America,United States of America,Opioids,Govt.,-,2010,1.3,0.4,0.8
Americas,North America,United States of America,Opioids,ARQ,Heroin,2011,1.2,0.4,0.8
Americas,North America,United States of America,Opioids,ARQ,Heroin,2012,1.1,0.4,0.6
Americas,North America,United States of America,Opioids,ARQ,Heroin with needle,2012,0.7,0.2,0.4
Americas,North America,United States of America,Opioids,ARQ,Heroin,2013,1,0.3,0.6
Americas,North America,United States of America,Opioids,ARQ,Heroin,2014,0.9,0.4,0.5
Americas,North America,United States of America,Opioids,ARQ,Heroin. Monitoring the future,2015,0.7,0.2,0.5
Americas,North America,United States of America,Opioids,ARQ,Heroin,2016,0.6,0.2,0.3
Americas,North America,United States of America,Opioids,ARQ,Heroin,2017,0.4,,
Americas,North America,United States of America,Opioids,ARQ,Opium,2017,,0.1,0.2
Americas,North America,United States of America,Opioids,ARQ,Pharmaceutical opioids,2017,,,1.85
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,1991,1.1,0.2,0.5
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,1992,1.3,0.3,0.6
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,1993,1.3,0.3,0.6
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,1994,1.6,0.4,0.9
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,1995,1.9,0.6,1.2
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,1996,2.1,0.6,1.3
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,1997,2.1,0.6,1.3
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,1998,2.2,0.6,1.2
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,1999,2.2,0.6,1.3
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2000,2.1,0.6,1.3
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2001,1.7,0.4,0.9
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2002,1.7,0.5,1
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2003,1.5,0.4,0.8
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2004,1.5,0.5,0.9
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2005,1.5,0.5,0.8
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2006,1.4,0.4,0.8
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2007,1.4,0.4,0.8
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2008,1.3,0.4,0.8
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2009,1.4,0.4,0.8
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2010,1.4,0.4,0.8
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2011,1.2,0.4,0.7
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2012,1,0.3,0.6
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2013,1,0.3,0.6
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2014,0.9,0.3,0.5
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2015,0.7,0.2,0.4
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2016,0.6,0.2,0.3
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2017,0.6,0.2,0.3
Americas,North America,United States of America,Opioids,"Monitoring the future, Adolescent Drug Use",Heroin,2018,0.4,,
Americas,South America,Argentina,Opioids,ARQ,-,2007,0.9,,
Americas,South America,Argentina,Opioids,ARQ,-,2009,1,,
Americas,South America,Argentina,Opioids,ARQ,Heroin,2011,0.7,,
Americas,South America,Argentina,Opioids,ARQ,Pharmaceutical opioids,2014,0.8,,
Americas,South America,Argentina,Opioids,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Heroin,2017,0.02,,
Americas,South America,Argentina,Opioids,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Opium,2017,0,,
Americas,South America,Argentina,Opioids,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Morphine,2017,0.02,,
Americas,South America,Argentina,Opioids,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Opioid analgesics,2017,2.6,,
Americas,South America,Bolivia (Plurinational State of),Opioids,ARQ,-,2004,0.6,0.2,0.3
Americas,South America,Bolivia (Plurinational State of),Opioids,ARQ,Heroin,2012,0.06,0.01,0.01
Americas,South America,Bolivia (Plurinational State of),Opioids,ARQ,Morphine,2012,0.38,0,0.01
Americas,South America,Bolivia (Plurinational State of),Opioids,ARQ,Heroin,2016,0.27,0.08,0.08
Americas,South America,Bolivia (Plurinational State of),Opioids,ARQ,Opium,2016,0.51,,
Americas,South America,Bolivia (Plurinational State of),Opioids,ARQ,Pharmaceutical opioids,2016,0.38,,
Americas,South America,Brazil,Opioids,ARQ,Heroin,2010,0.3,,
Americas,South America,Brazil,Opioids,ARQ,Prescription opioids,2010,0.6,,
Americas,South America,Chile,Opioids,ARQ,Heroin,2009,3.5,0.7,1.4
Americas,South America,Chile,Opioids,ARQ,Heroin,2011,1.95,0.45,1.39
Americas,South America,Chile,Opioids,ARQ,Heroin,2013,2.01,0.35,0.82
Americas,South America,Chile,Opioids,ARQ,-,2015,1.98,0.28,0.74
Americas,South America,Chile,Opioids,ARQ,Heroin,2015,1.98,0.28,0.74
Americas,South America,Chile,Opioids,ARQ,Heroin,2017,1.92,0.4,0.96
Americas,South America,Colombia,Opioids,ARQ,Heroin,2004,1.3,,1.2
Americas,South America,Colombia,Opioids,ARQ,Heroin,2011,0.51,0.19,0.36
Americas,South America,Colombia,Opioids,ARQ,Heroin,2012,0.25,0.03,0.07
Americas,South America,Colombia,Opioids,Government,-,2016,0.39,0.01,0.04
Americas,South America,Ecuador,Opioids,ARQ,-,2005,0.9,,0.5
Americas,South America,Ecuador,Opioids,IV ENCUESTA NACIONAL SOBRE EL USO DE DROGAS EN ESTUDIANTES DE  12 A 17 AÑOS,Opium,2012,0.4,0.04,0.1
Americas,South America,Ecuador,Opioids,IV ENCUESTA NACIONAL SOBRE EL USO DE DROGAS EN ESTUDIANTES DE  12 A 17 AÑOS,Heroin,2012,1,0.2,0.5
Americas,South America,Ecuador,Opioids,IV ENCUESTA NACIONAL SOBRE EL USO DE DROGAS EN ESTUDIANTES DE  12 A 17 AÑOS,MORPHINE,2012,0.4,0.06,0.13
Americas,South America,Ecuador,Opioids,ARQ,-,2012,1.3,0.24,0.63
Americas,South America,Ecuador,Opioids,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",-,2016,3.21,0.75,2.51
Americas,South America,Guyana,Opioids,ARQ,-,2002,0.7,0.2,0.3
Americas,South America,Paraguay,Opioids,ARQ,Ages not specified,2005,0.3,,
Americas,South America,Paraguay,Opioids,ARQ,Heroin. School in cities of at least 30000,2014,0.5,0,0
Americas,South America,Peru,Opioids,OAS (MEM),-,2005,1,,
Americas,South America,Suriname,Opioids,OAS (MEM),-,2006,0.5,0,0
Americas,South America,Uruguay,Opioids,ARQ,-,2003,0.5,,0.3
Americas,South America,Uruguay,Opioids,ARQ,-,2011,0.5,,
Americas,South America,Uruguay,Opioids,ARQ,Opium,2011,0.2,,
Americas,South America,Uruguay,Opioids,ARQ,Heroin,2011,0.03,,
Americas,South America,Uruguay,Opioids,ARQ,Prescription opioids,2011,0.4,,
Americas,South America,Uruguay,Opioids,ARQ,Heroin,2014,0.2,,
Americas,South America,Uruguay,Opioids,ARQ,Opium,2014,0.1,,
Americas,South America,Uruguay,Opioids,ARQ,Pharmaceutical opioids,2014,0.3,,
Americas,South America,Uruguay,Opioids,ARQ,-,2014,0.5,,
Americas,South America,Uruguay,Opioids,ARQ,Heroin,2016,0.1,,
Americas,South America,Uruguay,Opioids,ARQ,-,2016,1.1,,
Americas,South America,Uruguay,Opioids,ARQ,Opium,2016,0.2,,
Americas,South America,Uruguay,Opioids,ARQ,Pharmaceutical opioids,2016,0.9,,
Americas,South America,Uruguay,Opioids,ARQ,-,2016,1.1,,
Americas,South America,Uruguay,Opioids,ARQ,Opium,2016,0.2,,
Americas,South America,Uruguay,Opioids,ARQ,Heroin,2016,0.1,,
Americas,South America,Uruguay,Opioids,ARQ,Pharmaceutical opioids,2016,0.9,,
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,ARQ,Heroin,2009,0.421088092,0.147380832,0.1
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,ARQ,Heroin,2014,0.06,,
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",Heroin,2016,0.22,0.1,0.14
Asia,Central Asia and Transcaucasia,Armenia,Opioids,ESPAD,-,2007,1,,
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Research,Select regions (capital);  Georgian Medical News No3 (180) 2010,2010,0.6,,
Asia,Central Asia and Transcaucasia,Georgia,Opioids,ARQ,Heroin,2015,1.8,,
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,ARQ,6 provinces and 2 cities,2012,0.9,0.4,0.6
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,ARQ,-,2001,1,,
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,ARQ,Opium,2010,,,0.0001
Asia,East and South-East Asia,China,Opioids,ARQ,-,2016,,,15.7
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,-,2007,,,0.007
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,Heroin,2011,,,0.01
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,-,2011,,,0.01
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,-,2013,0.01,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,Heroin,2013,0.01,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,"Heroin, Central Registry",2014,,,0.01
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,Central Registry,2014,,,0.01
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,Central Registry,2014,,,0
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,Central Registry,2015,,,0.01
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,ARQ,"Heroin, Central Registry",2015,,,0.01
Asia,East and South-East Asia,"China, Macao SAR",Opioids,ARQ,-,2006,0.76,,
Asia,East and South-East Asia,"China, Taiwan Province of China",Opioids,Govt.,-,2006,0.1,,
Asia,East and South-East Asia,Indonesia,Opioids,ARQ,Heroin,2011,0.2,0.1,0.18
Asia,East and South-East Asia,Indonesia,Opioids,ARQ,Opium,2011,0.1,0.1,0.1
Asia,East and South-East Asia,Indonesia,Opioids,ARQ,Opioids. 20 provinces,2015,0.23,,0.21
Asia,East and South-East Asia,Indonesia,Opioids,ARQ,Opium. 20 provinces,2015,0.16,,0
Asia,East and South-East Asia,Indonesia,Opioids,ARQ,Heroin. Male. 20 provinces,2015,0.09,,
Asia,East and South-East Asia,Indonesia,Opioids,ARQ,Heroin. Female. 20 provinces,2015,0,,
Asia,East and South-East Asia,Indonesia,Opioids,ARQ,Tramadol. 20 provinces,2015,0.17,,0.15
Asia,East and South-East Asia,Indonesia,Opioids,ARQ,"Pharmaceutical opioids only, 13 out of 34 Provinces",2018,,,1.8
Asia,East and South-East Asia,Indonesia,Opioids,ARQ,"Tramadol only, 13 out of 34 Provinces",2018,,,4.8
Asia,East and South-East Asia,Myanmar,Opioids,ARQ,-,2004,0.2,,0.2
Asia,East and South-East Asia,Thailand,Opioids,ARQ,-,2005,0.23,,
Asia,Near and Middle East /South-West Asia,Israel,Opioids,ARQ,-,2009,,,1.9
Asia,Near and Middle East /South-West Asia,Israel,Opioids,ARQ,Prescription opioids,2009,3.59,2.78,2.99
Asia,Near and Middle East /South-West Asia,Israel,Opioids,ARQ,"Heroin, Opium crack, cocaine together",2014,,,3.8
Asia,Near and Middle East /South-West Asia,Israel,Opioids,ARQ,Prescription opioids,2014,,,4.1
Asia,Near and Middle East /South-West Asia,Israel,Opioids,ARQ,Methadone,2014,,,3.9
Asia,Near and Middle East /South-West Asia,Israel,Opioids,ARQ,"Heroin, Opium crack, cocaine together",2014,,,2.6
Asia,Near and Middle East /South-West Asia,Jordan,Opioids,ARQ,-,2001,,,0.9
Asia,Near and Middle East /South-West Asia,Lebanon,Opioids,ARQ,-,2001,,,0.8
Asia,Near and Middle East /South-West Asia,Oman,Opioids,ARQ,-,2002,,,3
Asia,Near and Middle East /South-West Asia,Oman,Opioids,ARQ,Heroin,2017,,,38
Asia,Near and Middle East /South-West Asia,Pakistan,Opioids,ARQ,Opium,2013,0.3,,
Asia,Near and Middle East /South-West Asia,Pakistan,Opioids,ARQ,Heroin,2013,0.8,,
Asia,Near and Middle East /South-West Asia,Pakistan,Opioids,ARQ,Prescription opioids,2013,1.5,,
Asia,South Asia,Bangladesh,Opioids,ARQ,-,2001,,,0.7
Asia,South Asia,Bhutan,Opioids,ARQ,Prescription opioids. General population survey,2010,,,0.048
Asia,South Asia,India,Opioids,ARQ,-,2018,,,1.78
Europe,Eastern Europe,Belarus,Opioids,ARQ,Heroin,2010,0.3,,
Europe,Eastern Europe,Republic of Moldova,Opioids,ESPAD,-,2008,0.4,,
Europe,Eastern Europe,Republic of Moldova,Opioids,Govt.,-,2010,0.1,,
Europe,Eastern Europe,Republic of Moldova,Opioids,ARQ,"Heroin, General population survey",2012,0.1,0.1,0.1
Europe,Eastern Europe,Republic of Moldova,Opioids,ARQ,"Opium, General Population Survey",2012,0.5,0.1,0.2
Europe,Eastern Europe,Republic of Moldova,Opioids,ESPAD,Heroin,2015,0,,
Europe,Eastern Europe,Russian Federation,Opioids,ARQ,Heroin,2007,0.4,,
Europe,Eastern Europe,Russian Federation,Opioids,ARQ,-,2013,0.001,,
Europe,Eastern Europe,Russian Federation,Opioids,ARQ,Heroin,2011,0.9,,
Europe,Eastern Europe,Ukraine,Opioids,ARQ,Heroin,2010,,0.1,0.1
Europe,Eastern Europe,Ukraine,Opioids,ARQ,"Heroin, Registered users",2011,0.9,,
Europe,Eastern Europe,Ukraine,Opioids,ARQ,-,2015,,,11
Europe,South-Eastern Europe,Albania,Opioids,ARQ,-,2004,1.8,,
Europe,South-Eastern Europe,Albania,Opioids,ARQ / ESPAD,Heroin,2015,1.7,,
Europe,South-Eastern Europe,Albania,Opioids,ARQ / ESPAD,Pharmaceutical opioids,2015,3.3,,
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,ARQ,Heroin,2011,0.4,,
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,ARQ,Pharmaceutical opioids,2011,1.4,,
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,ARQ,Pharmaceutical opioids,2012,0.2,,
Europe,South-Eastern Europe,Bulgaria,Opioids,ARQ,-,2008,4.3,1.5,2.2
Europe,South-Eastern Europe,Bulgaria,Opioids,ARQ,Heroin,2008,3.1,1.1,1.6
Europe,South-Eastern Europe,Bulgaria,Opioids,ARQ,Prescription opioids,2008,3.2,1.2,1.6
Europe,South-Eastern Europe,Bulgaria,Opioids,ARQ,Heroin,2011,2.5,,
Europe,South-Eastern Europe,Bulgaria,Opioids,ARQ,Pharmaceutical opioids,2013,2.9,1.6,2.2
Europe,South-Eastern Europe,Bulgaria,Opioids,ARQ,-,2013,3.5,2.2,2.8
Europe,South-Eastern Europe,Bulgaria,Opioids,ARQ,Heroin,2013,2.7,1.5,2.2
Europe,South-Eastern Europe,Bulgaria,Opioids,ARQ / ESPAD,Heroin,2015,3.3,,
Europe,South-Eastern Europe,Bulgaria,Opioids,ARQ / ESPAD,Pharmaceutical opioids,2015,4,,
Europe,South-Eastern Europe,Croatia,Opioids,ARQ,-,2007,1.1,,
Europe,South-Eastern Europe,Croatia,Opioids,ESPAD,Heroin,2015,1,,
Europe,South-Eastern Europe,Montenegro,Opioids,ESPAD,Heroin,2011,1.2,,
Europe,South-Eastern Europe,Montenegro,Opioids,ESPAD,-,2008,1,,
Europe,South-Eastern Europe,Montenegro,Opioids,ARQ,Heroin,2015,2,,
Europe,South-Eastern Europe,Montenegro,Opioids,ARQ,Heroin,2015,3,,
Europe,South-Eastern Europe,North Macedonia,Opioids,ESPAD,Heroin,2015,1,,
Europe,South-Eastern Europe,North Macedonia,Opioids,ARQ,Heroin,2015,0.9,,
Europe,South-Eastern Europe,Romania,Opioids,ESPAD,-,2007,0.3,,
Europe,South-Eastern Europe,Romania,Opioids,ARQ,-,2011,1.1,,
Europe,South-Eastern Europe,Romania,Opioids,ARQ,-,2015,1.8,,
Europe,South-Eastern Europe,Romania,Opioids,ARQ,Heroin,2015,1.8,,
Europe,South-Eastern Europe,Serbia,Opioids,ARQ,-,2008,0.8,,
Europe,South-Eastern Europe,Serbia,Opioids,ARQ / ESPAD,-,2011,1.1,,
Europe,South-Eastern Europe,Turkey,Opioids,ESPAD,-,2003,1.5,,0.8
Europe,Western and Central Europe,Austria,Opioids,ESPAD,-,2007,1.8,,
Europe,Western and Central Europe,Austria,Opioids,ARQ,Heroin,2007,1.7,,
Europe,Western and Central Europe,Austria,Opioids,ARQ / ESPAD,Heroin,2015,0.6,,
Europe,Western and Central Europe,Belgium,Opioids,ARQ,Heroin,2010,0.89,,0.3
Europe,Western and Central Europe,Belgium,Opioids,ARQ,Heroin,2011,0.8,,0.2
Europe,Western and Central Europe,Belgium,Opioids,ARQ,Heroin,2012,0.4,,0.2
Europe,Western and Central Europe,Belgium,Opioids,ARQ,"Heroin, Flemish part",2012,0.6,,0.3
Europe,Western and Central Europe,Belgium,Opioids,ESPAD,"Heroin, Flemish part",2014,1,,
Europe,Western and Central Europe,Belgium,Opioids,ESPAD,"Heroin, Flemish part",2015,1,,
Europe,Western and Central Europe,Cyprus,Opioids,ESPAD,-,2007,2,,
Europe,Western and Central Europe,Cyprus,Opioids,ARQ,Heroin,2007,2,,
Europe,Western and Central Europe,Cyprus,Opioids,ESPAD,Heroin,2011,3,,
Europe,Western and Central Europe,Cyprus,Opioids,ESPAD,-,2011,3,,
Europe,Western and Central Europe,Cyprus,Opioids,ARQ,Heroin,2012,,,0.1
Europe,Western and Central Europe,Cyprus,Opioids,ESPAD,Heroin,2015,3,,
Europe,Western and Central Europe,Cyprus,Opioids,ESPAD,Heroin,2016,0.3,,
Europe,Western and Central Europe,Czechia,Opioids,Govt./ ESPAD,Heroin and opiates,2007,2,0.6,1.2
Europe,Western and Central Europe,Czechia,Opioids,ARQ,Heroin,2007,1,,
Europe,Western and Central Europe,Czechia,Opioids,ARQ,-,2011,1.4,0.3,0.7
Europe,Western and Central Europe,Czechia,Opioids,ARQ / ESPAD,Heroin,2015,0.7,,
Europe,Western and Central Europe,Czechia,Opioids,ARQ / ESPAD,Heroin,2016,1.1,0.2,0.5
Europe,Western and Central Europe,Denmark,Opioids,ARQ,-,2007,0.5,,
Europe,Western and Central Europe,Denmark,Opioids,ESPAD,Heroin,2015,1,,
Europe,Western and Central Europe,Estonia,Opioids,ARQ,-,2007,1.3,,
Europe,Western and Central Europe,Estonia,Opioids,ARQ,Heroin,2011,1,,
Europe,Western and Central Europe,Estonia,Opioids,ARQ,Heroin,2013,0.3,,
Europe,Western and Central Europe,Estonia,Opioids,ARQ,"Pharmaceutical opioids, Fentanly",2013,0.2,,
Europe,Western and Central Europe,Estonia,Opioids,ARQ (ESPAD),Heroin,2015,1,,
Europe,Western and Central Europe,Faroe Islands,Opioids,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Faroe Islands,Opioids,ESPAD,Heroin,2015,0,,
Europe,Western and Central Europe,Finland,Opioids,ARQ,Heroin,2007,1,,
Europe,Western and Central Europe,Finland,Opioids,ARQ,Prescription opioids,2007,1,,
Europe,Western and Central Europe,Finland,Opioids,ARQ,Heroin,2011,1,,
Europe,Western and Central Europe,Finland,Opioids,ARQ,Prescription opioids,2011,1,,
Europe,Western and Central Europe,Finland,Opioids,ARQ,Heroin,2013,1,,
Europe,Western and Central Europe,Finland,Opioids,ARQ,Pharmaceutical opioids,2013,1,,
Europe,Western and Central Europe,Finland,Opioids,ARQ,-,2013,2,,
Europe,Western and Central Europe,Finland,Opioids,ARQ (ESPAD),Heroin,2015,1,,
Europe,Western and Central Europe,France,Opioids,ESPAD,-,2007,3,,
Europe,Western and Central Europe,France,Opioids,ARQ,-,2011,0.9,,0.6
Europe,Western and Central Europe,France,Opioids,ARQ,Heroin. Urban areas (excluding overseas departments),2014,1,,0.4
Europe,Western and Central Europe,France,Opioids,ESPAD,Heroin,2015,2,,
Europe,Western and Central Europe,France,Opioids,ARQ,Heroin,2017,0.7,,0.3
Europe,Western and Central Europe,Germany,Opioids,Die Drogenaffinität Jugendlicher in der Bundesrepublik Deutschland 2008.,Heroin,2008,0.3,,
Europe,Western and Central Europe,Germany,Opioids,ARQ,"Heroin, Select regions",2007,1.1,,
Europe,Western and Central Europe,Germany,Opioids,ARQ,Heroin. Select regions,2011,0.8,,
Europe,Western and Central Europe,Germany,Opioids,ARQ,Heroin.  Region Frankfurt am Main,2012,0,,
Europe,Western and Central Europe,Germany,Opioids,ARQ,Heroin.  Region Frankfurt am Main,2015,0.5,,
Europe,Western and Central Europe,Germany,Opioids,ARQ / DAS Data,Heroin,2015,1,0.5,
Europe,Western and Central Europe,Gibraltar,Opioids,ARQ,-,2002,,,1.5
Europe,Western and Central Europe,Gibraltar,Opioids,ARQ,other illicit opioids,2019,,0.26,0.74
Europe,Western and Central Europe,Greece,Opioids,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Greece,Opioids,ARQ,Heroin,2011,1,,
Europe,Western and Central Europe,Greece,Opioids,ARQ / ESPAD,Heroin,2015,0.66,,
Europe,Western and Central Europe,Greece,Opioids,ARQ / ESPAD,-,2015,1.81,,
Europe,Western and Central Europe,Greenland,Opioids,ESPAD,-,2003,1,,1
Europe,Western and Central Europe,Hungary,Opioids,ESPAD,-,2007,1.3,,
Europe,Western and Central Europe,Hungary,Opioids,ESPAD,Heroin,2015,1.4,,
Europe,Western and Central Europe,Iceland,Opioids,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Iceland,Opioids,ESPAD,Heroin,2015,1,,
Europe,Western and Central Europe,Ireland,Opioids,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Ireland,Opioids,ARQ,Heroin,2011,1,,
Europe,Western and Central Europe,Ireland,Opioids,ARQ,Heroin,2015,0.4,,
Europe,Western and Central Europe,Ireland,Opioids,ARQ,Heroin,2017,0.4,,
Europe,Western and Central Europe,Italy,Opioids,ARQ,Heroin,2010,0.8,0.4,0.5
Europe,Western and Central Europe,Italy,Opioids,ARQ,Heroin,2012,0.33,0.19,0.25
Europe,Western and Central Europe,Italy,Opioids,ARQ,-,2013,1.22,0.38,0.71
Europe,Western and Central Europe,Italy,Opioids,ARQ,Heroin,2013,0.48,0.19,0.32
Europe,Western and Central Europe,Italy,Opioids,ARQ,Heroin. Male.,2014,1.8,1.3,1.5
Europe,Western and Central Europe,Italy,Opioids,ARQ,Heroin. Female.,2014,1,0.6,0.8
Europe,Western and Central Europe,Italy,Opioids,ARQ,-,2015,1.3,0.7,1
Europe,Western and Central Europe,Italy,Opioids,ARQ,Heroin,2015,1.3,0.7,1
Europe,Western and Central Europe,Italy,Opioids,ARQ,Heroin,2016,1.47,0.94,1.13
Europe,Western and Central Europe,Italy,Opioids,ARQ,Heroin,2017,1.05,0.55,0.78
Europe,Western and Central Europe,Italy,Opioids,ARQ,-,2018,1.48,0.53,0.94
Europe,Western and Central Europe,Italy,Opioids,ARQ,Heroin,2018,0.54,0.26,0.39
Europe,Western and Central Europe,Italy,Opioids,ARQ,other illicit opioids,2018,1.28,0.45,0.82
Europe,Western and Central Europe,Latvia,Opioids,ARQ,Heroin; Riga City,2010,1.5,,
Europe,Western and Central Europe,Latvia,Opioids,ESPAD,Heroin,2011,2.3,,
Europe,Western and Central Europe,Latvia,Opioids,ARQ,Heroin,2015,2.1,,
Europe,Western and Central Europe,Liechtenstein,Opioids,ARQ,-,2005,0.2,,0.2
Europe,Western and Central Europe,Liechtenstein,Opioids,ARQ,Heroin,2005,0.2,,0.3
Europe,Western and Central Europe,Liechtenstein,Opioids,ARQ,Heroin,2011,3,,
Europe,Western and Central Europe,Liechtenstein,Opioids,ARQ,-,2011,3,,
Europe,Western and Central Europe,Liechtenstein,Opioids,ARQ,-,2015,0.3,,
Europe,Western and Central Europe,Liechtenstein,Opioids,ARQ,Heroin,2015,0.3,,
Europe,Western and Central Europe,Lithuania,Opioids,ESPAD,-,2007,1.1,,
Europe,Western and Central Europe,Lithuania,Opioids,ARQ,Heroin,2013,1.6,,
Europe,Western and Central Europe,Lithuania,Opioids,ARQ,Heroin,2015,1.3,,
Europe,Western and Central Europe,Luxembourg,Opioids,ARQ,-,1999,1.2,,0.6
Europe,Western and Central Europe,Luxembourg,Opioids,ARQ,-,2010,0.7,,0.5
Europe,Western and Central Europe,Luxembourg,Opioids,National Drug Report 2017,Heroin,2015,0,0,0
Europe,Western and Central Europe,Luxembourg,Opioids,National Drug Report 2017,-,1999,0.8,,0.6
Europe,Western and Central Europe,Luxembourg,Opioids,National Drug Report 2017,-,1999,0.8,,
Europe,Western and Central Europe,Luxembourg,Opioids,National Drug Report 2017,-,2010,1,,
Europe,Western and Central Europe,Luxembourg,Opioids,National Drug Report 2017,-,1999,0.8,,
Europe,Western and Central Europe,Luxembourg,Opioids,National Drug Report 2017,-,2010,0.6,,
Europe,Western and Central Europe,Malta,Opioids,ARQ,Heroin,2007,1.1,,
Europe,Western and Central Europe,Malta,Opioids,ESPAD,Heroin,2011,1,,
Europe,Western and Central Europe,Malta,Opioids,ARQ / ESPAD,Heroin,2015,0.8,,
Europe,Western and Central Europe,Monaco,Opioids,ESPAD,-,2007,2,,
Europe,Western and Central Europe,Monaco,Opioids,ESPAD,Heroin,2015,2,,
Europe,Western and Central Europe,Netherlands,Opioids,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Netherlands,Opioids,ARQ,Heroin,2007,0.8,0.4,
Europe,Western and Central Europe,Netherlands,Opioids,ARQ,Heroin,2010,0.6,0.2,
Europe,Western and Central Europe,Netherlands,Opioids,ARQ,Heroin,2011,0.6,0.2,
Europe,Western and Central Europe,Netherlands,Opioids,ARQ / ESPAD,-,2015,0.4,0.3,
Europe,Western and Central Europe,Norway,Opioids,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Poland,Opioids,ARQ,-,2007,1.4,,1
Europe,Western and Central Europe,Poland,Opioids,ARQ,Heroin,2010,1.9,0.5,0.8
Europe,Western and Central Europe,Poland,Opioids,ARQ,Heroin,2012,1.3,,
Europe,Western and Central Europe,Poland,Opioids,ARQ,Polish Heroin,2012,2.4,,
Europe,Western and Central Europe,Poland,Opioids,ARQ,Heroin,2013,1.6,0.7,1
Europe,Western and Central Europe,Poland,Opioids,ARQ,Polish Heroin,2013,1.5,0.4,0.7
Europe,Western and Central Europe,Poland,Opioids,ESPAD,Heroin,2015,2,,
Europe,Western and Central Europe,Poland,Opioids,ARQ,Heroin,2016,1.9,0.7,0.7
Europe,Western and Central Europe,Poland,Opioids,ARQ,Heroin,2018,1.8,1,1.2
Europe,Western and Central Europe,Poland,Opioids,ARQ,Polish Heroin,2018,1.3,0.7,0.8
Europe,Western and Central Europe,Portugal,Opioids,ESPAD,-,2007,2.3,,
Europe,Western and Central Europe,Portugal,Opioids,ESPAD,Opium,2011,2,,
Europe,Western and Central Europe,Portugal,Opioids,ARQ,-,2015,1,,
Europe,Western and Central Europe,Portugal,Opioids,ARQ,Heroin,2015,1,,
Europe,Western and Central Europe,Slovakia,Opioids,ARQ,Heroin,2010,0.6,0.2,0.2
Europe,Western and Central Europe,Slovakia,Opioids,ARQ,Heroin,2015,1,,
Europe,Western and Central Europe,Slovakia,Opioids,ARQ,Heroin,2018,0.7,,
Europe,Western and Central Europe,Slovenia,Opioids,ARQ,Heroin,2007,1.6,,
Europe,Western and Central Europe,Slovenia,Opioids,ARQ,Heroin,2011,1,,
Europe,Western and Central Europe,Slovenia,Opioids,ARQ / ESPAD,Heroin,2015,0.86,,
Europe,Western and Central Europe,Spain,Opioids,ARQ,-,2010,1,0.5,0.6
Europe,Western and Central Europe,Spain,Opioids,ARQ,-,2012,1,0.6,0.7
Europe,Western and Central Europe,Spain,Opioids,ARQ,Heroin,2012,1,0.6,0.7
Europe,Western and Central Europe,Spain,Opioids,ARQ,-,2014,0.6,0.3,0.5
Europe,Western and Central Europe,Spain,Opioids,ARQ,Heroin,2014,0.6,0.3,0.5
Europe,Western and Central Europe,Spain,Opioids,ARQ,-,2016,0.8,0.3,0.6
Europe,Western and Central Europe,Spain,Opioids,ARQ,Heroin,2016,0.8,0.3,0.6
Europe,Western and Central Europe,Sweden,Opioids,ARQ,-,2009,1,,
Europe,Western and Central Europe,Sweden,Opioids,ARQ,Heroin. Male.,2014,0.4,,
Europe,Western and Central Europe,Sweden,Opioids,ARQ,Heroin. Female.,2014,0.3,,
Europe,Western and Central Europe,Sweden,Opioids,ARQ,Heroin. Male.,2015,0.8,,
Europe,Western and Central Europe,Sweden,Opioids,ARQ,Heroin. Female.,2015,0.2,,
Europe,Western and Central Europe,Sweden,Opioids,ARQ,Heroin,2016,0.3,,
Europe,Western and Central Europe,Sweden,Opioids,ARQ,Heroin,2017,0.3,,
Europe,Western and Central Europe,Sweden,Opioids,ARQ,Heroin,2018,0.5,,
Europe,Western and Central Europe,Switzerland,Opioids,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Switzerland,Opioids,ARQ,Heroin. Male.,2014,0.7,,
Europe,Western and Central Europe,Switzerland,Opioids,ARQ,Heroin. Female.,2014,0.3,,
Europe,Western and Central Europe,Switzerland,Opioids,"Addiction Monitoring in Switzerland, July 2017",Heroin,2016,0,0,0
Europe,Western and Central Europe,Switzerland,Opioids,"Addiction Monitoring in Switzerland, July 2017",Methadone,2016,,,0
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Any opiates,2010,1.9,0.7,1.7
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Heroin,2011,1,0.5,0.8
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Any opioids,2012,1.2,0.5,0.9
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Heroin,2012,0.7,0.4,0.5
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Methadone,2012,0.6,0.2,0.5
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Heroin,2013,0.7,0.4,0.5
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Methadone,2013,0.7,0.3,0.6
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Any opioids,2013,1.3,0.5,0.9
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Any opioids,2014,0.6,0.3,0.5
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Heroin,2014,0.3,0.1,0.3
Europe,Western and Central Europe,United Kingdom (England),Opioids,ARQ,Methadone,2014,0.5,0.2,0.4
Europe,Western and Central Europe,United Kingdom (England),Opioids,Government,-,2016,1,0.6,0.9
Europe,Western and Central Europe,United Kingdom (England),Opioids,Government,Heroin,2016,0.7,0.4,0.6
Europe,Western and Central Europe,United Kingdom (England),Opioids,Government,Methadone,2016,0.3,0.3,0.3
Europe,Western and Central Europe,United Kingdom (Scotland),Opioids,Govt.,"Heroin, methadone",2013,1,1,1
Europe,Western and Central Europe,United Kingdom (Scotland),Opioids,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),-,2015,1.6,1,1.4
Europe,Western and Central Europe,United Kingdom (Scotland),Opioids,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Heroin,2015,1.5,0.9,1.3
Europe,Western and Central Europe,United Kingdom (Scotland),Opioids,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Methadone,2015,1.2,0.8,1
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 1996,Methadone,1996,0.37401662,0.1,0.11317353
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 1998,Methadone,1998,1.15497701,0.5,0.5980672
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2000,Methadone,2000,0.59392913,0,0.13096896
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2001/2002,Methadone,2001,0.63498444,0,0.0168943
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2002/2003,Methadone,2002,0.42635561,0.1,0.17223506
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2003/2004,Methadone,2003,0.73394647,0.1,0.25069691
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2004/2005,Methadone,2004,0.33395338,0,0.03863573
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2005/2006,Methadone,2005,0.39729581,0.1,0.07213608
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2006/2007,Methadone,2006,0.27485493,0.07090047,0.12950919
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2007/2008,Methadone,2007,0.28026313,0.04742071,0.12808116
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2008/2009,Methadone,2008,0.17060847,0.00645853,0.00645853
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2009/2010,Methadone,2009,0.37589829,0.10172897,0.19551417
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2010/2011,Methadone,2010,0.77081581,0.1724749,0.36194432
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2011/2012,Methadone,2011,0.85897047,0.3102569,0.40636642
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2012/2013,Methadone,2012,0.42180768,,0.00790607
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2013/2014,Methadone,2013,0.63278061,,0.15853275
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2014/2015,Methadone,2014,0.40539273,0.01884864,0.01884864
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2015/2016,Methadone,2015,0.53244965,0.05107851,0.05107851
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2016/2017,Methadone,2016,0.30657364,0,0.05320871
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 1996,Heroin,1996,0.92129609,0.1,0.350505
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 1998,Heroin,1998,0.93226489,0.2,0.28289398
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2000,Heroin,2000,1.61142268,0.3,0.81267352
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2001/2002,Heroin,2001,0.80978567,0.2,0.29198789
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2002/2003,Heroin,2002,0.83828609,0.2,0.2425644
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2003/2004,Heroin,2003,1.09643203,0.3,0.39708788
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2004/2005,Heroin,2004,0.58769833,0.1,0.16248587
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2005/2006,Heroin,2005,0.53685768,0.1,0.16629502
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2006/2007,Heroin,2006,0.63979331,0.13464512,0.17688131
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2007/2008,Heroin,2007,0.41987331,0.03718683,0.10399578
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2008/2009,Heroin,2008,0.40708336,0.01277135,0.02122974
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2009/2010,Heroin,2009,0.46233482,0.06802167,0.07355728
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2010/2011,Heroin,2010,0.21963316,0.01246456,0.05905866
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2011/2012,Heroin,2011,0.20840839,0.02587401,0.07469508
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2012/2013,Heroin,2012,0.08813393,,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2013/2014,Heroin,2013,0.15600992,,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2014/2015,Heroin,2014,0.03771001,0,0.01885501
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2015/2016,Heroin,2015,0.14209787,0,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2016/2017,Heroin,2016,0.14478916,0,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 1996,All Opiates,1996,1.2,0.1,0.40690048
Africa,Southern Africa,South Africa,Amphetamines,ARQ,Methamphetamine,2008,6.6,,
Africa,Southern Africa,South Africa,Amphetamines,ARQ,Stimulants (inclds Amphetamines),2008,6.9,,
Africa,Southern Africa,South Africa,Amphetamines,ARQ,Cape Town only,2011,2,,
Africa,Southern Africa,South Africa,Amphetamines,ARQ,Methamphetamine,2011,5.5,,
Africa,Southern Africa,South Africa,Amphetamines,ARQ,Prescription stimulants,2011,11.5,,
Africa,Southern Africa,Namibia,Amphetamines,Govt.,Prescription stimulants,2015,8,4,7
Africa,West and Central Africa,Ghana,Amphetamines,ARQ,Amphetamines (inclds. non-ATS stimulants),2007,,,7.6
Africa,West and Central Africa,Ghana,Amphetamines,ARQ,Methamphetamine,2007,,,5
Africa,West and Central Africa,Côte d'Ivoire,Amphetamines,Government,Amphetamine,2017,1.4,0.4,0.8
Africa,West and Central Africa,Côte d'Ivoire,Amphetamines,Government,Methamphetamine,2017,1.5,0.3,0.6
Africa,West and Central Africa,Nigeria,Amphetamines,UNODC Report,Amphetamines,2017,,,0.2
Africa,West and Central Africa,Nigeria,Amphetamines,UNODC Report,Methamphetamine,2017,,,0.1
Africa,West and Central Africa,Cabo Verde,Amphetamines,2018 National Survey on Substance Use and Health (NSSUH),Amphetamine,2018,,,0.3
Africa,East Africa,Kenya,Cocaine,Govt.,-,2007,0.2,0.2,
Africa,East Africa,Kenya,Cocaine,ARQ,Cocaine salts,2016,1.1,0.2,
Africa,North Africa,Morocco,Cocaine,MedSPAD,Cocaine,2009,1.2,0.4,0.7
Africa,North Africa,Morocco,Cocaine,MedSPAD,Crack,2009,0.7,0.4,0.4
Africa,North Africa,Morocco,Cocaine,ARQ,Cocaine salts,2013,1.3,0.1,0.6
Africa,North Africa,Morocco,Cocaine,ARQ,Crack,2013,1.2,0.1,0.6
Africa,North Africa,Morocco,Cocaine,MedSPAD,Cocaine,2013,1.3,,
Africa,North Africa,Morocco,Cocaine,MedSPAD,Crack,2013,1.2,,
Africa,North Africa,Tunisia,Cocaine,MedSPAD,Cocaine,2013,0.52,0.16,0.25
Africa,North Africa,Algeria,Cocaine,ARQ,-,2016,0.71,0.38,0.48
Africa,North Africa,Egypt,Cocaine,MedSPAD,Cocaine,2016,1.1,0.5,0.76
Africa,North Africa,Tunisia,Cocaine,MedSPAD Survey 2016/2017,-,2016,0.4,0.2,0.2
Africa,North Africa,Morocco,Cocaine,MedSPAD,Cocaine,2017,1.3,0.3,0.7
Africa,North Africa,Morocco,Cocaine,MedSPAD,Crack,2017,0.6,0.3,0.4
Africa,Southern Africa,South Africa,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack); Select regions (Cape Town)",2008,6.7,,
Africa,Southern Africa,South Africa,Cocaine,ARQ,Cape Town only,2011,1,,
Africa,Southern Africa,South Africa,Cocaine,ARQ,-,2011,4.9,,
Africa,Southern Africa,Namibia,Cocaine,Govt.,"Cocaine, Crack Cocaine",2015,3.2,,
Africa,West and Central Africa,Ghana,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2007,,,2.9
Africa,West and Central Africa,Central African Republic,Cocaine,ARQ,-,2016,2,,
Africa,West and Central Africa,Côte d'Ivoire,Cocaine,Government,Cocaine,2017,2.3,0.6,1
Africa,West and Central Africa,Côte d'Ivoire,Cocaine,Government,Crack,2017,1.4,0.5,0.6
Africa,West and Central Africa,Nigeria,Cocaine,UNODC Report,-,2017,,,0.1
Africa,West and Central Africa,Cabo Verde,Cocaine,2018 National Survey on Substance Use and Health (NSSUH),-,2018,,,1.6
Africa,East Africa,Kenya,Ecstasy,Govt.,-,2007,0.6,0.6,
Africa,North Africa,Tunisia,Ecstasy,MedSPAD,-,2013,0.2,0.15,0.16
Africa,North Africa,Algeria,Ecstasy,ARQ,-,2016,1.81,0.71,1.09
Africa,North Africa,Egypt,Ecstasy,MedSPAD,-,2016,2.16,1.13,1.65
Africa,North Africa,Tunisia,Ecstasy,MedSPAD Survey 2016/2017,-,2016,1.4,0.4,0.9
Africa,North Africa,Tunisia,Ecstasy,,-,2018,,,4.81
Africa,Southern Africa,South Africa,Ecstasy,ARQ,Select regions (Cape Town),2006,3.2,,1.2
Africa,Southern Africa,South Africa,Ecstasy,ARQ,-,2008,6.8,,
Africa,Southern Africa,South Africa,Ecstasy,ARQ,Cape Town only,2011,1,,
Africa,Southern Africa,South Africa,Ecstasy,ARQ,-,2011,3.6,,
Africa,Southern Africa,Namibia,Ecstasy,Govt.,-,2015,3.1,,
Africa,West and Central Africa,Côte d'Ivoire,Ecstasy,Government,-,2017,1.3,0.3,0.5
Africa,West and Central Africa,Nigeria,Ecstasy,UNODC Report,-,2017,,,0.1
Africa,West and Central Africa,Cabo Verde,Ecstasy,2018 National Survey on Substance Use and Health (NSSUH),-,2018,,,1.9
Africa,North Africa,Morocco,Tranquillizers and sedatives,MedSPAD,-,2009,4,1.3,2.2
Africa,North Africa,Algeria,Tranquillizers and sedatives,ARQ,-,2010,0.17,0.03,0.03
Africa,North Africa,Morocco,Tranquillizers and sedatives,MedSPAD,-,2013,5.4,2.3,3.7
Africa,North Africa,Morocco,Tranquillizers and sedatives,MedSPAD,Benzodiazepines,2013,4,2,3
Africa,North Africa,Tunisia,Tranquillizers and sedatives,MedSPAD,-,2013,2.1,0.7,1.1
Africa,North Africa,Kenya,Tranquillizers and sedatives,ARQ,-,2016,0.6,0.1,
Africa,North Africa,Egypt,Tranquillizers and sedatives,MedSPAD,-,2016,5.08,1.67,1.67
Africa,North Africa,Tunisia,Tranquillizers and sedatives,MedSPAD Survey 2016/2017,-,2016,3,1.1,1.4
Africa,North Africa,Morocco,Tranquillizers and sedatives,MedSpad,-,2017,4,2,2
Africa,North Africa,Tunisia,Tranquillizers and sedatives,,-,2018,,,2.47
Africa,Southern Africa,South Africa,Tranquillizers and sedatives,,Methaqualone,2008,7.4,,
Africa,Southern Africa,South Africa,Tranquillizers and sedatives,ARQ,Methaqualone,2011,2.1,,
Africa,Southern Africa,South Africa,Tranquillizers and sedatives,ARQ,Methaqualone,2011,5.4,,
Africa,Southern Africa,Namibia,Tranquillizers and sedatives,Govt.,Methaqualone,2015,0.4,0.1,0.4
Africa,West and Central Africa,Central African Republic,Tranquillizers and sedatives,ARQ,Barbiturates,2017,5,1,
Africa,West and Central Africa,Central African Republic,Tranquillizers and sedatives,ARQ,Benzodiazepines,2017,35,29,
Africa,West and Central Africa,Côte d'Ivoire,Tranquillizers and sedatives,Government,-,2017,9.6,7.3,8.3
Africa,West and Central Africa,Nigeria,Tranquillizers and sedatives,UNODC Report,-,2017,,,0.2
Africa,West and Central Africa,Cabo Verde,Tranquillizers and sedatives,2018 National Survey on Substance Use and Health (NSSUH),-,2018,,,1.2
Americas,Caribbean,Turks and Caicos Islands,Amphetamines,ARQ,Methamphetamine,2002,0.9,,0.3
Americas,Caribbean,Grenada,Amphetamines,Govt.,Stimulants (inclds Amphetamines),2005,3.4,1.5,2.2
Americas,Caribbean,Grenada,Amphetamines,Govt.,Methamphetamine,2005,0.3,0.2,0.2
Americas,Caribbean,Puerto Rico,Amphetamines,Govt.,Methamphetamine/ Youth Risk Behavior Survey,2005,1.9,,
Americas,Caribbean,Antigua and Barbuda,Amphetamines,OAS (MEM),Stimulants (inclds Amphetamines),2005,2.6,1.1,1.5
Americas,Caribbean,Haiti,Amphetamines,OAS (MEM),Stimulants (inclds Amphetamines),2005,24.4,7.5,11.7
Americas,Caribbean,Saint Lucia,Amphetamines,OAS (MEM),Stimulants (inclds Amphetamines),2005,6,2.2,3.7
Americas,Caribbean,Saint Kitts and Nevis,Amphetamines,Govt.,Stimulants (inclds Amphetamines),2006,2.99,1.32,1.58
Americas,Caribbean,Jamaica,Amphetamines,OAS,Stimulants (inclds Amphetamines),2006,6.3,2.4,3.5
Americas,Caribbean,Barbados,Amphetamines,OAS (MEM),Stimulants (inclds Amphetamines),2006,3.5,1.6,2.4
Americas,Caribbean,Dominica,Amphetamines,OAS (MEM),Stimulants (inclds Amphetamines),2006,4.3,1.6,2.2
Americas,Caribbean,Saint Vincent and the Grenadines,Amphetamines,OAS (MEM),Stimulants (inclds Amphetamines),2006,2.91,1.21,1.66
Americas,Caribbean,Trinidad and Tobago,Amphetamines,OAS (MEM),Stimulants (inclds Amphetamines),2006,3.41,1.6,2.12
Americas,Caribbean,Dominican Republic,Amphetamines,CICAD/ OAS,Prescription stimulants,2008,9.12,2.83,4.21
Americas,Caribbean,Bahamas,Amphetamines,Govt.,-,2008,1.4,,0.9
Americas,Caribbean,Jamaica,Amphetamines,ARQ,Amphetamine,2010,2.5,,
Americas,Caribbean,Jamaica,Amphetamines,ARQ,Methamphetamine,2010,1.4,,
Americas,Caribbean,Bahamas,Amphetamines,ARQ,-,2011,2.7,1.2,1.83
Americas,Caribbean,Bahamas,Amphetamines,CICAD/ OAS,Prescription stimulants,2011,3.33,1.14,1.83
Americas,Caribbean,Dominica,Amphetamines,CICAD/ OAS,Prescription stimulants,2011,15.58,2.93,6.39
Americas,Caribbean,Antigua and Barbuda,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,2.74,1.33,1.64
Americas,Caribbean,Barbados,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,3.66,1.59,1.95
Americas,Caribbean,Grenada,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,4.35,1.8,2.88
Americas,Caribbean,Jamaica,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,3.46,1.15,1.79
Americas,Caribbean,Saint Kitts and Nevis,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,4.05,1.14,2.29
Americas,Caribbean,Saint Lucia,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,5.01,2.54,3.4
Americas,Caribbean,Saint Vincent and the Grenadines,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,3,1.53,2.03
Americas,Caribbean,Trinidad and Tobago,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,3.91,1,1.38
Americas,Caribbean,Haiti,Amphetamines,CICAD/ OAS,Prescription stimulants,2014,7.65,1.55,3.36
Americas,Central America,Guatemala,Amphetamines,ARQ,Amphetamine,2002,7.3,,3.8
Americas,Central America,Belize,Amphetamines,OAS (MEM),Methamphetamine,2002,0.4,0.1,0.1
Americas,Central America,Belize,Amphetamines,OAS (MEM),Stimulants (inclds Amphetamines),2002,4.6,1.9,2.7
Americas,Central America,Honduras,Amphetamines,CICAD/ OAS,Prescription stimulants,2005,7.43,1.98,3.05
Americas,Central America,El Salvador,Amphetamines,ARQ,-,2008,1.7,0.9,1.1
Americas,Central America,Honduras,Amphetamines,ARQ,Stimulants (inclds Amphetamines); Central District,2008,4.3,,2.3
Americas,Central America,Panama,Amphetamines,CICAD/ OAS,Prescription stimulants,2008,4.7,0.5,1.2
Americas,Central America,Costa Rica,Amphetamines,ARQ,Other stimulants,2009,7.1,2.1,3.8
Americas,Central America,Costa Rica,Amphetamines,ARQ/ Govt.,Any amphetamines without prescription,2009,9.6,3.59,6.85
Americas,Central America,Costa Rica,Amphetamines,ARQ,-,2012,3.55,0.9,1.3
Americas,Central America,Costa Rica,Amphetamines,ARQ,-,2012,3.69,1.3,1.97
Americas,Central America,Costa Rica,Amphetamines,ARQ,Prescription stimulants,2012,3.2,1.1,1.63
Americas,Central America,El Salvador,Amphetamines,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Use amongst young population without medical prescription,2012,2.4,0.7,0.7
Americas,Central America,Panama,Amphetamines,ARQ,-,2013,0.53,0.14,0.32
Americas,Central America,Panama,Amphetamines,ARQ,Amphetamine,2013,0.35,0,0.11
Americas,Central America,Panama,Amphetamines,ARQ,Methamphetamine,2013,0.7,0.1,0.2
Americas,Central America,Belize,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,3.25,1.03,1.6
Americas,Central America,Guatemala,Amphetamines,ARQ,-,2014,3.74,0.97,1.35
Americas,Central America,Honduras,Amphetamines,ARQ,Prescription stimulants,2014,8.4,1.2,2
Americas,Central America,Costa Rica,Amphetamines,ARQ,-,2015,1.848,,1.76
Americas,Central America,Costa Rica,Amphetamines,ARQ,Prescription stimulants,2015,0.18,,0.09
Americas,Central America,Honduras,Amphetamines,ARQ,-,2015,6.8,1.1,3.4
Americas,Central America,El Salvador,Amphetamines,ARQ,-,2016,2.7,0.6,0.9
Americas,Central America,El Salvador,Amphetamines,ARQ,Prescription stimulants,2016,2.7,0.6,0.9
Americas,Central America,Honduras,Amphetamines,ARQ,-,2016,1.9,1,1.7
Americas,Central America,Costa Rica,Amphetamines,ARQ,Amphetamine,2018,0.94,0.35,0.52
Americas,Central America,Costa Rica,Amphetamines,ARQ,Methamphetamine,2018,0.89,0.34,0.51
Americas,Central America,Costa Rica,Amphetamines,ARQ,Prescription stimulants,2018,5.55,3.3,4.21
Americas,Central America,El Salvador,Amphetamines,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",-,2018,5.2,0.8,1.1
Americas,Central America,El Salvador,Amphetamines,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",Amphetamine,2018,1.2,,
Americas,Central America,El Salvador,Amphetamines,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",Methamphetamine,2018,1.3,,
Americas,Central America,El Salvador,Amphetamines,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",Prescription stimulants,2018,1.8,0.6,0.8
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,1991,12.9,3,7.5
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,1992,12.5,3.3,7.3
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,1993,13.8,3.9,8.4
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,1994,14.3,4,9.1
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,1995,15.2,4.5,10
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,1996,15.5,4.8,10.4
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,1997,15.2,4.5,10.1
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,1998,14.5,4.3,9.3
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,1999,14,4.2,9
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,1999,6.5,1.5,4.1
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2000,13.5,4.5,9.2
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2000,6.2,1.5,3.5
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2001,13.9,4.7,9.6
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2001,5.8,1.4,3.4
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2002,13.1,4.4,8.9
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2002,5.3,1.5,3.2
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2003,11.8,3.9,8
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2003,5,1.4,3
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2004,11.2,3.6,7.6
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2004,4.5,1.1,2.6
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2005,10.3,3.3,7
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2005,3.9,0.9,2.4
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2006,10.1,3,6.8
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2006,3.4,0.7,2
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2007,9.5,3.2,6.5
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2007,2.5,0.5,1.4
Americas,North America,Canada,Amphetamines,ARQ,"Pharmaceutical stimulants used to ""get high""",2008,7.1,,4.5
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2008,8.6,2.6,5.8
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2008,2.5,0.7,1.3
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2009,8.6,2.7,5.9
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2009,2.2,0.5,1.3
Americas,North America,Canada,Amphetamines,ARQ,-,2010,10.9,,7.7
Americas,North America,Canada,Amphetamines,ARQ,Amphetamine and/or methamphetamine,2010,5.2,,3.7
Americas,North America,Canada,Amphetamines,ARQ,Prescription stimulants,2010,4,,2.7
Americas,North America,Canada,Amphetamines,ARQ,-,2010,7.4,1.6,4.3
Americas,North America,Canada,Amphetamines,ARQ,Amphetamine,2010,3.4,,2
Americas,North America,United States of America,Amphetamines,Govt.,Any amphetamines without prescription,2010,10.6,3.3,7.6
Americas,North America,United States of America,Amphetamines,Govt.,Methamphetamine,2010,2.5,0.7,1.6
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2010,8.9,2.7,6.2
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2010,2.2,0.6,1.3
Americas,North America,Mexico,Amphetamines,ARQ,-,2011,0.3,,0.1
Americas,North America,Mexico,Amphetamines,ARQ,Amphetamine,2011,0.001,0.001,
Americas,North America,United States of America,Amphetamines,ARQ,Amphetamine,2011,9,3.1,6.6
Americas,North America,United States of America,Amphetamines,ARQ,Methamphetamine,2011,2.1,0.5,1.4
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2011,8.6,2.8,5.9
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2011,1.8,0.5,1.2
Americas,North America,Mexico,Amphetamines,National Addiction Household Survey,Amphetamine,2011,0.3,0,0.1
Americas,North America,Canada,Amphetamines,ARQ,-,2012,6.9,,4.44
Americas,North America,Canada,Amphetamines,ARQ,Amphetamine and/or methamphetamine,2012,3.38,,2.1
Americas,North America,Canada,Amphetamines,ARQ,Prescription stimulants,2012,2.83,,1.63
Americas,North America,United States of America,Amphetamines,ARQ,-,2012,8.9,2.8,6.5
Americas,North America,United States of America,Amphetamines,ARQ,Methamphetamine,2012,1.8,0.6,1
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2012,8.3,2.5,5.6
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2012,1.6,0.5,1
Americas,North America,United States of America,Amphetamines,ARQ,-,2013,8.1,2.8,5.9
Americas,North America,United States of America,Amphetamines,ARQ,Methamphetamine,2013,1.6,0.4,1
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2013,10.5,3.2,7
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2013,1.5,0.4,1
Americas,North America,Canada,Amphetamines,ARQ,-,2014,6.13,,4.78
Americas,North America,Canada,Amphetamines,ARQ,Amphetamine,2014,2.08,,1.31
Americas,North America,Canada,Amphetamines,ARQ,Prescription stimulants,2014,2.89,,2.42
Americas,North America,Mexico,Amphetamines,ARQ,Amphetamine,2014,2.5,0.9,1.8
Americas,North America,Mexico,Amphetamines,ARQ,Methamphetamine,2014,2,0.7,1.3
Americas,North America,United States of America,Amphetamines,ARQ,Methamphetamine,2014,1.4,0.3,0.8
Americas,North America,United States of America,Amphetamines,CICAD/ OAS,Prescription stimulants,2014,3.5,0.8,2.2
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2014,9.7,3.2,6.6
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2014,1.4,0.3,0.8
Americas,North America,United States of America,Amphetamines,ARQ,Amphetamine. Monitoring the future,2015,9.7,3.1,6.8
Americas,North America,United States of America,Amphetamines,ARQ,Methamphetamine. Monitoring the future,2015,1.3,0.3,0.8
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2015,9.1,2.7,6.2
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2015,1.1,0.3,0.6
Americas,North America,Canada,Amphetamines,ARQ,-,2016,7.46,,5.88
Americas,North America,Canada,Amphetamines,ARQ,Amphetamine,2016,2.2,,1.73
Americas,North America,Canada,Amphetamines,ARQ,Other stimulants,2016,0.57,,0.31
Americas,North America,Canada,Amphetamines,ARQ,Prescription stimulants,2016,5.49,,4.39
Americas,North America,Mexico,Amphetamines,ARQ,Methamphetamine,2016,0.1,0,0.1
Americas,North America,Mexico,Amphetamines,ARQ,Amphetamine,2016,0.6,0.1,0.2
Americas,North America,Mexico,Amphetamines,ARQ,Methamphetamine,2016,0.1,,0.1
Americas,North America,Mexico,Amphetamines,ARQ,Prescription stimulants,2016,0.01,,
Americas,North America,United States of America,Amphetamines,ARQ,Amphetamine,2016,8.8,2.7,6.1
Americas,North America,United States of America,Amphetamines,ARQ,Methamphetamine,2016,0.7,0.2,0.4
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2016,8.1,2.5,5.4
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2016,0.8,0.3,0.5
Americas,North America,United States of America,Amphetamines,ARQ,Amphetamine,2017,8.2,2.7,6.1
Americas,North America,United States of America,Amphetamines,ARQ,Methamphetamine,2017,0.9,0.2,0.4
Americas,North America,United States of America,Amphetamines,ARQ,Prescription stimulants,2017,,,4
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2017,7.7,2.2,5
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2017,0.9,0.2,0.5
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Amphetamine,2018,8.6,2.4,5.7
Americas,North America,United States of America,Amphetamines,"Monitoring the future, Adolescent Drug Use",Methamphetamine,2018,0.8,0.1,0.4
Americas,South America,Guyana,Amphetamines,ARQ,-,2002,2,0.4,0.7
Americas,South America,Guyana,Amphetamines,ARQ,Methamphetamine,2002,1.5,0.3,0.8
Americas,South America,Colombia,Amphetamines,ARQ,Amphetamine,2004,5.6,,
Americas,South America,Bolivia (Plurinational State of),Amphetamines,CICAD/ OAS,Stimulants,2004,6.8,1.8,3
Americas,South America,Argentina,Amphetamines,CICAD/ OAS,-,2005,4.54,1.92,3
Americas,South America,Brazil,Amphetamines,CICAD/ OAS,-,2005,4.86,2.96,4.3
Americas,South America,Colombia,Amphetamines,CICAD/ OAS,-,2005,6.36,2.83,3.69
Americas,South America,Ecuador,Amphetamines,CICAD/ OAS,-,2005,3.03,1.11,1.58
Americas,South America,Paraguay,Amphetamines,CICAD/ OAS,-,2005,4.07,1.15,2.56
Americas,South America,Peru,Amphetamines,CICAD/ OAS,-,2005,1.2,0.37,0.59
Americas,South America,Suriname,Amphetamines,CICAD/ OAS,Prescription stimulants,2006,5.06,1.76,3
Americas,South America,Suriname,Amphetamines,OAS (MEM),Stimulants (inclds Amphetamines),2006,4.8,1.5,2.7
Americas,South America,Bolivia (Plurinational State of),Amphetamines,CICAD/ OAS,Prescription stimulants,2008,9.1,2.4,4
Americas,South America,Argentina,Amphetamines,ARQ,Prescription stimulants,2009,3.3,1.2,2
Americas,South America,Chile,Amphetamines,ARQ,-,2009,6.80833,1.30823,2.73695
Americas,South America,Chile,Amphetamines,ARQ,Prescription stimulants,2009,5.32236,0.87926,1.92404
Americas,South America,Ecuador,Amphetamines,ARQ,Prescription stimulants,2009,1.17,0.11,0.32
Americas,South America,Uruguay,Amphetamines,ARQ,ATS,2009,3,,
Americas,South America,Uruguay,Amphetamines,ARQ,Prescription stimulants,2009,2.1,0.5,1.2
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamines,ARQ,Prescription stimulants,2009,2.6,0.8,1.2
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamines,ARQ,methamphetamine,2009,0.433180501,0.164552333,0.246125285
Americas,South America,Brazil,Amphetamines,ARQ,Methamphetamine,2010,0.3,,
Americas,South America,Brazil,Amphetamines,ARQ,Prescription stimulants,2010,2.2,0.9,1.7
Americas,South America,Peru,Amphetamines,ARQ,Prescription stimulants,2010,0.149034893,0,0.0001
Americas,South America,Argentina,Amphetamines,ARQ,-,2011,2.8,0.9,1.4
Americas,South America,Chile,Amphetamines,ARQ,-,2011,3.12,0.56,1.66
Americas,South America,Chile,Amphetamines,ARQ,Prescription stimulants,2011,2.42,0.44,1.18
Americas,South America,Colombia,Amphetamines,ARQ,Prescription stimulants,2011,0.33,0.1,0.21
Americas,South America,Uruguay,Amphetamines,ARQ,-,2011,2.9,0.2,1.2
Americas,South America,Uruguay,Amphetamines,ARQ,Non-specified ATS,2011,1.6,,
Americas,South America,Uruguay,Amphetamines,ARQ,Prescription stimulants,2011,1.5,,1
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamines,ARQ,Prescription stimulants,2011,1.31,,
Americas,South America,Bolivia (Plurinational State of),Amphetamines,ARQ,Amphetamine,2012,0.45,,
Americas,South America,Bolivia (Plurinational State of),Amphetamines,ARQ,Methamphetamine,2012,0.41,,
Americas,South America,Colombia,Amphetamines,ARQ,Amphetamine,2012,0.77,0.02,0.12
Americas,South America,Colombia,Amphetamines,ARQ,Methamphetamine,2012,0.36,0.05,0.09
Americas,South America,Ecuador,Amphetamines,ARQ,-,2012,5.31,1.28,2.83
Americas,South America,Ecuador,Amphetamines,ARQ,Amphetamine,2012,0.41,0.1,0.13
Americas,South America,Peru,Amphetamines,ARQ,-,2012,0.14,,
Americas,South America,Peru,Amphetamines,ARQ,Prescription stimulants,2012,2.77,1.21,1.71
Americas,South America,Ecuador,Amphetamines,CICAD/ OAS,Prescription stimulants,2012,3.8,1,2.2
Americas,South America,Peru,Amphetamines,DEVIDA,Amphetamines,2012,0.1,,
Americas,South America,Peru,Amphetamines,DEVIDA,Prescription stimulants,2012,2.4,1,1.5
Americas,South America,Bolivia (Plurinational State of),Amphetamines,,Prescription stimulants,2013,0.31,0.05,0.05
Americas,South America,Chile,Amphetamines,ARQ,-,2013,6.61,1.61,3.68
Americas,South America,Chile,Amphetamines,ARQ,Prescription stimulants,2013,4.27,0.88,2.01
Americas,South America,Guyana,Amphetamines,CICAD/ OAS,Prescription stimulants,2013,2.87,0.86,1.15
Americas,South America,Argentina,Amphetamines,ARQ,Amphetamine,2014,0.9,,
Americas,South America,Argentina,Amphetamines,ARQ,Prescription stimulants,2014,2.8,1,1.5
Americas,South America,Paraguay,Amphetamines,ARQ,Prescription stimulants. Cities with at least 30000,2014,2.3,0.8,1.4
Americas,South America,Uruguay,Amphetamines,ARQ,-,2014,1.9,0.3,1.4
Americas,South America,Uruguay,Amphetamines,ARQ,Amphetamine,2014,0.2,0.1,0.2
Americas,South America,Uruguay,Amphetamines,ARQ,Prescription stimulants,2014,1.1,,0.6
Americas,South America,Uruguay,Amphetamines,ARQ,methamphetamine,2014,0.3,0.1,0.3
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamines,ARQ,Amphetamine,2014,0.11,,
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamines,ARQ,Methamphetamine,2014,0.07,,
Americas,South America,Chile,Amphetamines,ARQ,-,2015,7.62,1.65,3.88
Americas,South America,Chile,Amphetamines,ARQ,Prescription stimulants,2015,4.8,0.7,1.9
Americas,South America,Bolivia (Plurinational State of),Amphetamines,ARQ,-,2016,1.26,0.13,0.27
Americas,South America,Bolivia (Plurinational State of),Amphetamines,ARQ,Amphetamine,2016,0.21,,0.09
Americas,South America,Bolivia (Plurinational State of),Amphetamines,ARQ,Methamphetamine,2016,0.67,,0.13
Americas,South America,Colombia,Amphetamines,ARQ,Prescription stimulants,2016,1.42,0.56,1
Americas,South America,Uruguay,Amphetamines,ARQ,-,2016,3.2,0.4,1.9
Americas,South America,Uruguay,Amphetamines,ARQ,-,2016,3.2,0.4,1.9
Americas,South America,Uruguay,Amphetamines,ARQ,Amphetamine,2016,0.5,,
Americas,South America,Uruguay,Amphetamines,ARQ,Amphetamine,2016,0.5,,
Americas,South America,Uruguay,Amphetamines,ARQ,Methamphetamine,2016,0.7,,
Americas,South America,Uruguay,Amphetamines,ARQ,Prescription stimulants,2016,1.4,,0.8
Americas,South America,Uruguay,Amphetamines,ARQ,Prescription stimulants,2016,1.4,,0.8
Americas,South America,Uruguay,Amphetamines,ARQ,methamphetamine,2016,0.7,,
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamines,ARQ,-,2016,0.6,0.26,0.41
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamines,ARQ,Amphetamine,2016,0.2,0.09,0.12
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamines,ARQ,Methamphetamine,2016,0.16,0.05,0.11
Americas,South America,Colombia,Amphetamines,Government,Amphetamine,2016,1.06,0.06,0.27
Americas,South America,Colombia,Amphetamines,Government,Methamphetamine,2016,0.53,0.03,0.13
Americas,South America,Colombia,Amphetamines,Government,Prescription stimulants,2016,0.96,0.17,0.37
Americas,South America,Chile,Amphetamines,ARQ,-,2017,5.22,1.05,2.67
Americas,South America,Chile,Amphetamines,ARQ,Prescription stimulants,2017,4.27,0.85,2.15
Americas,South America,Argentina,Amphetamines,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Stimulants,2017,0.1,,0.05
Americas,South America,Peru,Amphetamines,OAS / DEVIDA,Prescription stimulants,2017,2.8,0.6,1
Americas,South America,Peru,Amphetamines,OAS / DEVIDA,Methamphetamine,2017,0.6,,
Americas,Caribbean,Dominican Republic,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2000,2.7,,
Americas,Caribbean,Turks and Caicos Islands,Cocaine,ARQ,-,2002,1.7,,0.7
Americas,Caribbean,Turks and Caicos Islands,Cocaine,ARQ,Crack,2002,,,0.8
Americas,Caribbean,Haiti,Cocaine,ARQ,-,2005,3.2,,2
Americas,Caribbean,Haiti,Cocaine,ARQ,Crack,2005,2.8,,1.6
Americas,Caribbean,Grenada,Cocaine,Govt.,Crack,2005,0.9,0.2,0.5
Americas,Caribbean,Puerto Rico,Cocaine,Govt.,Youth Risk Behavior Survey,2005,2.1,1.3,
Americas,Caribbean,Antigua and Barbuda,Cocaine,OAS (MEM),Ages not specified,2005,1.7,0.7,1
Americas,Caribbean,Antigua and Barbuda,Cocaine,OAS (MEM),Crack,2005,1.7,0.5,0.8
Americas,Caribbean,Saint Lucia,Cocaine,OAS (MEM),-,2005,1.5,0.5,0.8
Americas,Caribbean,Saint Kitts and Nevis,Cocaine,Govt.,-,2006,2.45,0.91,1.29
Americas,Caribbean,Saint Kitts and Nevis,Cocaine,Govt.,Crack,2006,2.58,1.04,1.3
Americas,Caribbean,Jamaica,Cocaine,OAS,-,2006,3.2,1.3,2.1
Americas,Caribbean,Jamaica,Cocaine,OAS,Crack,2006,1.7,,
Americas,Caribbean,Barbados,Cocaine,OAS (MEM),-,2006,2,0.5,0.9
Americas,Caribbean,Barbados,Cocaine,OAS (MEM),Crack,2006,2,0.5,0.7
Americas,Caribbean,Dominica,Cocaine,OAS (MEM),-,2006,0.6,0.3,0.4
Americas,Caribbean,Dominica,Cocaine,OAS (MEM),Crack,2006,0.8,0.4,0.6
Americas,Caribbean,Saint Vincent and the Grenadines,Cocaine,OAS (MEM),-,2006,0.6,0.21,0.32
Americas,Caribbean,Saint Vincent and the Grenadines,Cocaine,OAS (MEM),Crack,2006,0.32,0.11,0.21
Americas,Caribbean,Trinidad and Tobago,Cocaine,OAS (MEM),-,2006,0.83,,
Americas,Caribbean,Trinidad and Tobago,Cocaine,OAS (MEM),Crack,2006,0.74,,
Americas,Caribbean,Dominican Republic,Cocaine,ARQ,-,2008,0.8,0.2,0.5
Americas,Caribbean,Dominican Republic,Cocaine,ARQ,Crack,2008,0.7,0.2,0.5
Americas,Caribbean,Bahamas,Cocaine,Govt.,-,2008,0.3,,
Americas,Caribbean,Bahamas,Cocaine,Govt.,Crack,2008,0.3,,0.2
Americas,Caribbean,Jamaica,Cocaine,ARQ,-,2010,1,,
Americas,Caribbean,Bahamas,Cocaine,ARQ,-,2011,1.2,0.29,0.7
Americas,Caribbean,Bahamas,Cocaine,CICAD/ OAS,-,2011,1.5,0.29,0.7
Americas,Caribbean,Bahamas,Cocaine,CICAD/ OAS,Crack,2011,1.06,0.29,0.51
Americas,Caribbean,Dominica,Cocaine,CICAD/ OAS,-,2011,2.84,0.9,1.31
Americas,Caribbean,Dominica,Cocaine,CICAD/ OAS,Crack,2011,2.3,0.63,0.86
Americas,Caribbean,Antigua and Barbuda,Cocaine,CICAD/ OAS,Cocaine salts,2013,3.26,1.52,1.85
Americas,Caribbean,Antigua and Barbuda,Cocaine,CICAD/ OAS,Crack,2013,2.76,1.26,1.7
Americas,Caribbean,Barbados,Cocaine,CICAD/ OAS,-,2013,2.8,1.32,1.65
Americas,Caribbean,Barbados,Cocaine,CICAD/ OAS,Crack,2013,2.3,1.32,1.5
Americas,Caribbean,Grenada,Cocaine,CICAD/ OAS,Mainly crack,2013,3.25,1.61,2.2
Americas,Caribbean,Jamaica,Cocaine,CICAD/ OAS,Mainly crack,2013,2.08,0.51,1.08
Americas,Caribbean,Saint Kitts and Nevis,Cocaine,CICAD/ OAS,Cocaine salts,2013,2.93,1.12,1.77
Americas,Caribbean,Saint Kitts and Nevis,Cocaine,CICAD/ OAS,Crack,2013,3.38,1.78,2.1
Americas,Caribbean,Saint Lucia,Cocaine,CICAD/ OAS,Cocaine salts,2013,2.96,1.12,1.77
Americas,Caribbean,Saint Lucia,Cocaine,CICAD/ OAS,Crack,2013,2.34,1.24,1.62
Americas,Caribbean,Saint Vincent and the Grenadines,Cocaine,CICAD/ OAS,Cocaine salts,2013,1.21,0.64,0.64
Americas,Caribbean,Saint Vincent and the Grenadines,Cocaine,CICAD/ OAS,Crack,2013,0.72,0.57,0.65
Americas,Caribbean,Trinidad and Tobago,Cocaine,CICAD/ OAS,Cocaine salts,2013,2.81,0.86,1.49
Americas,Caribbean,Trinidad and Tobago,Cocaine,CICAD/ OAS,Crack,2013,2.17,0.7,1.14
Americas,Caribbean,Haiti,Cocaine,CICAD/ OAS,Mainly crack,2014,2.16,0.94,1.65
Americas,Central America,Belize,Cocaine,OAS (MEM),-,2002,1.4,0.5,0.7
Americas,Central America,Belize,Cocaine,OAS (MEM),Crack,2002,1.9,0.4,0.8
Americas,Central America,Guatemala,Cocaine,ARQ,-,2004,1.26,,0.54
Americas,Central America,Guatemala,Cocaine,ARQ,Crack,2004,0.37,,0.13
Americas,Central America,Nicaragua,Cocaine,ARQ,-,2004,2.3,,
Americas,Central America,Nicaragua,Cocaine,ARQ,Crack,2004,1.2,,
Americas,Central America,Honduras,Cocaine,ARQ,-,2005,,,0.88
Americas,Central America,Honduras,Cocaine,OAS (MEM),-,2005,2.14,0.4,0.88
Americas,Central America,Honduras,Cocaine,OAS (MEM),Crack,2005,0.43,0.1,0.21
Americas,Central America,El Salvador,Cocaine,ARQ,-,2008,1.94,0.5,1.08
Americas,Central America,El Salvador,Cocaine,ARQ,Crack,2008,1.2,0.4,0.6
Americas,Central America,Honduras,Cocaine,ARQ,Crack; Central District,2008,2.8,,1
Americas,Central America,Panama,Cocaine,CICAD/ OAS,-,2008,2.2,1.2,1.5
Americas,Central America,Panama,Cocaine,CICAD/ OAS,Crack,2008,1.2,1,1
Americas,Central America,Costa Rica,Cocaine,ARQ,Cocaine salts,2009,2.55,0.64,1.22
Americas,Central America,Costa Rica,Cocaine,ARQ,Crack,2009,1.25,0.38,0.57
Americas,Central America,Costa Rica,Cocaine,ARQ/ Govt.,-,2009,2,0.7,1.2
Americas,Central America,Costa Rica,Cocaine,ARQ/ Govt.,Crack,2009,1,0.35,0.5
Americas,Central America,Costa Rica,Cocaine,ARQ,Cocaine overall,2012,1.54,0.3,0.81
Americas,Central America,Costa Rica,Cocaine,ARQ,Cocaine salts,2012,1.35,0.23,0.64
Americas,Central America,Costa Rica,Cocaine,ARQ,Crack,2012,0.63,0.21,0.39
Americas,Central America,El Salvador,Cocaine,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",-,2012,2.7,0.2,0.4
Americas,Central America,El Salvador,Cocaine,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Cocaine salts,2012,2.3,0.2,0.4
Americas,Central America,El Salvador,Cocaine,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Crack,2012,0.4,0,0
Americas,Central America,Panama,Cocaine,ARQ,Cocaine salts,2013,1.27,0.11,0.28
Americas,Central America,Belize,Cocaine,CICAD/ OAS,-,2013,2.98,0.82,1.64
Americas,Central America,Belize,Cocaine,CICAD/ OAS,Crack,2013,1.75,0.56,0.72
Americas,Central America,Guatemala,Cocaine,ARQ,Cocaine salts,2014,3.6,0.82,1.4
Americas,Central America,Guatemala,Cocaine,ARQ,Crack,2014,2.84,0.55,0.94
Americas,Central America,Honduras,Cocaine,ARQ,Cocaine salts,2014,10,1.6,3.2
Americas,Central America,Costa Rica,Cocaine,ARQ,-,2015,2.158,0.28,1.95
Americas,Central America,Costa Rica,Cocaine,ARQ,Cocaine salts,2015,1.87,,1.67
Americas,Central America,Costa Rica,Cocaine,ARQ,Crack,2015,0.45,0.285,0.28
Americas,Central America,Honduras,Cocaine,ARQ,-,2015,6.8,1.1,3.4
Americas,Central America,El Salvador,Cocaine,ARQ,-,2016,4.7,0.8,1.4
Americas,Central America,El Salvador,Cocaine,ARQ,Cocaine salts,2016,3,0.5,0.9
Americas,Central America,El Salvador,Cocaine,ARQ,Crack,2016,1.7,0.3,0.5
Americas,Central America,Honduras,Cocaine,ARQ,Cocaine salts,2016,6,1.7,3.1
Americas,Central America,Honduras,Cocaine,ARQ,Crack,2016,3.2,0.8,1.2
Americas,Central America,Costa Rica,Cocaine,ARQ,-,2018,2.15,1.1,1.1
Americas,Central America,Costa Rica,Cocaine,ARQ,Cocaine salts,2018,1.83,0.48,0.91
Americas,Central America,Costa Rica,Cocaine,ARQ,Crack,2018,0.87,0.21,0.42
Americas,Central America,El Salvador,Cocaine,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",-,2018,2.8,0.6,0.9
Americas,Central America,El Salvador,Cocaine,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",Cocaine salts,2018,1.9,0.4,0.6
Americas,Central America,El Salvador,Cocaine,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",Crack,2018,0.9,0.2,0.3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,1991,4.6,0.8,2.2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,1991,2,0.4,1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,1991,4.1,0.7,2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,1992,4,0.9,2.1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,1992,1.9,0.5,1.1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,1992,3.5,0.7,1.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,1993,4.1,0.9,2.3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,1993,2,0.5,1.2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,1993,3.6,0.8,2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,1994,4.5,1.2,2.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,1994,2.5,0.7,1.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,1994,3.9,1.1,2.3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,1995,5.1,1.5,3.3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,1995,2.8,0.8,1.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,1995,4.2,1.2,2.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,1996,6,1.7,4
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,1996,3.2,0.9,2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,1996,5.2,1.3,3.4
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,1997,6.6,1.8,4.3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,1997,3.4,0.8,2.1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,1997,5.9,1.5,3.7
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,1998,7,1.9,4.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,1998,3.8,1,2.4
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,1998,6.1,1.6,3.7
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,1999,7.2,1.9,4.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,1999,3.8,0.9,2.2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,1999,6.3,1.7,4
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2000,6.5,1.7,3.9
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2000,3.5,0.9,2.1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2000,5.6,1.4,3.3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2001,5.9,1.5,3.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2001,3.2,0.9,1.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2001,5.1,1.3,3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2002,5.7,1.6,3.7
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2002,3.2,1,2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2002,4.8,1.3,3.1
Americas,North America,Mexico,Cocaine,National Adiction Household Survey,-,2002,,,0.2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2003,5.3,1.4,3.3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2003,2.9,0.8,1.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2003,4.5,1.2,2.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2004,5.5,1.6,3.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2004,2.9,0.8,1.7
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2004,4.7,1.4,3.1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2005,5.5,1.6,3.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2005,2.8,0.8,1.6
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2005,4.7,1.3,3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2006,5.3,1.6,3.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2006,2.6,0.7,1.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2006,4.7,1.4,3.1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2007,5.2,1.4,3.4
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2007,2.5,0.7,1.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2007,4.6,1.1,2.9
Americas,North America,Canada,Cocaine,ARQ,-,2008,7.2,,4.4
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2008,4.8,1.3,2.9
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2008,2.2,0.6,1.3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2008,4.1,1.1,2.6
Americas,North America,Mexico,Cocaine,National Adiction Household Survey,-,2008,,,0.4
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2009,4.2,1,2.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2009,2,0.5,1.2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2009,3.7,0.8,2.1
Americas,North America,Canada,Cocaine,ARQ,-,2010,2.6,,1.4
Americas,North America,Canada,Cocaine,ARQ,-,2010,3.1,,1.9
Americas,North America,United States of America,Cocaine,Govt.,(non-crack form),2010,3.7,0.9,2.2
Americas,North America,United States of America,Cocaine,Govt.,Crack,2010,1.8,0.5,1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2010,3.8,0.9,2.2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2010,1.9,0.5,1.1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2010,3.4,0.8,1.9
Americas,North America,Mexico,Cocaine,ARQ,Cocaine salts,2011,0.73,0.18,0.4
Americas,North America,Mexico,Cocaine,ARQ,-,2011,0.7,,0.4
Americas,North America,Mexico,Cocaine,ARQ,Crack,2011,0.1,,0.0001
Americas,North America,United States of America,Cocaine,ARQ,-,2011,3.3,0.7,1.9
Americas,North America,United States of America,Cocaine,ARQ,Crack,2011,1.6,0.4,0.9
Americas,North America,United States of America,Cocaine,ARQ,Other  coca type,2011,3,0.6,1.7
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2011,3.4,0.8,2
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2011,1.6,0.5,1
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2011,3.1,0.7,1.7
Americas,North America,Mexico,Cocaine,National Adiction Household Survey,-,2011,0.73,0.18,0.4
Americas,North America,Canada,Cocaine,ARQ,-,2012,3.33,,1.95
Americas,North America,United States of America,Cocaine,ARQ,-,2012,3.3,0.8,2
Americas,North America,United States of America,Cocaine,ARQ,Crack,2012,1.4,0.4,0.8
Americas,North America,United States of America,Cocaine,ARQ,Other  coca type,2012,3,0.7,1.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2012,3.3,0.8,1.9
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2012,1.5,0.4,0.9
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2012,2.9,0.7,1.7
Americas,North America,United States of America,Cocaine,ARQ,-,2013,3.3,0.8,1.9
Americas,North America,United States of America,Cocaine,ARQ,Crack,2013,1.5,0.4,0.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2013,3.1,0.8,1.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2013,1.5,0.4,0.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2013,2.7,0.6,1.5
Americas,North America,Canada,Cocaine,ARQ,-,2014,2.67,,1.93
Americas,North America,Mexico,Cocaine,ARQ,-,2014,3.3,0.9,1.7
Americas,North America,Mexico,Cocaine,ARQ,Crack,2014,1.6,,
Americas,North America,United States of America,Cocaine,ARQ,-,2014,2.6,0.6,1.9
Americas,North America,United States of America,Cocaine,ARQ,Crack,2014,1,0.3,0.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2014,2.9,0.7,1.6
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2014,1.3,0.4,0.7
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2014,2.5,0.6,1.5
Americas,North America,United States of America,Cocaine,ARQ,Cocaine salts. Monitoring the future,2015,2.7,0.8,1.8
Americas,North America,United States of America,Cocaine,ARQ,Other coca type. Monitoring the future,2015,1.1,0.3,0.7
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2015,2.7,0.8,1.7
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2015,1.3,0.4,0.8
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2015,2.3,0.7,1.5
Americas,North America,Canada,Cocaine,ARQ,-,2016,3.24,,2.44
Americas,North America,Mexico,Cocaine,ARQ,-,2016,1.1,0.2,0.6
Americas,North America,Mexico,Cocaine,ARQ,Crack,2016,0.4,0.1,0.3
Americas,North America,United States of America,Cocaine,ARQ,-,2016,2.1,0.4,1.3
Americas,North America,United States of America,Cocaine,ARQ,Crack,2016,0.8,0.2,0.4
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2016,2.3,0.5,1.4
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2016,1,0.3,0.6
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2016,2.1,0.4,1.2
Americas,North America,United States of America,Cocaine,ARQ,-,2017,2.1,0.4,1.4
Americas,North America,United States of America,Cocaine,ARQ,Cocaine salts,2017,1.9,0.4,1.2
Americas,North America,United States of America,Cocaine,ARQ,Crack,2017,0.8,0.3,0.6
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2017,2.5,0.7,1.6
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2017,1.1,0.4,0.7
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2017,2.1,0.6,1.3
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Cocaine,2018,2.6,0.3,1.5
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Crack,2018,1,0.3,0.6
Americas,North America,United States of America,Cocaine,"Monitoring the future, Adolescent Drug Use",Other cocaine,2018,2.4,0.5,1.4
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,1994,,,1.2
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,1994,,,0.8
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,1996,,,0.8
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,1996,,,0.9
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,1998,,,1
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,1998,,,0.9
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,2000,,,0.7
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,2000,,,1.1
Americas,South America,Guyana,Cocaine,ARQ,Crack; Limited Geography,2002,0.5,0.1,0.2
Americas,South America,Guyana,Cocaine,ARQ,Limited geography,2002,0.7,0.1,0.3
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,2002,,,0.2
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,2002,,,0.8
Americas,South America,Colombia,Cocaine,CICAD,-,2004,1.8,,1.6
Americas,South America,Colombia,Cocaine,CICAD,Coca paste / coca base,2004,1.4,,1.2
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,2004,,,0.7
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,2004,,,0.7
Americas,South America,Ecuador,Cocaine,ARQ,Crack,2005,0.6,,
Americas,South America,Brazil,Cocaine,CICAD/ OAS,"Cocaine, includes coca paste",2005,1.94,1.19,1.77
Americas,South America,Colombia,Cocaine,CICAD/ OAS,-,2005,2,0.5,1.74
Americas,South America,Paraguay,Cocaine,CICAD/ OAS,-,2005,1.09,0.51,0.73
Americas,South America,Paraguay,Cocaine,OAS (MEM),Crack; Ages not specified,2005,0.3,,
Americas,South America,Peru,Cocaine,ARQ,-,2006,1.43,0.686,1.113
Americas,South America,Peru,Cocaine,ARQ,Coca paste / coca base,2006,1.13,0.696,1.13
Americas,South America,Peru,Cocaine,ARQ,Cocaine salts,2006,1.018,0.696,0.696
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,2006,,,0.6
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,2006,,,0.7
Americas,South America,Peru,Cocaine,DEVIDA,Cocaine includes coca Pasta,2006,1,0.3,0.5
Americas,South America,Suriname,Cocaine,OAS (MEM),-,2006,0.7,0.07,0.17
Americas,South America,Suriname,Cocaine,OAS (MEM),-,2006,0.6,0.1,0.2
Americas,South America,Argentina,Cocaine,ARQ,-,2007,4.1,,2.5
Americas,South America,Argentina,Cocaine,ARQ,Crack,2007,0.8,,
Americas,South America,Peru,Cocaine,DEVIDA,Cocaine includes coca Pasta,2007,2.6,0.6,1.2
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Coca paste / coca base,2008,1.9,0.8,1.3
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Cocaine,2008,3.1,1.2,1.9
Americas,South America,Ecuador,Cocaine,ARQ,-,2008,2.2,,1.3
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,2008,,,0.4
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,2008,,,1
Americas,South America,Argentina,Cocaine,ARQ,Coca paste / coca base,2009,2.7,1,1.5
Americas,South America,Argentina,Cocaine,ARQ,Cocaine salts,2009,4.8,1.8,2.9
Americas,South America,Argentina,Cocaine,ARQ,Crack,2009,1.1,,
Americas,South America,Chile,Cocaine,ARQ,-,2009,8.48331,2.58402,4.94272
Americas,South America,Chile,Cocaine,ARQ,Coca paste / coca base,2009,5.43285,1.40826,2.85625
Americas,South America,Chile,Cocaine,ARQ,Cocaine salts,2009,6.54473,1.70828,3.38003
Americas,South America,Chile,Cocaine,ARQ,Crack,2009,3.42408,0.98271,1.77214
Americas,South America,Uruguay,Cocaine,ARQ,-,2009,4,1.1,2.6
Americas,South America,Uruguay,Cocaine,ARQ,Coca paste / coca base,2009,1.3,0.2,0.6
Americas,South America,Uruguay,Cocaine,ARQ,Cocaine salts,2009,3.9,1.1,2.5
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine,ARQ,Crack,2009,0.5,0.2,0.2
Americas,South America,Brazil,Cocaine,ARQ,Cocaine salts,2010,2.5,1,1.8
Americas,South America,Brazil,Cocaine,ARQ,Crack,2010,0.6,0.3,0.4
Americas,South America,Peru,Cocaine,ARQ,Cocaine salts,2010,0.441547216,0.40697611,0.40697611
Americas,South America,Peru,Cocaine,ARQ,Other  coca type PBC,2010,0.95703365,0.30028208,0.668887502
Americas,South America,Argentina,Cocaine,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Cocaine,2010,0.4,0.2,0.4
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,2010,,,0.3
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,2010,,,0.4
Americas,South America,Argentina,Cocaine,ARQ,-,2011,4.8,1.5,2.8
Americas,South America,Argentina,Cocaine,ARQ,Cocaine paste (paco),2011,2,0.6,1.1
Americas,South America,Argentina,Cocaine,ARQ,Crack,2011,0.8,,
Americas,South America,Argentina,Cocaine,ARQ,Cocaine salts,2011,3.2,,
Americas,South America,Chile,Cocaine,ARQ,-,2011,7.12,2.38,4.72
Americas,South America,Chile,Cocaine,ARQ,Coca paste / coca base,2011,4.11,1.31,2.36
Americas,South America,Chile,Cocaine,ARQ,Cocaine salts,2011,5.46,1.56,3.55
Americas,South America,Colombia,Cocaine,ARQ,Coca paste / coca base (Basuco),2011,0.66,0.22,0.47
Americas,South America,Colombia,Cocaine,ARQ,Cocaine salts,2011,2.77,1.02,1.87
Americas,South America,Uruguay,Cocaine,ARQ,-,2011,3.1,0.6,1.6
Americas,South America,Uruguay,Cocaine,ARQ,Cocaine salts,2011,2.6,0.6,1.4
Americas,South America,Uruguay,Cocaine,ARQ,Crack,2011,0.2,,
Americas,South America,Uruguay,Cocaine,ARQ,Other  coca type,2011,0.9,0.2,0.4
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine,ARQ,Cocaine salts,2011,0.49,0.07,0.25
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Coca paste / coca base,2012,0.3,0,0.1
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Cocaine salts,2012,1.55,0.03,0.24
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Crack,2012,0.17,0,0
Americas,South America,Colombia,Cocaine,ARQ,Coca paste / coca base (Basuco),2012,0.64,0.03,0.08
Americas,South America,Colombia,Cocaine,ARQ,Cocaine salts,2012,7,0.87,2.12
Americas,South America,Ecuador,Cocaine,ARQ,-,2012,2.92,0.5,1.3
Americas,South America,Ecuador,Cocaine,ARQ,Coca paste / coca base,2012,1.2,0.2,0.6
Americas,South America,Ecuador,Cocaine,ARQ,Cocaine salts,2012,2.2,0.4,1
Americas,South America,Ecuador,Cocaine,ARQ,Crack,2012,0.7,0.12,0.31
Americas,South America,Peru,Cocaine,ARQ,-,2012,2.14,0.81,1.02
Americas,South America,Peru,Cocaine,ARQ,Cocaine salts,2012,2.14,0.81,1.02
Americas,South America,Peru,Cocaine,ARQ,Pasta Basica,2012,2.22,0.79,1
Americas,South America,Brazil,Cocaine,CICAD/ OAS,Cocaine salts,2012,7.7,1.8,3
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,2012,,,0.2
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,2012,,,0.3
Americas,South America,Peru,Cocaine,DEVIDA,Cocaine salts,2012,1.8,0.7,0.9
Americas,South America,Peru,Cocaine,DEVIDA,Crack,2012,0.3,,
Americas,South America,Peru,Cocaine,DEVIDA,Pasta Basica,2012,1.9,0.7,0.9
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Coca paste / coca base,2013,0.02,0.02,0.02
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Cocaine salts,2013,0.4,0.02,0.11
Americas,South America,Chile,Cocaine,ARQ,-,2013,7.27,2.22,4.47
Americas,South America,Chile,Cocaine,ARQ,Coca paste / coca base,2013,4.15,1.13,2.25
Americas,South America,Chile,Cocaine,ARQ,Cocaine salts,2013,5.56,1.49,3.32
Americas,South America,Guyana,Cocaine,CICAD/ OAS,-,2013,1.52,0.66,1.05
Americas,South America,Guyana,Cocaine,CICAD/ OAS,-,2013,6.8,1,3.4
Americas,South America,Guyana,Cocaine,CICAD/ OAS,Crack,2013,2.07,0.45,1.1
Americas,South America,Argentina,Cocaine,ARQ,Cocaine paste (paco),2014,1.8,0.4,0.9
Americas,South America,Argentina,Cocaine,ARQ,Cocaine salts,2014,3.8,1,2.1
Americas,South America,Argentina,Cocaine,ARQ,Crack,2014,0.8,,
Americas,South America,Uruguay,Cocaine,ARQ,-,2014,3,0.9,2.3
Americas,South America,Uruguay,Cocaine,ARQ,Coca paste / coca base,2014,0.9,0.1,0.5
Americas,South America,Uruguay,Cocaine,ARQ,Cocaine salts,2014,2.7,0.9,2.1
Americas,South America,Uruguay,Cocaine,ARQ,Crack,2014,0.2,,
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine,ARQ,Coca paste / coca base,2014,0.06,,
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine,ARQ,Cocaine salts,2014,0.65,0.06,0.29
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine,ARQ,Crack,2014,0.08,,
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,2014,,,0.3
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,2014,,,1.6
Americas,South America,Paraguay,Cocaine,Survey in school,Cocaine salts. Schools in city with more than 30000,2014,2,0.7,1.7
Americas,South America,Paraguay,Cocaine,Survey in school,Crack. Schools in city with more than 30000,2014,1,0.3,0.6
Americas,South America,Chile,Cocaine,ARQ,-,2015,8.19,2.26,4.97
Americas,South America,Chile,Cocaine,ARQ,Cocaine salts,2015,6.34,1.49,3.84
Americas,South America,Chile,Cocaine,ARQ,Other coca/cocaine type,2015,4.7,1.23,2.63
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Cocaine salts,2016,1.39,0.22,0.41
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Coca paste/cocaine base,2016,0.34,0.04,0.04
Americas,South America,Bolivia (Plurinational State of),Cocaine,ARQ,Crack,2016,0.13,,
Americas,South America,Colombia,Cocaine,ARQ,Coca paste/cocaine base,2016,1.29,0.58,0.89
Americas,South America,Colombia,Cocaine,ARQ,Cocaine salts,2016,4.27,1.58,2.85
Americas,South America,Uruguay,Cocaine,ARQ,-,2016,3.8,1.1,2.6
Americas,South America,Uruguay,Cocaine,ARQ,-,2016,3.8,1.1,2.6
Americas,South America,Uruguay,Cocaine,ARQ,Coca paste / coca base,2016,0.9,0.2,0.5
Americas,South America,Uruguay,Cocaine,ARQ,Cocaine salts,2016,3.5,1.1,2.5
Americas,South America,Uruguay,Cocaine,ARQ,Cocaine salts,2016,3.5,1.1,2.5
Americas,South America,Uruguay,Cocaine,ARQ,Crack,2016,0.6,,
Americas,South America,Uruguay,Cocaine,ARQ,Crack,2016,0.6,,
Americas,South America,Chile,Cocaine,Chile XII study 2017,Base Paste,2016,,,0.3
Americas,South America,Chile,Cocaine,Chile XII study 2017,Cocaine hydrochloride,2016,,,0.3
Americas,South America,Ecuador,Cocaine,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",Coca paste/cocaine base,2016,2.29,0.44,1.96
Americas,South America,Ecuador,Cocaine,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",Cocaine salts,2016,2.92,0.43,2.3
Americas,South America,Ecuador,Cocaine,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",Crack,2016,1.2,0.59,1.18
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",Bazuco,2016,0.2,0.08,0.12
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",Cocaine salts,2016,0.59,0.28,0.4
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",Crack,2016,0.25,0.12,0.17
Americas,South America,Colombia,Cocaine,Government,Cocaine salts,2016,6.94,1.19,2.71
Americas,South America,Colombia,Cocaine,Government,coca base (Basuco),2016,0.57,0.05,0.14
Americas,South America,Ecuador,Cocaine,Government,Cocaine salts,2016,4.41,0.47,1.52
Americas,South America,Peru,Cocaine,OAS,Cocaine salts,2016,1.82,0.15,0.29
Americas,South America,Chile,Cocaine,ARQ,-,2017,6.57,1.71,3.99
Americas,South America,Chile,Cocaine,ARQ,Base Paste,2017,3.05,0.74,1.42
Americas,South America,Chile,Cocaine,ARQ,Cocaine salts,2017,5.21,1.17,3.18
Americas,South America,Argentina,Cocaine,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Cocaine,2017,1.2,0.1,0.4
Americas,South America,Argentina,Cocaine,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Cocaine paste (paco),2017,0.2,,0
Americas,South America,Argentina,Cocaine,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Crack,2017,0,,
Americas,South America,Peru,Cocaine,OAS / DEVIDA,Cocaine salts,2017,2.6,0.5,1
Americas,South America,Peru,Cocaine,OAS / DEVIDA,crack,2017,0.6,,
Americas,South America,Peru,Cocaine,OAS / DEVIDA,Pasta Basica,2017,2.3,0.3,0.7
Americas,Caribbean,Turks and Caicos Islands,Ecstasy,ARQ,-,2002,2.2,,1.6
Americas,Caribbean,Haiti,Ecstasy,ARQ,-,2005,3,,2
Americas,Caribbean,Grenada,Ecstasy,Govt.,-,2005,1,0.2,0.5
Americas,Caribbean,Puerto Rico,Ecstasy,Govt.,Youth Risk Behavior Survey,2005,2.2,,
Americas,Caribbean,Antigua and Barbuda,Ecstasy,OAS (MEM),-,2005,1.2,,
Americas,Caribbean,Saint Kitts and Nevis,Ecstasy,Govt.,-,2006,2.06,0.52,0.91
Americas,Caribbean,Jamaica,Ecstasy,OAS,-,2006,3,,
Americas,Caribbean,Barbados,Ecstasy,OAS (MEM),-,2006,1.8,0.4,0.6
Americas,Caribbean,Dominica,Ecstasy,OAS (MEM),-,2006,0.6,,
Americas,Caribbean,Saint Vincent and the Grenadines,Ecstasy,OAS (MEM),-,2006,0.54,0,0.11
Americas,Caribbean,Trinidad and Tobago,Ecstasy,OAS (MEM),-,2006,0.87,,
Americas,Caribbean,Dominican Republic,Ecstasy,ARQ,-,2008,0.5,,
Americas,Caribbean,Bahamas,Ecstasy,Govt.,-,2008,0.9,,0.4
Americas,Caribbean,Bahamas,Ecstasy,ARQ,-,2011,1.1,,
Americas,Caribbean,Bahamas,Ecstasy,CICAD/ OAS,-,2011,1.06,,
Americas,Caribbean,Dominica,Ecstasy,CICAD/ OAS,-,2011,2.57,,
Americas,Caribbean,Antigua and Barbuda,Ecstasy,CICAD/ OAS,-,2013,3.73,,
Americas,Caribbean,Barbados,Ecstasy,CICAD/ OAS,-,2013,2.4,,
Americas,Caribbean,Grenada,Ecstasy,CICAD/ OAS,-,2013,1.88,,
Americas,Caribbean,Jamaica,Ecstasy,CICAD/ OAS,-,2013,1.62,,
Americas,Caribbean,Saint Kitts and Nevis,Ecstasy,CICAD/ OAS,-,2013,1.45,,
Americas,Caribbean,Saint Lucia,Ecstasy,CICAD/ OAS,-,2013,1.78,,
Americas,Caribbean,Saint Vincent and the Grenadines,Ecstasy,CICAD/ OAS,-,2013,0.39,,
Americas,Caribbean,Trinidad and Tobago,Ecstasy,CICAD/ OAS,-,2013,1.55,,
Americas,Caribbean,Haiti,Ecstasy,CICAD/ OAS,-,2014,0.88,,
Americas,Caribbean,El Salvador,Ecstasy,ARQ,-,2016,1.6,0.1,0.3
Americas,Caribbean,El Salvador,Ecstasy,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",-,2018,0.9,0.2,0.3
Americas,Central America,Belize,Ecstasy,OAS (MEM),-,2002,1.2,0.3,0.7
Americas,Central America,Guatemala,Ecstasy,ARQ,-,2004,0.32,,0.15
Americas,Central America,Nicaragua,Ecstasy,ARQ,-,2004,0.5,,
Americas,Central America,Honduras,Ecstasy,OAS (MEM),-,2005,0.24,0.05,0.08
Americas,Central America,Panama,Ecstasy,CICAD/ OAS,-,2008,1.4,0.9,1
Americas,Central America,Costa Rica,Ecstasy,ARQ,-,2009,2.1,,
Americas,Central America,Costa Rica,Ecstasy,ARQ,-,2012,0.67,0.32,0.52
Americas,Central America,Panama,Ecstasy,ARQ,-,2013,0.71,0.04,0.18
Americas,Central America,Belize,Ecstasy,CICAD/ OAS,-,2013,2.42,,
Americas,Central America,Costa Rica,Ecstasy,ARQ,-,2015,1.67,,1.67
Americas,Central America,Honduras,Ecstasy,ARQ,-,2016,2,0.3,1.2
Americas,Central America,Costa Rica,Ecstasy,ARQ,-,2018,0.99,0.34,0.58
Americas,Central America,Costa Rica,Ecstasy,Government provided CICAD university population data for 2018,-,2018,3.8,0.4,1.8
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,1996,4.9,1.5,3.1
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,1997,5.2,1.3,3.4
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,1998,4.5,1.2,2.9
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,1999,5.3,1.6,3.7
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2000,7.2,2.4,5.3
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2001,8,2.4,6
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2002,6.9,1.8,4.9
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2003,5.4,1,3.1
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2004,4.7,0.9,2.6
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2005,4,0.9,2.4
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2006,4.3,1,2.7
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2007,4.5,1.1,3
Americas,North America,Canada,Ecstasy,ARQ,-,2008,13.2,,9.2
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2008,4.1,1.2,2.9
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2009,4.6,1.2,3
Americas,North America,Canada,Ecstasy,ARQ,-,2010,6.6,,3.5
Americas,North America,Canada,Ecstasy,ARQ,-,2010,8.2,,5.8
Americas,North America,United States of America,Ecstasy,Govt.,-,2010,6.4,1.9,4.7
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2010,5.5,1.5,3.8
Americas,North America,United States of America,Ecstasy,ARQ,-,2011,6.6,1.6,4.5
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2011,5.5,1.4,3.7
Americas,North America,Canada,Ecstasy,ARQ,-,2012,4.46,,2.5
Americas,North America,United States of America,Ecstasy,ARQ,-,2012,5,1,3
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2012,4.6,0.8,2.5
Americas,North America,United States of America,Ecstasy,ARQ,-,2013,5.7,1.2,3.6
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2013,4.7,1,2.8
Americas,North America,Canada,Ecstasy,ARQ,-,2014,3.64,,2.64
Americas,North America,United States of America,Ecstasy,ARQ,-,2014,3.7,0.8,2.3
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2014,5,1.1,3.4
Americas,North America,United States of America,Ecstasy,ARQ,Monitoring the future,2015,3.8,0.9,2.4
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2015,4,0.8,2.4
Americas,North America,Canada,Ecstasy,ARQ,-,2016,3.15,,2.32
Americas,North America,Mexico,Ecstasy,ARQ,-,2016,0.66,,
Americas,North America,United States of America,Ecstasy,ARQ,-,2016,2.8,0.5,1.8
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2016,3.1,0.6,1.8
Americas,North America,United States of America,Ecstasy,ARQ,-,2017,2.8,0.5,1.8
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2017,3,0.6,1.7
Americas,North America,United States of America,Ecstasy,"Monitoring the future, Adolescent Drug Use",-,2018,2.4,0.4,1.4
Americas,South America,Guyana,Ecstasy,ARQ,-,2002,0.9,0.3,0.5
Americas,South America,Colombia,Ecstasy,ARQ,-,2004,3.3,,2.8
Americas,South America,Colombia,Ecstasy,CICAD/ OAS,-,2005,4.32,1.04,3.68
Americas,South America,Paraguay,Ecstasy,CICAD/ OAS,-,2005,0.5,0.32,0.41
Americas,South America,Peru,Ecstasy,ARQ,-,2006,0.285,,
Americas,South America,Suriname,Ecstasy,CICAD/ OAS,-,2006,1.45,,
Americas,South America,Suriname,Ecstasy,OAS (MEM),-,2006,1.2,0.2,0.2
Americas,South America,Argentina,Ecstasy,ARQ,-,2007,2,,
Americas,South America,Peru,Ecstasy,ARQ,-,2007,1.2,,0.6
Americas,South America,Bolivia (Plurinational State of),Ecstasy,ARQ,-,2008,1.6,,
Americas,South America,Ecuador,Ecstasy,ARQ,-,2008,1.3,,0.7
Americas,South America,Chile,Ecstasy,ARQ,-,2009,3.7,0.82,1.6
Americas,South America,Ecuador,Ecstasy,ARQ,-,2009,1.18,0.1,0.23
Americas,South America,Uruguay,Ecstasy,ARQ,-,2009,1.2,,
Americas,South America,Venezuela (Bolivarian Republic of),Ecstasy,ARQ,-,2009,0.5292483,0.206741447,0.266789585
Americas,South America,Brazil,Ecstasy,ARQ,-,2010,1.3,,
Americas,South America,Peru,Ecstasy,ARQ,-,2010,0.114410576,,0.114410576
Americas,South America,Argentina,Ecstasy,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Ecstasy,2010,0.1,0,0.03
Americas,South America,Brazil,Ecstasy,CICAD/ OAS,-,2010,7.5,1.9,3.1
Americas,South America,Argentina,Ecstasy,ARQ,-,2011,2.3,0.7,1.4
Americas,South America,Chile,Ecstasy,ARQ,-,2011,2.09,0.3,1.18
Americas,South America,Colombia,Ecstasy,ARQ,-,2011,1.22,0.38,0.79
Americas,South America,Uruguay,Ecstasy,ARQ,-,2011,0.5,0.2,0.3
Americas,South America,Bolivia (Plurinational State of),Ecstasy,ARQ,-,2012,0.57,0.01,0.01
Americas,South America,Colombia,Ecstasy,ARQ,-,2012,3.15,0.21,0.75
Americas,South America,Ecuador,Ecstasy,ARQ,-,2012,1.1,0.2,0.5
Americas,South America,Peru,Ecstasy,ARQ,-,2012,1.68,0.71,1.09
Americas,South America,Peru,Ecstasy,CICAD/ OAS,-,2012,1.09,0.08,0.28
Americas,South America,Peru,Ecstasy,DEVIDA,-,2012,1.6,0.7,1
Americas,South America,Bolivia (Plurinational State of),Ecstasy,ARQ,-,2013,0.02,,0.02
Americas,South America,Chile,Ecstasy,ARQ,-,2013,3.82,0.95,2.21
Americas,South America,Guyana,Ecstasy,CICAD/ OAS,-,2013,1.69,,
Americas,South America,Argentina,Ecstasy,ARQ,-,2014,2.4,1,1.6
Americas,South America,Paraguay,Ecstasy,ARQ,Cities with more than 30000,2014,1,0.4,0.7
Americas,South America,Uruguay,Ecstasy,ARQ,-,2014,1,0.2,0.8
Americas,South America,Venezuela (Bolivarian Republic of),Ecstasy,ARQ,-,2014,0.45,0.08,0.24
Americas,South America,Chile,Ecstasy,ARQ,-,2015,4.73,1.11,2.57
Americas,South America,Bolivia (Plurinational State of),Ecstasy,ARQ,-,2016,0.54,0.13,0.24
Americas,South America,Colombia,Ecstasy,ARQ,-,2016,2.21,0.67,1.4
Americas,South America,Uruguay,Ecstasy,ARQ,-,2016,1.9,0.4,1.3
Americas,South America,Ecuador,Ecstasy,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",-,2016,1.95,0.35,1.23
Americas,South America,Venezuela (Bolivarian Republic of),Ecstasy,"Encuesta sobre uso y consumo de drogas ilícitas  en estudiantes de 9no. EGB, 1ero. Y 3ero. De bachillerato, 2016.",-,2016,1.95,0.35,1.23
Americas,South America,Colombia,Ecstasy,Government,-,2016,4.77,0.52,2
Americas,South America,Peru,Ecstasy,Government,-,2016,0.51,0.03,0.06
Americas,South America,Ecuador,Ecstasy,OAS,-,2016,1.62,0.07,0.43
Americas,South America,Chile,Ecstasy,ARQ,-,2017,2.44,0.43,1.08
Americas,South America,Uruguay,Ecstasy,ARQ,-,2017,1.9,0.4,1.3
Americas,South America,Argentina,Ecstasy,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Ecstasy,2017,0.3,,0.1
Americas,South America,Peru,Ecstasy,OAS / DEVIDA,-,2017,2.3,0.3,0.8
Americas,Caribbean,Dominican Republic,Tranquillizers and sedatives,CICAD/OAS,-,2008,12.81,3.22,6.19
Americas,Caribbean,Jamaica,Tranquillizers and sedatives,,Benzodiazepines,2010,3.2,,
Americas,Caribbean,Bahamas,Tranquillizers and sedatives,CICAD/OAS,-,2011,3.8,1.3,2.3
Americas,Caribbean,Bahamas,Tranquillizers and sedatives,CICAD/OAS,-,2011,3.99,1.1,1.98
Americas,Caribbean,Dominica,Tranquillizers and sedatives,CICAD/OAS,-,2011,11.44,1.98,2.84
Americas,Caribbean,Antigua and Barbuda,Tranquillizers and sedatives,CICAD/OAS,-,2013,3.98,1.42,1.96
Americas,Caribbean,Barbados,Tranquillizers and sedatives,CICAD/OAS,-,2013,3.02,0.88,1.92
Americas,Caribbean,Grenada,Tranquillizers and sedatives,CICAD/OAS,-,2013,4,1.85,3.01
Americas,Caribbean,Jamaica,Tranquillizers and sedatives,CICAD/OAS,-,2013,3.24,0.96,1.74
Americas,Caribbean,Saint Kitts and Nevis,Tranquillizers and sedatives,CICAD/OAS,-,2013,3.85,1.3,2.57
Americas,Caribbean,Saint Lucia,Tranquillizers and sedatives,CICAD/OAS,-,2013,4.78,2.02,3.09
Americas,Caribbean,Saint Vincent and the Grenadines,Tranquillizers and sedatives,CICAD/OAS,-,2013,1.95,0.83,1.09
Americas,Caribbean,Trinidad and Tobago,Tranquillizers and sedatives,CICAD/OAS,-,2013,2.87,0.91,1.52
Americas,Caribbean,Haiti,Tranquillizers and sedatives,CICAD/OAS,-,2014,11.21,4.36,6.46
Americas,Central America,Honduras,Tranquillizers and sedatives,CICAD/OAS,-,2005,12.39,2.82,4.91
Americas,Central America,Panama,Tranquillizers and sedatives,CICAD/OAS,-,2008,7.4,1,1.6
Americas,Central America,El Salvador,Tranquillizers and sedatives,"Segundo Estudio Nacional sobre Consumo de Sustancias Psicoactivas en Población Escolar de El Salvador, 2008.",-,2008,2.8,1.3,1.8
Americas,Central America,Costa Rica,Tranquillizers and sedatives,,Benzodiazepines,2009,8,2.6,4.6
Americas,Central America,Costa Rica,Tranquillizers and sedatives,,-,2012,4.8,1.3,2.4
Americas,Central America,Costa Rica,Tranquillizers and sedatives,ARQ,-,2012,5.64,1.64,3.19
Americas,Central America,El Salvador,Tranquillizers and sedatives,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",-,2012,7.5,0.4,2.1
Americas,Central America,El Salvador,Tranquillizers and sedatives,"Estudio Nacional sobre Consumo de Drogas en Población Estudiantil Universitaria de El Salvador, 2012",Benzodiazepines,2012,7.5,0.4,2.1
Americas,Central America,Panama,Tranquillizers and sedatives,ARQ,-,2013,3.2,0.3,1.1
Americas,Central America,Belize,Tranquillizers and sedatives,CICAD/OAS,-,2013,4.68,1.49,2.72
Americas,Central America,Guatemala,Tranquillizers and sedatives,ARQ,-,2014,7,1.81,2.79
Americas,Central America,Honduras,Tranquillizers and sedatives,ARQ,Benzodiazepines,2014,14.8,3.2,6
Americas,Central America,Costa Rica,Tranquillizers and sedatives,ARQ,Benzodiazepines,2015,0.09,,0.09
Americas,Central America,Costa Rica,Tranquillizers and sedatives,ARQ,-,2015,4.8,1.52,2.78
Americas,Central America,Honduras,Tranquillizers and sedatives,ARQ,-,2015,8.3,1.9,4.2
Americas,Central America,Honduras,Tranquillizers and sedatives,ARQ,-,2015,7.2,1,2.7
Americas,Central America,El Salvador,Tranquillizers and sedatives,ARQ,-,2016,4.8,1,1.9
Americas,Central America,Costa Rica,Tranquillizers and sedatives,ARQ,-,2018,4.85,3.04,4.03
Americas,Central America,El Salvador,Tranquillizers and sedatives,"Población objetivo: Estudiantes cursando los grados de septimo noveno y segundo año de bachillerato. La encuesta se paso en 98 centros educativos seleccionados de forma aleatoria a nivel nacional, utilizando la metodología del Sistema Interamericano de Da",-,2018,4.7,1.5,2.2
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,1991,5.5,1.1,2.8
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,1992,5.3,1.1,2.8
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,1993,5.4,1.1,2.9
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,1994,5.5,1.3,3.1
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,1995,5.8,1.6,3.7
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,1996,6.5,1.7,4.1
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,1997,6.6,1.7,4.1
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,1998,6.9,1.9,4.4
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,1999,7,1.9,4.4
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2000,6.9,2.1,4.5
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2001,7.9,2.3,5.5
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2002,7.9,2.4,5.3
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2003,7.3,2.2,4.8
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2004,7.1,2.1,4.8
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2005,6.8,2.1,4.7
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2006,7,2.1,4.6
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2007,6.7,2,4.5
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2008,6.3,1.9,4.3
Americas,North America,United States of America,Tranquillizers and sedatives,,-,2009,7,2,5
Americas,North America,United States of America,Tranquillizers and sedatives,,Benzodiazepines,2009,0.7,0.3,0.4
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2009,6.5,1.9,4.5
Americas,North America,Canada,Tranquillizers and sedatives,,Pharmaceutical tranquilizers & sedatives,2010,2.4,,1.8
Americas,North America,Canada,Tranquillizers and sedatives,ARQ,-,2010,4.9,,3.5
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2010,6.6,1.9,4.4
Americas,North America,United States of America,Tranquillizers and sedatives,,Benzodiazepines,2011,1.2,0.3,0.6
Americas,North America,Mexico,Tranquillizers and sedatives,ARQ,Benzodiazepines,2011,0.4,,0.1
Americas,North America,Mexico,Tranquillizers and sedatives,ARQ,Barbiturates,2011,0.1,,
Americas,North America,United States of America,Tranquillizers and sedatives,ARQ,-,2011,6.8,2.2,4.5
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2011,6,1.7,3.9
Americas,North America,Canada,Tranquillizers and sedatives,ARQ,-,2012,6.14,,3.8
Americas,North America,Canada,Tranquillizers and sedatives,ARQ,Other sedatives and tranquillizers,2012,2.08,,1.3
Americas,North America,United States of America,Tranquillizers and sedatives,ARQ,-,2012,6.3,1.7,4.3
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2012,5.8,1.5,3.7
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2013,5.2,1.5,3.3
Americas,North America,Canada,Tranquillizers and sedatives,ARQ,-,2014,2.76,,2.12
Americas,North America,Mexico,Tranquillizers and sedatives,ARQ,-,2014,3.7,1.3,2.6
Americas,North America,United States of America,Tranquillizers and sedatives,CICAD/OAS,-,2014,5.3,1.5,3.4
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2014,5.3,1.5,3.4
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2015,5.2,1.5,3.4
Americas,North America,Canada,Tranquillizers and sedatives,ARQ,-,2016,6.93,,5.46
Americas,North America,Canada,Tranquillizers and sedatives,ARQ,Other sedatives and tranquillizers,2016,2.64,,2.1
Americas,North America,Mexico,Tranquillizers and sedatives,ARQ,-,2016,0.4,,0.3
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2016,5.5,1.4,3.5
Americas,North America,United States of America,Tranquillizers and sedatives,"Monitoring the future, Adolescent Drug Use",Tranquillizers,2017,5.6,1.4,3.6
Americas,South America,Colombia,Tranquillizers and sedatives,,Benzodiazepines,2004,9.9,,6.3
Americas,South America,Paraguay,Tranquillizers and sedatives,CICAD/OAS,-,2005,12.3,4.7,7.4
Americas,South America,Peru,Tranquillizers and sedatives,,-,2006,2.171,0.161,1.291
Americas,South America,Suriname,Tranquillizers and sedatives,CICAD/OAS,-,2006,10.91,3.78,6.35
Americas,South America,Bolivia (Plurinational State of),Tranquillizers and sedatives,Govt.,Tranquillizers,2008,14.3,3.6,6.9
Americas,South America,Argentina,Tranquillizers and sedatives,,-,2009,4.4,1.4,2.7
Americas,South America,Chile,Tranquillizers and sedatives,,-,2009,10.54832,2.93727,5.27
Americas,South America,Uruguay,Tranquillizers and sedatives,,-,2009,6.1,1.3,3.4
Americas,South America,Venezuela (Bolivarian Republic of),Tranquillizers and sedatives,,-,2009,3.9,1.1,2
Americas,South America,Brazil,Tranquillizers and sedatives,,Benzodiazepines,2010,5.3,1.3,2.6
Americas,South America,Peru,Tranquillizers and sedatives,ARQ,-,2010,0.717,0.0605,0.251
Americas,South America,Chile,Tranquillizers and sedatives,Chile XII study 2017,Tranquillizers,2010,,,0.4
Americas,South America,Argentina,Tranquillizers and sedatives,ARQ,-,2011,5.2,0.7,2.7
Americas,South America,Argentina,Tranquillizers and sedatives,ARQ,-,2011,2.5,,
Americas,South America,Chile,Tranquillizers and sedatives,ARQ,-,2011,16.2,2.92,7.62
Americas,South America,Colombia,Tranquillizers and sedatives,ARQ,-,2011,1.09,0.37,0.78
Americas,South America,Uruguay,Tranquillizers and sedatives,ARQ,-,2011,7.6,,3.8
Americas,South America,Venezuela (Bolivarian Republic of),Tranquillizers and sedatives,ARQ,-,2011,4.21,,
Americas,South America,Colombia,Tranquillizers and sedatives,ARQ,-,2012,3.34,0.64,1.43
Americas,South America,Ecuador,Tranquillizers and sedatives,ARQ,-,2012,5.4,1.4,2.9
Americas,South America,Peru,Tranquillizers and sedatives,ARQ,-,2012,4.64,1.45,2.55
Americas,South America,Chile,Tranquillizers and sedatives,Chile XII study 2017,Tranquillizers,2012,,,0.5
Americas,South America,Peru,Tranquillizers and sedatives,DEVIDA,-,2012,4,1.3,2.3
Americas,South America,Bolivia (Plurinational State of),Tranquillizers and sedatives,ARQ,Benzodiazepines,2013,1.4,,
Americas,South America,Chile,Tranquillizers and sedatives,ARQ,Benzodiazepines,2013,16.39,3.96,9.96
Americas,South America,Guyana,Tranquillizers and sedatives,CICAD/OAS,-,2013,3.31,0.95,1.43
Americas,South America,Argentina,Tranquillizers and sedatives,ARQ,-,2014,5.2,1.5,2.9
Americas,South America,Paraguay,Tranquillizers and sedatives,ARQ,Cities with more than 30000,2014,6.1,2,3.6
Americas,South America,Uruguay,Tranquillizers and sedatives,ARQ,-,2014,6.1,,3.1
Americas,South America,Uruguay,Tranquillizers and sedatives,ARQ,-,2014,9.5,,5.4
Americas,South America,Venezuela (Bolivarian Republic of),Tranquillizers and sedatives,ARQ,-,2014,5.3,0.8,2.7
Americas,South America,Chile,Tranquillizers and sedatives,Chile XII study 2017,Tranquillizers,2014,,,0.2
Americas,South America,Chile,Tranquillizers and sedatives,ARQ,-,2015,16.9,3.66,9.97
Americas,South America,Chile,Tranquillizers and sedatives,ARQ,Benzodiazepines,2015,16.9,3.66,9.97
Americas,South America,Bolivia (Plurinational State of),Tranquillizers and sedatives,ARQ,-,2016,3.14,0.54,1.18
Americas,South America,Colombia,Tranquillizers and sedatives,ARQ,-,2016,3.4,1.13,2.33
Americas,South America,Uruguay,Tranquillizers and sedatives,ARQ,-,2016,9.5,,5.4
Americas,South America,Venezuela (Bolivarian Republic of),Tranquillizers and sedatives,ARQ,-,2016,1.65,0.66,1.12
Americas,South America,Chile,Tranquillizers and sedatives,Chile XII study 2017,Tranquillizers,2016,,,0.8
Americas,South America,Colombia,Tranquillizers and sedatives,Government,-,2016,4.98,0.58,1.81
Americas,South America,Chile,Tranquillizers and sedatives,ARQ,Benzodiazepines,2017,15.38,3.42,8.76
Americas,South America,Argentina,Tranquillizers and sedatives,Argentina Estudio Nacional en poblacion de 12-65_Consumo 2017,Tranquillizers,2017,0.8,0,0.6
Americas,South America,Peru,Tranquillizers and sedatives,OAS / DEVIDA,-,2017,5.1,2.5,3.2
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamines,ARQ,Ages not specified,2007,0.8,,
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamines,ARQ,Amphetamine; Ages not specified,2007,0.5,,
Asia,Central Asia and Transcaucasia,Armenia,Amphetamines,ESPAD,-,2007,0,,
Asia,Central Asia and Transcaucasia,Georgia,Amphetamines,Research,Amphetamine; select regions (capital); Georgian Medical News No3 (180) 2010,2010,1.9,,
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamines,ARQ,Amphetamine,2012,1,,
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamines,ARQ,Prescription stimulants,2012,0.6,,
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamines,ARQ,Amphetamine . 6 regions and 2 cities,2012,1,,
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamines,ARQ,Prescription stimulants. 6 regions and 2 cities.,2012,0.6,,
Asia,Central Asia and Transcaucasia,Georgia,Amphetamines,ARQ / ESPAD,Amphetamine,2015,3,,1.1
Asia,Central Asia and Transcaucasia,Georgia,Amphetamines,ARQ / ESPAD,Methamphetamine,2015,1.1,,0.7
Asia,East and South-East Asia,Thailand,Amphetamines,ARQ,Methamphetamine; Ages not specified,2003,,,2.4
Asia,East and South-East Asia,Myanmar,Amphetamines,ARQ,Methamphetamine; Yangon,2004,0.4,,0.2
Asia,East and South-East Asia,"China, Taiwan Province of China",Amphetamines,Govt.,Methamphetamine,2006,0.05,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,,-,2007,,,0.108
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,Govt.,Methamphetamine,2008,0.88,,
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,-,2010,0.25,0.11,0.11
Asia,East and South-East Asia,Japan,Amphetamines,ARQ,-,2010,0.3,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,Amphetamine,2011,,,0.072
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,Methamphetamine,2011,,,0.069
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,Amphetamine,2011,0.2,0.1,0.17
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,Amphetamine,2011,0.21,0.35,0.32
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,Methamphetamine,2011,0.3,0.2,0.26
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,Methamphetamine,2011,0.35,0.45,0.45
Asia,East and South-East Asia,Japan,Amphetamines,ARQ,Methamphetamine,2011,0.2,,
Asia,East and South-East Asia,Japan,Amphetamines,ARQ,Methamphetamine,2012,0.2,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,-,2013,,,0.05
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,Methamphetamine,2013,,,0.05
Asia,East and South-East Asia,Japan,Amphetamines,ARQ,Methamphetamine,2013,0.2,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,Central Registry,2014,,,0.04
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,Methamphetamine,2014,,,0.04
Asia,East and South-East Asia,Japan,Amphetamines,ARQ,Methamphetamine,2014,0.2,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,Central registry of drug abuse,2015,,,0.04
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,Methamphetamine,2015,,,0.04
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,20 provinces,2015,0.42,,0.19
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,Amphetamine. 20 provinces,2015,0.02,,0.02
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,Methamphetamine. 20 provinces,2015,0.3,,0.15
Asia,East and South-East Asia,China,Amphetamines,ARQ,-,2016,,,81.1
Asia,East and South-East Asia,Japan,Amphetamines,ARQ,Methamphetamine,2016,0.3,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,-,2018,,0.02,
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamines,ARQ,Methamphetamine,2018,,0.01,
Asia,East and South-East Asia,"China, Macao SAR",Amphetamines,ARQ,Central Registry,2018,,20,
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,Amphetamine / 13 out of 34 Provinces in Indonesia,2018,,,0.6
Asia,East and South-East Asia,Indonesia,Amphetamines,ARQ,Methamphetamine /  13 out of 34 Provinces in Indonesia,2018,,,3
Asia,East and South-East Asia,Japan,Amphetamines,ARQ,Methamphetamine,2018,0.3,,
Asia,Near and Middle East /South-West Asia,Jordan,Amphetamines,ARQ,Unversity students,2001,,,2.6
Asia,Near and Middle East /South-West Asia,Lebanon,Amphetamines,ARQ,Rapid Situation Assesment,2001,,,0.5
Asia,Near and Middle East /South-West Asia,Israel,Amphetamines,ARQ,Amphetamine,2009,,,2.1
Asia,Near and Middle East /South-West Asia,Israel,Amphetamines,ARQ,Cathinone (hagigat),2009,,,6.8
Asia,Near and Middle East /South-West Asia,Israel,Amphetamines,ARQ,Amphetamine,2009,4.38,2.73,3.27
Asia,Near and Middle East /South-West Asia,Israel,Amphetamines,ARQ,Other stimulants,2009,,,8.3
Asia,Near and Middle East /South-West Asia,Israel,Amphetamines,ARQ,Methamphetamine,2010,1.9,,
Asia,Near and Middle East /South-West Asia,Israel,Amphetamines,ARQ,Other stimulants,2010,,0.9,
Asia,Near and Middle East /South-West Asia,Pakistan,Amphetamines,ARQ,-,2013,0.08,,
Asia,Near and Middle East /South-West Asia,Pakistan,Amphetamines,ARQ,Amphetamine,2013,0.07,,
Asia,Near and Middle East /South-West Asia,Pakistan,Amphetamines,ARQ,Methamphetamine,2013,0.02,,
Asia,Near and Middle East /South-West Asia,Israel,Amphetamines,ARQ,Prescription stimulants - Ritalin,2014,,3.2,
Asia,South Asia,India,Amphetamines,ARQ,-,2018,,,0.18
Asia,Central Asia and Transcaucasia,Armenia,Cocaine,ESPAD,-,2007,1,,
Asia,Central Asia and Transcaucasia,Georgia,Cocaine,Research,Crack; select regions (capital);  Georgian Medical News No3 (180) 2010,2010,1.1,,
Asia,Central Asia and Transcaucasia,Georgia,Cocaine,Research,Select regions (capital);  Georgian Medical News No3 (180) 2010,2010,0.6,,
Asia,Central Asia and Transcaucasia,Kazakhstan,Cocaine,ARQ,-,2012,0.8,,
Asia,Central Asia and Transcaucasia,Georgia,Cocaine,ARQ,Cocaine salts,2014,3.2,,1.6
Asia,Central Asia and Transcaucasia,Georgia,Cocaine,ARQ,Crack,2014,1.1,,0.4
Asia,Central Asia and Transcaucasia,Georgia,Cocaine,ARQ / ESPAD,-,2015,1.8,,1.2
Asia,Central Asia and Transcaucasia,Georgia,Cocaine,ARQ / ESPAD,Crack,2015,1,,1.4
Asia,East and South-East Asia,Thailand,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack); Ages not specified",2003,0.3,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine,Govt.,"Cocaine, any (HCl and/ or Crack)",2008,0.59,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine,ARQ,-,2011,,,0.052
Asia,East and South-East Asia,Indonesia,Cocaine,ARQ,Cocaine salts,2011,0.15,0.1,0.15
Asia,East and South-East Asia,Indonesia,Cocaine,ARQ,Crack,2011,0.15,0.1,0.15
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine,ARQ,Central Registry,2014,,,0.03
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine,ARQ,Cocaine salts. Central registry of drug abuse,2015,0.03,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine,ARQ,Cocaine salts. Central registry of drug abuse,2018,,0.04,
Asia,East and South-East Asia,Indonesia,Cocaine,ARQ,13 out of 34 Provinces in Indonesia,2018,,,2.4
Asia,Near and Middle East /South-West Asia,Lebanon,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack); Rapid Assessment",2001,,,1.2
Asia,Near and Middle East /South-West Asia,Israel,Cocaine,ARQ,-,2009,,,1.6
Asia,Near and Middle East /South-West Asia,Israel,Cocaine,ARQ,Crack,2009,,,2
Asia,Near and Middle East /South-West Asia,Israel,Cocaine,ARQ,Cocaine salts,2009,3.39,0.99,2.86
Asia,Near and Middle East /South-West Asia,Israel,Cocaine,ARQ,Crack,2009,2.63,0.27,2.14
Asia,Near and Middle East /South-West Asia,Pakistan,Cocaine,ARQ,-,2013,0.01,,
Asia,South Asia,India,Cocaine,ARQ,-,2018,,,0.06
Asia,Central Asia  and Transcaucasia,Kazakhstan,Ecstasy,ARQ,-,2007,0.3,,
Asia,Central Asia  and Transcaucasia,Armenia,Ecstasy,ESPAD,-,2007,1,,
Asia,Central Asia  and Transcaucasia,Georgia,Ecstasy,Research,Select regions (capital);  Georgian Medical News No3 (180) 2010,2010,7.5,1.4,4.5
Asia,Central Asia  and Transcaucasia,Kazakhstan,Ecstasy,ARQ,-,2012,2.3,0.7,1
Asia,Central Asia  and Transcaucasia,Georgia,Ecstasy,ARQ / ESPAD,-,2015,4.4,,2.7
Asia,East and South-East Asia,Thailand,Ecstasy,ARQ,Ages not specified,2003,0.3,,
Asia,East and South-East Asia,"China, Taiwan Province of China",Ecstasy,Govt.,-,2006,0.52,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Ecstasy,Govt.,-,2008,1.38,,
Asia,East and South-East Asia,"China, Hong Kong SAR",Ecstasy,ARQ,-,2011,0.008,,
Asia,East and South-East Asia,Indonesia,Ecstasy,ARQ,-,2011,0.4,0.2,0.34
Asia,East and South-East Asia,Indonesia,Ecstasy,ARQ,20 provinces,2015,0.15,,0.02
Asia,East and South-East Asia,Indonesia,Ecstasy,ARQ,13 out of 34 Provinces in Indonesia,2018,,,1.8
Asia,Near and Middle East /South-West Asia,Israel,Ecstasy,ARQ,-,2009,,,2.6
Asia,Near and Middle East /South-West Asia,Israel,Ecstasy,ARQ,-,2009,3.63,2.8,3.1
Asia,Near and Middle East /South-West Asia,Lebanon,Ecstasy,MedSPAD,-,2009,3.9,,
Asia,Near and Middle East /South-West Asia,Israel,Ecstasy,ARQ,-,2010,,,4.5
Asia,Central Asia  and Transcaucasia,Kazakhstan,Tranquillizers and sedatives,ARQ,Other sedatives and tranquillizers,2012,0.6,,
Asia,Central Asia  and Transcaucasia,Kazakhstan,Tranquillizers and sedatives,ARQ,-,2012,2.1,,
Asia,Central Asia  and Transcaucasia,Kazakhstan,Tranquillizers and sedatives,ARQ,-,2012,1.5,,
Asia,Central Asia  and Transcaucasia,Georgia,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Asia,East and South-East Asia,Indonesia,Tranquillizers and sedatives,,Benzodiazepines,2010,0.11,0.02,0.04
Asia,East and South-East Asia,Indonesia,Tranquillizers and sedatives,,Benzodiazepines,2011,40,0.1,0.34
Asia,East and South-East Asia,"China, Hong Kong SAR",Tranquillizers and sedatives,ARQ,-,2011,,,0.01
Asia,East and South-East Asia,"China, Hong Kong SAR",Tranquillizers and sedatives,ARQ,Benzodiazepines,2011,,,0.01
Asia,East and South-East Asia,Indonesia,Tranquillizers and sedatives,ARQ,Barbiturates,2011,0.1,0.1,0.09
Asia,East and South-East Asia,Indonesia,Tranquillizers and sedatives,ARQ,-,2015,0.21,,0.11
Asia,East and South-East Asia,Indonesia,Tranquillizers and sedatives,ARQ,-,2015,0.17,,0.15
Asia,East and South-East Asia,Indonesia,Tranquillizers and sedatives,ARQ,Barbiturates. 20 provincies,2015,0.06,,0
Asia,Near and Middle East /South-West Asia,Israel,Tranquillizers and sedatives,,Benzodiazepines,2009,9,4.29,5.99
Asia,Near and Middle East /South-West Asia,Pakistan,Tranquillizers and sedatives,ARQ,-,2013,1.4,,
Asia,South Asia,India,Tranquillizers and sedatives,ARQ,-,2018,,,0.58
Europe,Eastern Europe,Russian Federation,Amphetamines,ARQ/ ESPAD,Amphetamine,2007,1.3,,
Europe,Eastern Europe,Ukraine,Amphetamines,ESPAD,-,2007,1,,
Europe,Eastern Europe,Republic of Moldova,Amphetamines,ESPAD,-,2008,1.5,,
Europe,Eastern Europe,Republic of Moldova,Amphetamines,Govt.,Amphetamine,2010,0.1,0.1,0.1
Europe,Eastern Europe,Russian Federation,Amphetamines,ARQ,Amphetamine,2011,3,,
Europe,Eastern Europe,Ukraine,Amphetamines,ARQ,Amphetamine,2011,2,,
Europe,Eastern Europe,Republic of Moldova,Amphetamines,ARQ,Amphetamine,2012,0.1,,0.1
Europe,Eastern Europe,Republic of Moldova,Amphetamines,ARQ,Methamphetamine,2012,,0.1,
Europe,Eastern Europe,Russian Federation,Amphetamines,ARQ,Other stimulants,2013,0.0003,,
Europe,Eastern Europe,Ukraine,Amphetamines,ARQ,Amphetamine,2015,,,0
Europe,Eastern Europe,Republic of Moldova,Amphetamines,ESPAD,Amphetamine,2015,1,,
Europe,Eastern Europe,Republic of Moldova,Amphetamines,ESPAD,Methamphetamine,2015,0,,
Europe,South-Eastern Europe,Turkey,Amphetamines,ESPAD,-,2003,1.9,,0.8
Europe,South-Eastern Europe,Albania,Amphetamines,ARQ,-,2004,4.9,,
Europe,South-Eastern Europe,Croatia,Amphetamines,ARQ,Amphetamine,2007,1.7,,
Europe,South-Eastern Europe,Romania,Amphetamines,ESPAD,Amphetamine,2007,0.6,,
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamines,ARQ,-,2008,,,4
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ARQ,-,2008,10.4,3.8,6.7
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ARQ,Amphetamine,2008,8.5,3.1,5.4
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ARQ,Methamphetamine,2008,2.6,1.3,1.5
Europe,South-Eastern Europe,Serbia,Amphetamines,ARQ,Stimulants (inclds Amphetamines),2008,1.5,,
Europe,South-Eastern Europe,Montenegro,Amphetamines,ESPAD,-,2008,1,,
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamines,ARQ,Amphetamine,2011,0.9,,
Europe,South-Eastern Europe,Romania,Amphetamines,ARQ,Amphetamine,2011,1.7,,
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ESPAD,Amphetamine,2011,8.4,,
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ESPAD,Methamphetamine,2011,3.3,,
Europe,South-Eastern Europe,Serbia,Amphetamines,ESPAD,Amphetamine,2011,1.7,,
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ARQ,-,2013,7.9,3.2,5.6
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ARQ,Amphetamine,2013,6.4,2.3,4.3
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ARQ,Methamphetamine,2013,4.2,1.9,3.2
Europe,South-Eastern Europe,Montenegro,Amphetamines,ARQ,Amphetamine,2015,3,,
Europe,South-Eastern Europe,Montenegro,Amphetamines,ARQ,Methamphetamine,2015,2,,
Europe,South-Eastern Europe,North Macedonia,Amphetamines,ARQ,Amphetamine,2015,1.4,,1.4
Europe,South-Eastern Europe,North Macedonia,Amphetamines,ARQ,Methamphetamine,2015,1.1,,1
Europe,South-Eastern Europe,North Macedonia,Amphetamines,ARQ,Prescription stimulants,2015,1.9,,1.4
Europe,South-Eastern Europe,Romania,Amphetamines,ARQ,Amphetamine,2015,1.1,,
Europe,South-Eastern Europe,Romania,Amphetamines,ARQ,Methamphetamine,2015,1,,
Europe,South-Eastern Europe,Albania,Amphetamines,ARQ / ESPAD,Amphetamine,2015,1.4,,
Europe,South-Eastern Europe,Albania,Amphetamines,ARQ / ESPAD,Methamphetamine,2015,1.6,,
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ARQ / ESPAD,Amphetamine,2015,6.5,,5.1
Europe,South-Eastern Europe,Bulgaria,Amphetamines,ARQ / ESPAD,Methamphetamine,2015,5,,4.2
Europe,South-Eastern Europe,Croatia,Amphetamines,ESPAD,Amphetamine,2015,3,,
Europe,South-Eastern Europe,Croatia,Amphetamines,ESPAD,Methamphetamine,2015,1,,
Europe,South-Eastern Europe,North Macedonia,Amphetamines,ESPAD,Amphetamine,2015,1,,
Europe,South-Eastern Europe,North Macedonia,Amphetamines,ESPAD,Methamphetamine,2015,1,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 1996,Amphetamines,1996,18.75182697,5.7,11.84764785
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 1998,Amphetamines,1998,21.53087682,5.3,9.87835563
Europe,Western and Central Europe,Luxembourg,Amphetamines,,-,1999,3.7,,2.2
Europe,Western and Central Europe,Luxembourg,Amphetamines,National Drug Report 2017,-,1999,2.9,,1.9
Europe,Western and Central Europe,Luxembourg,Amphetamines,National Drug Report 2017,-,1999,2.3,,
Europe,Western and Central Europe,Luxembourg,Amphetamines,National Drug Report 2017,-,1999,3.1,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2000,Amphetamines,2000,21.2441149,2.9,6.1784399
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2001/2002,Amphetamines,2001,16.24045252,1.9,4.98739358
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2002/2003,Amphetamines,2002,15.29111387,1.7,3.75249154
Europe,Western and Central Europe,Greenland,Amphetamines,ESPAD,-,2003,0,,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2003/2004,Amphetamines,2003,13.07245984,1.6,4.01956048
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2004/2005,Amphetamines,2004,11.57640156,1.3,3.23673493
Europe,Western and Central Europe,Liechtenstein,Amphetamines,ARQ,-,2005,1.1,,0.4
Europe,Western and Central Europe,Liechtenstein,Amphetamines,ARQ,Amphetamine,2005,1.1,,0.8
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2005/2006,Amphetamines,2005,11.29360904,1.6,3.28026131
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2006/2007,Amphetamines,2006,11.29578627,1.1332691,3.53400508
Europe,Western and Central Europe,Cyprus,Amphetamines,ARQ,Amphetamine,2007,3,,
Europe,Western and Central Europe,Denmark,Amphetamines,ARQ,-,2007,5,,
Europe,Western and Central Europe,Estonia,Amphetamines,ARQ,-,2007,3.8,,
Europe,Western and Central Europe,Finland,Amphetamines,ARQ,Amphetamine,2007,1,,
Europe,Western and Central Europe,Germany,Amphetamines,ARQ,Amphetamine. Select regions,2007,5.8,,
Europe,Western and Central Europe,Hungary,Amphetamines,ARQ,Amphetamine,2007,3.5,,
Europe,Western and Central Europe,Latvia,Amphetamines,ARQ,Amphetamine,2007,5.6,,3.7
Europe,Western and Central Europe,Malta,Amphetamines,ARQ,Amphetamine,2007,5.2,,
Europe,Western and Central Europe,Netherlands,Amphetamines,ARQ,Amphetamine,2007,1.9,0.8,
Europe,Western and Central Europe,Slovenia,Amphetamines,ARQ,Amphetamine,2007,2.2,,
Europe,Western and Central Europe,Czechia,Amphetamines,ARQ./ ESPAD,Methamphetamine,2007,3.5,,2.1
Europe,Western and Central Europe,Austria,Amphetamines,ESPAD,May include non-ATS stimulants,2007,7.7,,
Europe,Western and Central Europe,Cyprus,Amphetamines,ESPAD,-,2007,3,,
Europe,Western and Central Europe,Faroe Islands,Amphetamines,ESPAD,-,2007,1,,
Europe,Western and Central Europe,France,Amphetamines,ESPAD,-,2007,4,,
Europe,Western and Central Europe,Greece,Amphetamines,ESPAD,-,2007,3,,
Europe,Western and Central Europe,Iceland,Amphetamines,ESPAD,-,2007,4,,
Europe,Western and Central Europe,Ireland,Amphetamines,ESPAD,-,2007,3,,
Europe,Western and Central Europe,Lithuania,Amphetamines,ESPAD,-,2007,3,,
Europe,Western and Central Europe,Netherlands,Amphetamines,ESPAD,-,2007,2,,
Europe,Western and Central Europe,Norway,Amphetamines,ESPAD,Amphetamine,2007,2,,
Europe,Western and Central Europe,Portugal,Amphetamines,ESPAD,-,2007,2.5,,
Europe,Western and Central Europe,Slovenia,Amphetamines,ESPAD,-,2007,2.3,,
Europe,Western and Central Europe,Switzerland,Amphetamines,ESPAD,-,2007,3,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2007/2008,Amphetamines,2007,8.73889181,0.87281876,2.37483763
Europe,Western and Central Europe,Gibraltar,Amphetamines,ARQ,-,2008,,,0.2
Europe,Western and Central Europe,Slovakia,Amphetamines,ARQ,Amphetamine,2008,1.9,,0.7
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2008/2009,Amphetamines,2008,9.71811181,0.90101508,2.58271739
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2008/2009,Any amphetamines,2008,10.00100111,0.97756308,2.64679277
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2008/2009,Methamphetamine,2008,0.8485236,0.11720396,0.18410665
Europe,Western and Central Europe,Germany,Amphetamines,Govt.,Amphetamine,2008,2.7,0.4,1
Europe,Western and Central Europe,Belgium,Amphetamines,ARQ,Select regions (Flanders),2009,,,1.4
Europe,Western and Central Europe,Sweden,Amphetamines,ARQ,-,2009,1,,1
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2009/2010,Amphetamines,2009,9.50439344,0.70715395,2.38793986
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2009/2010,Any amphetamines,2009,9.87392447,0.73453129,2.41763956
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2009/2010,Methamphetamine,2009,0.87301462,0.02561774,0.04850218
Europe,Western and Central Europe,Belgium,Amphetamines,ARQ,Amphetamine,2010,2.77,,1.33
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Amphetamine,2010,0.8,0.3,0.5
Europe,Western and Central Europe,Latvia,Amphetamines,ARQ,Riga City,2010,3.8,1.7,2.7
Europe,Western and Central Europe,Luxembourg,Amphetamines,ARQ,-,2010,1.4,,1.1
Europe,Western and Central Europe,Netherlands,Amphetamines,ARQ,Amphetamine,2010,1.8,0.6,
Europe,Western and Central Europe,Poland,Amphetamines,ARQ,Amphetamine,2010,7,2,3
Europe,Western and Central Europe,Slovakia,Amphetamines,ARQ,Methamphetamine,2010,1.4,0.5,0.8
Europe,Western and Central Europe,Spain,Amphetamines,ARQ,Amphetamine,2010,2.6,0.9,1.6
Europe,Western and Central Europe,Spain,Amphetamines,ARQ,Methamphetamine,2010,0.8,0.4,0.6
Europe,Western and Central Europe,United Kingdom (England),Amphetamines,ARQ,Amphetamines,2010,2.1,0.6,1.7
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2010/2011,Amphetamines,2010,8.60559097,0.87016121,2.44820256
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2010/2011,Any amphetamines,2010,8.78085561,0.87152922,2.53986823
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2010/2011,Methamphetamine,2010,0.78971796,,0.11227889
Europe,Western and Central Europe,Luxembourg,Amphetamines,National Drug Report 2017,-,2010,1.1,,
Europe,Western and Central Europe,Luxembourg,Amphetamines,National Drug Report 2017,-,2010,1.5,,
Europe,Western and Central Europe,Belgium,Amphetamines,ARQ,Amphetamine,2011,2.1,,0.6
Europe,Western and Central Europe,Czechia,Amphetamines,ARQ,Methamphetamine,2011,1.9,0.5,1.2
Europe,Western and Central Europe,Denmark,Amphetamines,ARQ,-,2011,2.5,,
Europe,Western and Central Europe,Estonia,Amphetamines,ARQ,Amphetamine,2011,2.8,,
Europe,Western and Central Europe,Finland,Amphetamines,ARQ,Amphetamine,2011,1,,
Europe,Western and Central Europe,Finland,Amphetamines,ARQ,Amphetamine,2011,1,,
Europe,Western and Central Europe,France,Amphetamines,ARQ,Amphetamine,2011,2.4,,1.9
Europe,Western and Central Europe,Germany,Amphetamines,ARQ,Amphetamine,2011,,,0.4
Europe,Western and Central Europe,Germany,Amphetamines,ARQ,Amphetamine,2011,6,,
Europe,Western and Central Europe,Greece,Amphetamines,ARQ,Amphetamine,2011,2,,
Europe,Western and Central Europe,Ireland,Amphetamines,ARQ,Amphetamine,2011,2,,
Europe,Western and Central Europe,Liechtenstein,Amphetamines,ARQ,-,2011,5,,
Europe,Western and Central Europe,Lithuania,Amphetamines,ARQ,Amphetamine,2011,2.8,,
Europe,Western and Central Europe,Netherlands,Amphetamines,ARQ,Amphetamine,2011,1.8,0.6,
Europe,Western and Central Europe,Portugal,Amphetamines,ARQ,-,2011,3,,
Europe,Western and Central Europe,Slovenia,Amphetamines,ARQ,Amphetamine,2011,2,,
Europe,Western and Central Europe,United Kingdom (England),Amphetamines,ARQ,-,2011,1.9,0.9,1.8
Europe,Western and Central Europe,Cyprus,Amphetamines,ESPAD,Amphetamine,2011,4,,
Europe,Western and Central Europe,Iceland,Amphetamines,ESPAD,Amphetamine,2011,3,,
Europe,Western and Central Europe,Latvia,Amphetamines,ESPAD,Amphetamine,2011,3.8,1.6,2.7
Europe,Western and Central Europe,Malta,Amphetamines,ESPAD,Amphetamine,2011,3,,
Europe,Western and Central Europe,Malta,Amphetamines,ESPAD,Mephedrone,2011,3.5,,
Europe,Western and Central Europe,Norway,Amphetamines,ESPAD,Amphetamine,2011,1,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2011/2012,Amphetamines,2011,7.96471662,0.8107729,1.9563748
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2011/2012,Any amphetamines,2011,8.38085523,0.81188923,1.99440457
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2011/2012,Methamphetamine,2011,0.91327343,0.02190615,0.10157615
Europe,Western and Central Europe,Belgium,Amphetamines,ARQ,Amphetamine,2012,1.8,,0.8
Europe,Western and Central Europe,Belgium,Amphetamines,ARQ,Amphetamine,2012,1.8,,1
Europe,Western and Central Europe,Cyprus,Amphetamines,ARQ,Amphetamine,2012,0.4,0.2,0.3
Europe,Western and Central Europe,Germany,Amphetamines,ARQ,Methamphetamine. Region Frankfurt am Main,2012,1,,
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,-,2012,1.1,0.38,0.71
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Amphetamine,2012,0.57,0.2,0.35
Europe,Western and Central Europe,Poland,Amphetamines,ARQ,Amphetamine,2012,4.6,,
Europe,Western and Central Europe,Spain,Amphetamines,ARQ,Amphetamine,2012,2.4,1,1.7
Europe,Western and Central Europe,Spain,Amphetamines,ARQ,Methamphetamine,2012,0.9,0.4,0.7
Europe,Western and Central Europe,United Kingdom (England),Amphetamines,ARQ,-,2012,1.8,0.5,1.7
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2012/2013,Amphetamines,2012,7.12350374,,1.31636519
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2012/2013,Any amphetamines,2012,7.19650621,,1.35248188
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2012/2013,Methamphetamine,2012,0.63782779,,0.08237832
Europe,Western and Central Europe,Belgium,Amphetamines,ARQ,"Amphetamine, flemish part",2013,1.2,,0.6
Europe,Western and Central Europe,Denmark,Amphetamines,ARQ,-,2013,2.5,,
Europe,Western and Central Europe,Estonia,Amphetamines,ARQ,Amphetamine,2013,0.9,,
Europe,Western and Central Europe,Estonia,Amphetamines,ARQ,Methamphetamine,2013,0.4,,
Europe,Western and Central Europe,Finland,Amphetamines,ARQ,-,2013,2,,
Europe,Western and Central Europe,Finland,Amphetamines,ARQ,-,2013,6,,
Europe,Western and Central Europe,Germany,Amphetamines,ARQ,Methamphetamine. Region Frankfurt am Main,2013,1,,
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,-,2013,1.14,0.42,0.74
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Amphetamine,2013,0.6,0.21,0.36
Europe,Western and Central Europe,Poland,Amphetamines,ARQ,Amphetamine,2013,6.9,1.7,3.4
Europe,Western and Central Europe,United Kingdom (England),Amphetamines,ARQ,Amphetamine,2013,1,0.3,0.8
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2013/2014,Amphetamines,2013,6.98767211,,1.64255592
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2013/2014,Any amphetamines,2013,7.25585764,,1.70616761
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2013/2014,Methamphetamine,2013,0.79505489,,0.13848936
Europe,Western and Central Europe,United Kingdom (Scotland),Amphetamines,Govt.,Amphetamines,2013,1,1,1
Europe,Western and Central Europe,Belgium,Amphetamines,ARQ,"Amphetamine, flemish part",2014,1.3,,0.5
Europe,Western and Central Europe,France,Amphetamines,ARQ,Amphetamine.  Urban areas (excluding overseas departments),2014,2.3,,1.3
Europe,Western and Central Europe,Germany,Amphetamines,ARQ, Region Frankfurt am Main,2014,5,1,
Europe,Western and Central Europe,Germany,Amphetamines,ARQ,Methamphetamine. Region Frankfurt am Main,2014,,1,
Europe,Western and Central Europe,Germany,Amphetamines,ARQ,Speed. Region Frankfurt am Main,2014,4,,
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Female,2014,1.9,0.8,1.3
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Male,2014,3.3,1.7,2.5
Europe,Western and Central Europe,Netherlands,Amphetamines,ARQ,Amphetamine,2014,1.8,,0.6
Europe,Western and Central Europe,Spain,Amphetamines,ARQ,Amphetamine,2014,1.4,0.5,0.9
Europe,Western and Central Europe,Spain,Amphetamines,ARQ,Methamphetamine,2014,0.8,0.3,0.5
Europe,Western and Central Europe,Sweden,Amphetamines,ARQ,Amphetamine. Female,2014,0.8,,
Europe,Western and Central Europe,Sweden,Amphetamines,ARQ,Amphetamine. Male,2014,0.7,,
Europe,Western and Central Europe,Switzerland,Amphetamines,ARQ,Amphetamine. Female,2014,1.1,,
Europe,Western and Central Europe,Switzerland,Amphetamines,ARQ,Amphetamine. Male,2014,1.3,,
Europe,Western and Central Europe,United Kingdom (England),Amphetamines,ARQ,Amphetamine,2014,1.5,0.6,1.1
Europe,Western and Central Europe,Belgium,Amphetamines,ESPAD,Amphetamine,2014,2,,
Europe,Western and Central Europe,Belgium,Amphetamines,ESPAD,Methamphetamine,2014,1,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2014/2015,Amphetamines,2014,6.57598016,0.39585855,1.24635187
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2014/2015,Any amphetamines,2014,6.72023476,0.46777192,1.27417186
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2014/2015,Methamphetamine,2014,0.62789812,0.07133008,0.17102694
Europe,Western and Central Europe,Ireland,Amphetamines,ARQ,Amphetamine,2015,1.9,,1.3
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,-,2015,3.8,1.6,2.6
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Amphetamine,2015,1.8,0.9,1.3
Europe,Western and Central Europe,Latvia,Amphetamines,ARQ,Amphetamine,2015,2.9,,1.5
Europe,Western and Central Europe,Latvia,Amphetamines,ARQ,Methamphetamine,2015,2.4,,1
Europe,Western and Central Europe,Liechtenstein,Amphetamines,ARQ,Amphetamine,2015,1.5,,
Europe,Western and Central Europe,Liechtenstein,Amphetamines,ARQ,Methamphetamine,2015,0.3,,
Europe,Western and Central Europe,Lithuania,Amphetamines,ARQ,Methamphetamine,2015,1,,
Europe,Western and Central Europe,Portugal,Amphetamines,ARQ,Amphetamine,2015,1,,
Europe,Western and Central Europe,Portugal,Amphetamines,ARQ,Methamphetamine,2015,1,,
Europe,Western and Central Europe,Slovakia,Amphetamines,ARQ,Amphetamine,2015,1.3,,0.7
Europe,Western and Central Europe,Slovakia,Amphetamines,ARQ,Amphetamine type stimulants,2015,3.4,,1.9
Europe,Western and Central Europe,Slovakia,Amphetamines,ARQ,Methamphetamine,2015,2.1,,1.2
Europe,Western and Central Europe,Sweden,Amphetamines,ARQ,Amphetamine. Female,2015,0.6,,
Europe,Western and Central Europe,Sweden,Amphetamines,ARQ,Amphetamine. Male,2015,0.7,,
Europe,Western and Central Europe,Finland,Amphetamines,ARQ (ESPAD),Amphetamine,2015,1,,
Europe,Western and Central Europe,Germany,Amphetamines,ARQ / DAS Data,Amphetamine.,2015,,,0.3
Europe,Western and Central Europe,Germany,Amphetamines,ARQ / DAS Data,Methamphetamine,2015,0.5,0.5,
Europe,Western and Central Europe,Germany,Amphetamines,ARQ / DAS Data,Other stimulants,2015,2,2,
Europe,Western and Central Europe,Austria,Amphetamines,ARQ / ESPAD,Amphetamine,2015,2.7,,1.8
Europe,Western and Central Europe,Czechia,Amphetamines,ARQ / ESPAD,Amphetamine,2015,0.9,0.2,0.4
Europe,Western and Central Europe,Denmark,Amphetamines,ARQ / ESPAD,Amphetamine,2015,0.9,,
Europe,Western and Central Europe,Malta,Amphetamines,ARQ / ESPAD,Amphetamine,2015,1.7,,1.1
Europe,Western and Central Europe,Netherlands,Amphetamines,ARQ / ESPAD,Amphetamine,2015,1.1,0.6,0.9
Europe,Western and Central Europe,Austria,Amphetamines,ESPAD,Methamphetamine,2015,1,,
Europe,Western and Central Europe,Belgium,Amphetamines,ESPAD,Amphetamine,2015,2,,
Europe,Western and Central Europe,Belgium,Amphetamines,ESPAD,Methamphetamine,2015,1,,
Europe,Western and Central Europe,Cyprus,Amphetamines,ESPAD,Amphetamine,2015,3,,
Europe,Western and Central Europe,Cyprus,Amphetamines,ESPAD,Methamphetamine,2015,2,,
Europe,Western and Central Europe,Czechia,Amphetamines,ESPAD,Methamphetamine,2015,1,,
Europe,Western and Central Europe,Denmark,Amphetamines,ESPAD,Methamphetamine,2015,0,,
Europe,Western and Central Europe,Estonia,Amphetamines,ESPAD,Amphetamine,2015,2,,
Europe,Western and Central Europe,Faroe Islands,Amphetamines,ESPAD,Amphetamine,2015,0,,
Europe,Western and Central Europe,Faroe Islands,Amphetamines,ESPAD,Methamphetamine,2015,0,,
Europe,Western and Central Europe,France,Amphetamines,ESPAD,Amphetamine,2015,2,,
Europe,Western and Central Europe,France,Amphetamines,ESPAD,Methamphetamine,2015,2,,
Europe,Western and Central Europe,Greece,Amphetamines,ESPAD,Amphetamine,2015,1.55,,1.15
Europe,Western and Central Europe,Greece,Amphetamines,ESPAD,Methamphetamine,2015,0.94,,0.65
Europe,Western and Central Europe,Hungary,Amphetamines,ESPAD,Amphetamine. ESPAD,2015,4.2,,2.5
Europe,Western and Central Europe,Hungary,Amphetamines,ESPAD,Methamphetamine. ESPAD,2015,2.9,,1.6
Europe,Western and Central Europe,Iceland,Amphetamines,ESPAD,Amphetamine,2015,2,,
Europe,Western and Central Europe,Iceland,Amphetamines,ESPAD,Methamphetamine,2015,1,,
Europe,Western and Central Europe,Ireland,Amphetamines,ESPAD,Amphetamine,2015,3,,
Europe,Western and Central Europe,Ireland,Amphetamines,ESPAD,Methamphetamine,2015,2,,
Europe,Western and Central Europe,Malta,Amphetamines,ESPAD,Methamphetamine,2015,1,,
Europe,Western and Central Europe,Monaco,Amphetamines,ESPAD,Amphetamine,2015,2,,
Europe,Western and Central Europe,Monaco,Amphetamines,ESPAD,Methamphetamine,2015,2,,
Europe,Western and Central Europe,Netherlands,Amphetamines,ESPAD,Amphetamine,2015,2,,
Europe,Western and Central Europe,Netherlands,Amphetamines,ESPAD,Methamphetamine,2015,1,,
Europe,Western and Central Europe,Norway,Amphetamines,ESPAD,Amphetamine,2015,1,,
Europe,Western and Central Europe,Poland,Amphetamines,ESPAD,Amphetamine,2015,4,,
Europe,Western and Central Europe,Poland,Amphetamines,ESPAD,Methamphetamine,2015,3,,
Europe,Western and Central Europe,Slovenia,Amphetamines,ESPAD,Amphetamine,2015,1,,
Europe,Western and Central Europe,Slovenia,Amphetamines,ESPAD,Methamphetamine,2015,2,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2015/2016,Amphetamines,2015,6.01441216,0.29331307,1.12592778
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2015/2016,Any amphetamines,2015,6.3056719,0.2936045,1.12704648
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2015/2016,Methamphetamine,2015,0.87107378,0.12107615,0.16935471
Europe,Western and Central Europe,United Kingdom (Scotland),Amphetamines,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Amphetamines,2015,2.3,1.1,2
Europe,Western and Central Europe,Luxembourg,Amphetamines,National Drug Report 2017,-,2015,0,0,0
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,-,2016,3.6,1.55,2.42
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Amphetamine,2016,2.04,1,1.46
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Methamphetamine,2016,1.26,0.7,0.89
Europe,Western and Central Europe,Poland,Amphetamines,ARQ,Amphetamine,2016,7.2,1.4,3.3
Europe,Western and Central Europe,Spain,Amphetamines,ARQ,Amphetamine,2016,1.7,0.5,1.2
Europe,Western and Central Europe,Spain,Amphetamines,ARQ,Methamphetamine,2016,1.4,0.4,1
Europe,Western and Central Europe,Sweden,Amphetamines,ARQ,Amphetamine,2016,0.5,,
Europe,Western and Central Europe,United Kingdom (England),Amphetamines,ARQ,Amphetamine,2016,1.3,0.5,1.1
Europe,Western and Central Europe,United Kingdom (England),Amphetamines,ARQ,Other stimulants,2016,1,0.3,0.7
Europe,Western and Central Europe,Switzerland,Amphetamines,"Addiction Monitoring in Switzerland, July 2017","Amphetaminsulphat, Dexedrin",2016,,,0.5
Europe,Western and Central Europe,Switzerland,Amphetamines,"Addiction Monitoring in Switzerland, July 2017",Meth,2016,,,0
Europe,Western and Central Europe,Cyprus,Amphetamines,ESPAD,Amphetamine,2016,0.6,0.1,0.1
Europe,Western and Central Europe,Czechia,Amphetamines,ESPAD,Methamphetamine,2016,1.2,0.4,0.8
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2016/2017,Amphetamines,2016,5.45880965,0.17045167,1.05506507
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2016/2017,Any amphetamines,2016,5.57795811,0.21286341,1.10509678
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2016/2017,Methamphetamine,2016,0.66363725,0.04224951,0.04984032
Europe,Western and Central Europe,United Kingdom (England),Amphetamines,Government report,Amphetamines,2016,1.3,0.5,1.1
Europe,Western and Central Europe,Belgium,Amphetamines,ARQ,-,2017,1.4,,0.6
Europe,Western and Central Europe,Belgium,Amphetamines,ARQ,Other stimulants,2017,1.9,,1
Europe,Western and Central Europe,France,Amphetamines,ARQ,Amphetamine,2017,2.3,,1.2
Europe,Western and Central Europe,Iceland,Amphetamines,ARQ,Amphetamine,2017,1,,
Europe,Western and Central Europe,Ireland,Amphetamines,ARQ,Amphetamine,2017,1.9,,1.3
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,-,2017,3.09,1.01,1.81
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Amphetamine,2017,1.75,0.67,1.07
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Methamphetamine,2017,1.05,0.51,0.75
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Other stimulants,2017,0.72,,
Europe,Western and Central Europe,Sweden,Amphetamines,ARQ,Amphetamine,2017,0.7,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2017/2018,Amphetamines,2017,6.5,0.1,1.5
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2017/2018,Any amphetamines,2017,6.7,0.2,1.5
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2017/2018,Methamphetamine,2017,0.6,0,0.1
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,-,2018,2.6,0.72,1.42
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Amphetamine.,2018,1.15,0.38,0.71
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Methamphetamine,2018,0.66,0.28,0.38
Europe,Western and Central Europe,Italy,Amphetamines,ARQ,Other stimulants,2018,0.45,,
Europe,Western and Central Europe,Poland,Amphetamines,ARQ,Amphetamine,2018,5.9,1.3,3.2
Europe,Western and Central Europe,Slovakia,Amphetamines,ARQ,-,2018,3.95,,
Europe,Western and Central Europe,Sweden,Amphetamines,ARQ,Amphetamine,2018,0.72,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2018/2019,Amphetamines,2018,5.3,0.2,1
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2018/2019,Any amphetamines,2018,5.4,0.2,1
Europe,Western and Central Europe,United Kingdom (England and Wales),Amphetamines,Government 2018/2019,Methamphetamine,2018,0.2,0,0
Europe,Western and Central Europe,Gibraltar,Amphetamines,ARQ,-,2019,,,0.11
Europe,Western and Central Europe,Gibraltar,Amphetamines,ARQ,Amphetamine.,2019,,0.07,0.22
Europe,Eastern Europe,Belarus,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack); Limited geography",2007,0.4,,
Europe,Eastern Europe,Belarus,Cocaine,ARQ,Crack; Limited geography,2007,0.2,,
Europe,Eastern Europe,Belarus,Cocaine,ARQ,Limited geography,2007,0.2,,
Europe,Eastern Europe,Russian Federation,Cocaine,ARQ/ ESPAD,-,2007,0.4,,
Europe,Eastern Europe,Russian Federation,Cocaine,ARQ/ ESPAD,Crack,2007,0.6,,
Europe,Eastern Europe,Ukraine,Cocaine,ESPAD,-,2007,1,,
Europe,Eastern Europe,Ukraine,Cocaine,ESPAD,Crack,2007,0,,
Europe,Eastern Europe,Republic of Moldova,Cocaine,ESPAD,-,2008,0.8,,
Europe,Eastern Europe,Ukraine,Cocaine,ARQ,-,2010,,0.1,0.2
Europe,Eastern Europe,Republic of Moldova,Cocaine,Govt.,-,2010,0.1,,
Europe,Eastern Europe,Russian Federation,Cocaine,ARQ,-,2011,1.9,,
Europe,Eastern Europe,Russian Federation,Cocaine,ARQ,Cocaine salts,2011,1.4,,
Europe,Eastern Europe,Ukraine,Cocaine,ARQ,-,2011,1.1,,
Europe,Eastern Europe,Ukraine,Cocaine,ARQ,Crack,2011,0.9,,
Europe,Eastern Europe,Ukraine,Cocaine,ARQ,-,2015,,,0
Europe,Eastern Europe,Republic of Moldova,Cocaine,ESPAD,-,2015,1,,
Europe,Eastern Europe,Republic of Moldova,Cocaine,ESPAD,Crack,2015,0,,
Europe,South-Eastern Europe,Turkey,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2003,1.6,,0.8
Europe,South-Eastern Europe,Albania,Cocaine,ARQ,-,2004,1.4,,
Europe,South-Eastern Europe,Albania,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2004,1.4,,
Europe,South-Eastern Europe,Croatia,Cocaine,ARQ,-,2007,1.6,,
Europe,South-Eastern Europe,Croatia,Cocaine,ARQ,Crack,2007,1.5,,
Europe,South-Eastern Europe,Romania,Cocaine,ESPAD,-,2007,1.5,,
Europe,South-Eastern Europe,Romania,Cocaine,ESPAD,Crack,2007,0.3,,
Europe,South-Eastern Europe,Bulgaria,Cocaine,ARQ,Cocaine salts,2008,6,2.5,3.9
Europe,South-Eastern Europe,Serbia,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2008,0.9,,
Europe,South-Eastern Europe,Montenegro,Cocaine,ESPAD,-,2008,1.3,,
Europe,South-Eastern Europe,Montenegro,Cocaine,ESPAD,Crack,2008,1,,
Europe,South-Eastern Europe,Romania,Cocaine,ARQ,-,2011,2,,
Europe,South-Eastern Europe,Romania,Cocaine,ARQ,Crack,2011,0.9,,
Europe,South-Eastern Europe,Bulgaria,Cocaine,ESPAD,Cocaine salts,2011,4,,
Europe,South-Eastern Europe,Bulgaria,Cocaine,ESPAD,Crack,2011,2.4,,
Europe,South-Eastern Europe,Montenegro,Cocaine,ESPAD,-,2011,1.5,,
Europe,South-Eastern Europe,Montenegro,Cocaine,ESPAD,Crack,2011,1,,
Europe,South-Eastern Europe,Serbia,Cocaine,ESPAD,"Cocaine, any (HCl and/ or Crack)",2011,1.4,,
Europe,South-Eastern Europe,Serbia,Cocaine,ESPAD,Crack,2011,1.2,,
Europe,South-Eastern Europe,Bulgaria,Cocaine,ARQ,-,2013,4.3,2.1,3.4
Europe,South-Eastern Europe,Bulgaria,Cocaine,ARQ,Cocaine salts,2013,4.3,2.1,3.4
Europe,South-Eastern Europe,Montenegro,Cocaine,ARQ,Cocaine salts,2015,3,,
Europe,South-Eastern Europe,Montenegro,Cocaine,ARQ,Crack,2015,2,,
Europe,South-Eastern Europe,North Macedonia,Cocaine,ARQ,Cocaine salts,2015,1.5,,1.2
Europe,South-Eastern Europe,North Macedonia,Cocaine,ARQ,Crack,2015,0.9,,0.9
Europe,South-Eastern Europe,Romania,Cocaine,ARQ,-,2015,3.8,,
Europe,South-Eastern Europe,Romania,Cocaine,ARQ,Cocaine salts,2015,3.3,,
Europe,South-Eastern Europe,Romania,Cocaine,ARQ,Crack,2015,1.2,,
Europe,South-Eastern Europe,Albania,Cocaine,ARQ / ESPAD,Cocaine salts,2015,3.7,,
Europe,South-Eastern Europe,Albania,Cocaine,ARQ / ESPAD,Crack,2015,1.9,,
Europe,South-Eastern Europe,Bulgaria,Cocaine,ARQ / ESPAD,Cocaine salts,2015,4.8,,3.8
Europe,South-Eastern Europe,Bulgaria,Cocaine,ARQ / ESPAD,Crack,2015,3.3,,2.7
Europe,South-Eastern Europe,Croatia,Cocaine,ESPAD,-,2015,2,,
Europe,South-Eastern Europe,Croatia,Cocaine,ESPAD,Crack,2015,1,,
Europe,South-Eastern Europe,North Macedonia,Cocaine,ESPAD,-,2015,1,,
Europe,South-Eastern Europe,North Macedonia,Cocaine,ESPAD,Crack,2015,1,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 1996,Any Cocaine,1996,4.72866171,0.6,1.43244503
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 1996,Crack cocaine,1996,1.69553928,0.2,0.22348739
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 1996,Powder Cocaine,1996,4.26088175,0.5,1.2655059
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 1998,Any Cocaine,1998,7.06160153,1,3.2309685
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 1998,Crack cocaine,1998,1.50413905,0,0.31322755
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 1998,Powder Cocaine,1998,6.75020655,0.9,3.14465156
Europe,Western and Central Europe,Luxembourg,Cocaine,ARQ,-,1999,1.5,,1.5
Europe,Western and Central Europe,Luxembourg,Cocaine,National Drug Report 2017,-,1999,1.8,,1.2
Europe,Western and Central Europe,Luxembourg,Cocaine,National Drug Report 2017,-,1999,1.6,,
Europe,Western and Central Europe,Luxembourg,Cocaine,National Drug Report 2017,-,1999,1.5,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2000,Any Cocaine,2000,10.65385346,1.9,5.43287512
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2000,Crack cocaine,2000,2.25457429,0.2,0.89810183
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2000,Powder Cocaine,2000,10.39362304,1.8,5.22696683
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2001/2002,Any Cocaine,2001,8.66611467,2.2,5.10474317
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2001/2002,Crack cocaine,2001,1.21165282,0.1,0.48323914
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2001/2002,Powder Cocaine,2001,8.55369079,2.2,5.08994428
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2002/2003,Any Cocaine,2002,9.55552836,2.3,5.17973478
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2002/2003,Crack cocaine,2002,1.40319953,0.3,0.50613243
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2002/2003,Powder Cocaine,2002,9.32239302,2.1,5.08142568
Europe,Western and Central Europe,Greenland,Cocaine,ESPAD,-,2003,1,,1
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2003/2004,Any Cocaine,2003,9.96267866,2.8,5.35437368
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2003/2004,Crack cocaine,2003,1.61095162,0.2,0.39072389
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2003/2004,Powder Cocaine,2003,9.65744775,2.7,5.22568253
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2004/2005,Any Cocaine,2004,9.3112172,2.2,5.13450066
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2004/2005,Crack cocaine,2004,1.11881603,0.1,0.13325034
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2004/2005,Powder Cocaine,2004,9.05175333,2.1,5.09428717
Europe,Western and Central Europe,Liechtenstein,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2005,0.8,,0.6
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2005/2006,Any Cocaine,2005,10.77306848,3,5.92484362
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2005/2006,Crack cocaine,2005,1.30468711,0.2,0.39195221
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2005/2006,Powder Cocaine,2005,10.60774796,3,5.88985834
Europe,Western and Central Europe,Slovenia,Cocaine,ESPAD,-,2006,2.8,,
Europe,Western and Central Europe,Slovenia,Cocaine,ESPAD,Crack,2006,1.6,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2006/2007,Any Cocaine,2006,11.42124378,3.21846106,6.19616409
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2006/2007,Crack cocaine,2006,1.34906666,0.23901822,0.37496204
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2006/2007,Powder Cocaine,2006,11.06898582,3.15038437,6.08725284
Europe,Western and Central Europe,Austria,Cocaine,ARQ,-,2007,3.4,,
Europe,Western and Central Europe,Cyprus,Cocaine,ARQ,Cocaine salts,2007,3,,
Europe,Western and Central Europe,Cyprus,Cocaine,ARQ,Crack,2007,2,,
Europe,Western and Central Europe,Czechia,Cocaine,ARQ,Cocaine salts,2007,1,0.3,0.5
Europe,Western and Central Europe,Czechia,Cocaine,ARQ,Crack,2007,0.8,,
Europe,Western and Central Europe,Denmark,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2007,3.2,,
Europe,Western and Central Europe,Estonia,Cocaine,ARQ,-,2007,2.5,,
Europe,Western and Central Europe,Estonia,Cocaine,ARQ,Cocaine salts,2007,2.1,,
Europe,Western and Central Europe,Estonia,Cocaine,ARQ,Crack,2007,2.9,,
Europe,Western and Central Europe,Finland,Cocaine,ARQ,-,2007,1,,
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Cocaine salts. Select regions,2007,3.5,,
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Crack. Select regions,2007,2.3,,
Europe,Western and Central Europe,Hungary,Cocaine,ARQ,-,2007,1.9,,
Europe,Western and Central Europe,Hungary,Cocaine,ARQ,Crack,2007,1.3,,
Europe,Western and Central Europe,Latvia,Cocaine,ARQ,-,2007,1.6,,
Europe,Western and Central Europe,Latvia,Cocaine,ARQ,Crack,2007,1.4,,
Europe,Western and Central Europe,Malta,Cocaine,ARQ,Cocaine salts,2007,3.7,,
Europe,Western and Central Europe,Malta,Cocaine,ARQ,Crack,2007,1.9,,
Europe,Western and Central Europe,Netherlands,Cocaine,ARQ,-,2007,1.7,0.8,
Europe,Western and Central Europe,Poland,Cocaine,ARQ,Crack,2007,0.9,,0.3
Europe,Western and Central Europe,Slovenia,Cocaine,ARQ,-,2007,3,,
Europe,Western and Central Europe,Austria,Cocaine,ESPAD,-,2007,3.2,,
Europe,Western and Central Europe,Austria,Cocaine,ESPAD,Crack,2007,2.3,,
Europe,Western and Central Europe,Faroe Islands,Cocaine,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Faroe Islands,Cocaine,ESPAD,Crack,2007,1,,
Europe,Western and Central Europe,Finland,Cocaine,ESPAD,Crack,2007,1,,
Europe,Western and Central Europe,France,Cocaine,ESPAD,-,2007,5,,
Europe,Western and Central Europe,France,Cocaine,ESPAD,Crack,2007,6,,
Europe,Western and Central Europe,Greece,Cocaine,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Greece,Cocaine,ESPAD,Crack,2007,2,,
Europe,Western and Central Europe,Iceland,Cocaine,ESPAD,-,2007,3,,
Europe,Western and Central Europe,Iceland,Cocaine,ESPAD,Crack,2007,1,,
Europe,Western and Central Europe,Ireland,Cocaine,ESPAD,-,2007,4,,
Europe,Western and Central Europe,Ireland,Cocaine,ESPAD,Crack,2007,4,,
Europe,Western and Central Europe,Lithuania,Cocaine,ESPAD,"Cocaine, any (HCl and/ or Crack)",2007,1.5,,
Europe,Western and Central Europe,Lithuania,Cocaine,ESPAD,Crack,2007,1.2,,
Europe,Western and Central Europe,Monaco,Cocaine,ESPAD,-,2007,6,,
Europe,Western and Central Europe,Monaco,Cocaine,ESPAD,Crack,2007,4,,
Europe,Western and Central Europe,Netherlands,Cocaine,ESPAD,-,2007,3,,
Europe,Western and Central Europe,Netherlands,Cocaine,ESPAD,Crack,2007,2,,
Europe,Western and Central Europe,Norway,Cocaine,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Norway,Cocaine,ESPAD,Crack,2007,1,,
Europe,Western and Central Europe,Portugal,Cocaine,ESPAD,-,2007,2.3,,
Europe,Western and Central Europe,Portugal,Cocaine,ESPAD,Crack,2007,1.8,,
Europe,Western and Central Europe,Switzerland,Cocaine,ESPAD,-,2007,3,,
Europe,Western and Central Europe,Switzerland,Cocaine,ESPAD,Crack,2007,2,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2007/2008,Any Cocaine,2007,10.08490596,2.49904332,5.09213811
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2007/2008,Crack cocaine,2007,0.72364751,0.11820476,0.18469223
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2007/2008,Powder Cocaine,2007,9.8957337,2.44418312,5.07033317
Europe,Western and Central Europe,Andorra,Cocaine,ARQ,-,2008,,0.85,
Europe,Western and Central Europe,Germany,Cocaine,ARQ,-,2008,,0.3,0.9
Europe,Western and Central Europe,Gibraltar,Cocaine,ARQ,-,2008,,,2.6
Europe,Western and Central Europe,Gibraltar,Cocaine,ARQ,Crack,2008,,,1.9
Europe,Western and Central Europe,Poland,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2008,2.2,,1.1
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2008/2009,Any Cocaine,2008,12.28764463,3.64073117,6.55844419
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2008/2009,Crack cocaine,2008,1.07498524,0.04178198,0.14686713
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2008/2009,Powder Cocaine,2008,12.05212538,3.64009314,6.53432189
Europe,Western and Central Europe,Sweden,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2009,1,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2009/2010,Any Cocaine,2009,11.56801396,2.60203514,5.55331582
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2009/2010,Crack cocaine,2009,1.50899437,0.26942957,0.48379806
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2009/2010,Powder Cocaine,2009,11.48335059,2.48431925,5.45059913
Europe,Western and Central Europe,Belgium,Cocaine,ARQ,-,2010,2.52,,1.14
Europe,Western and Central Europe,Italy,Cocaine,ARQ,-,2010,2.2,0.9,1.6
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Cocaine salts,2010,1.6,0.7,1.2
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Crack,2010,1.3,0.5,0.9
Europe,Western and Central Europe,Latvia,Cocaine,ARQ,Riga City,2010,2.9,,
Europe,Western and Central Europe,Luxembourg,Cocaine,ARQ,-,2010,1.7,,1.3
Europe,Western and Central Europe,Netherlands,Cocaine,ARQ,-,2010,1.7,0.8,
Europe,Western and Central Europe,Poland,Cocaine,ARQ,-,2010,2.3,0.6,0.7
Europe,Western and Central Europe,Poland,Cocaine,ARQ,Crack,2010,2.3,0.5,0.6
Europe,Western and Central Europe,Slovakia,Cocaine,ARQ,Cocaine salts,2010,1,0.3,0.6
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Cocaine HCL,2010,3.2,1.2,2
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Powder and or crack,2010,3.9,1.5,2.6
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Cocaine salts,2010,2.7,0.6,2.1
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Crack,2010,0.9,0.2,0.5
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2010/2011,Any Cocaine,2010,10.03369111,1.6222838,4.44714488
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2010/2011,Crack cocaine,2010,1.08285584,0.10894288,0.27844744
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2010/2011,Powder Cocaine,2010,9.89765035,1.60959508,4.3751769
Europe,Western and Central Europe,Luxembourg,Cocaine,National Drug Report 2017,-,2010,0.8,,
Europe,Western and Central Europe,Luxembourg,Cocaine,National Drug Report 2017,-,2010,2.5,,
Europe,Western and Central Europe,Belgium,Cocaine,ARQ,-,2011,2,,0.6
Europe,Western and Central Europe,Czechia,Cocaine,ARQ,Cocaine salts,2011,1.1,,
Europe,Western and Central Europe,Czechia,Cocaine,ARQ,Crack,2011,0.7,,
Europe,Western and Central Europe,Denmark,Cocaine,ARQ,-,2011,1.9,,
Europe,Western and Central Europe,Estonia,Cocaine,ARQ,Cocaine salts,2011,1.7,,
Europe,Western and Central Europe,Estonia,Cocaine,ARQ,Crack,2011,1.8,,
Europe,Western and Central Europe,Finland,Cocaine,ARQ,-,2011,1,,
Europe,Western and Central Europe,France,Cocaine,ARQ,Cocaine salts,2011,3,,2.2
Europe,Western and Central Europe,France,Cocaine,ARQ,Crack,2011,0.8,,0.5
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Cocaine salts.,2011,,,0.2
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Crack,2011,,,0
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Cocaine salts. Select regions,2011,3.1,,
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Crack. Select regions,2011,1.9,,
Europe,Western and Central Europe,Greece,Cocaine,ARQ,-,2011,1.5,,
Europe,Western and Central Europe,Greece,Cocaine,ARQ,Crack,2011,1.1,,
Europe,Western and Central Europe,Ireland,Cocaine,ARQ,Cocaine salts,2011,3,,
Europe,Western and Central Europe,Ireland,Cocaine,ARQ,Crack,2011,2,,
Europe,Western and Central Europe,Liechtenstein,Cocaine,ARQ,Cocaine salts,2011,4,,
Europe,Western and Central Europe,Lithuania,Cocaine,ARQ,Cocaine salts,2011,2.4,,
Europe,Western and Central Europe,Lithuania,Cocaine,ARQ,Crack,2011,1,,
Europe,Western and Central Europe,Netherlands,Cocaine,ARQ,-,2011,1.7,0.8,
Europe,Western and Central Europe,Slovenia,Cocaine,ARQ,-,2011,3,,
Europe,Western and Central Europe,Slovenia,Cocaine,ARQ,Crack,2011,2,,
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,-,2011,2.2,0.7,1.8
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Cocaine any (HCL and/or crack),2011,2.8,0.9,2.3
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Crack,2011,1.1,0.4,0.7
Europe,Western and Central Europe,Cyprus,Cocaine,ESPAD,Cocaine salts,2011,4,,
Europe,Western and Central Europe,Iceland,Cocaine,ESPAD,Cocaine salts,2011,2,,
Europe,Western and Central Europe,Latvia,Cocaine,ESPAD,Cocaine salts,2011,3.5,,
Europe,Western and Central Europe,Latvia,Cocaine,ESPAD,Crack,2011,1.9,,
Europe,Western and Central Europe,Malta,Cocaine,ESPAD,Cocaine salts,2011,4,,
Europe,Western and Central Europe,Malta,Cocaine,ESPAD,Crack,2011,1,,
Europe,Western and Central Europe,Norway,Cocaine,ESPAD,-,2011,1,,
Europe,Western and Central Europe,Portugal,Cocaine,ESPAD,Cocaine salts,2011,3,,
Europe,Western and Central Europe,Portugal,Cocaine,ESPAD,Crack,2011,1,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2011/2012,Any Cocaine,2011,10.46474433,2.01960811,4.18154147
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2011/2012,Crack cocaine,2011,0.88193201,0.10082201,0.22059303
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2011/2012,Powder Cocaine,2011,10.42167646,2.01021427,4.11952374
Europe,Western and Central Europe,Belgium,Cocaine,ARQ,-,2012,1.7,,0.8
Europe,Western and Central Europe,Belgium,Cocaine,ARQ,Flemish part,2012,1.9,,0.8
Europe,Western and Central Europe,Cyprus,Cocaine,ARQ,-,2012,1.1,0.1,0.1
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Cocaine salts.   Region Frankfurt am Main,2012,4,1,
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Crack.   Region Frankfurt am Main,2012,1,,
Europe,Western and Central Europe,Italy,Cocaine,ARQ,-,2012,1.47,0.65,1.09
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Cocaine salts,2012,0.91,0.42,0.68
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Crack,2012,0.81,0.36,0.6
Europe,Western and Central Europe,Poland,Cocaine,ARQ,-,2012,3.3,,
Europe,Western and Central Europe,Poland,Cocaine,ARQ,Crack,2012,2.1,,
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Cocaine HCL,2012,2.9,1.1,2
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Powder and or crack,2012,3.6,1.5,2.5
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,-,2012,2.8,0.9,2.2
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Cocaine any (HCL and/or crack),2012,3.2,1.1,2.6
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Crack,2012,1.1,0.3,0.8
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2012/2013,Any Cocaine,2012,8.49334846,,3.10929051
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2012/2013,Crack cocaine,2012,0.8254152,,0.23860842
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2012/2013,Powder Cocaine,2012,8.31781203,,3.03852717
Europe,Western and Central Europe,Belgium,Cocaine,ARQ,"Cocaine salts, Flemish part",2013,1.5,,0.7
Europe,Western and Central Europe,Denmark,Cocaine,ARQ,-,2013,1.9,,
Europe,Western and Central Europe,Estonia,Cocaine,ARQ,-,2013,0.8,,
Europe,Western and Central Europe,Finland,Cocaine,ARQ,-,2013,2,,
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Cocaine salts.   Region Frankfurt am Main,2013,4,1,
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Crack.   Region Frankfurt am Main,2013,1,,
Europe,Western and Central Europe,Italy,Cocaine,ARQ,-,2013,1.77,0.8,1.31
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Cocaine salts,2013,1.16,0.54,0.87
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Crack,2013,0.96,0.38,0.45
Europe,Western and Central Europe,Poland,Cocaine,ARQ,-,2013,3.5,1.1,1.9
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Cocaine any (HCL and/or crack),2013,2.4,0.8,1.9
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Cocaine salts,2013,2,0.5,1.6
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Crack,2013,0.9,0.5,0.8
Europe,Western and Central Europe,United Kingdom (Scotland),Cocaine,Government,Cocaine,2013,2,1,2
Europe,Western and Central Europe,United Kingdom (Scotland),Cocaine,Government,Crack,2013,1,1,1
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2013/2014,Any Cocaine,2013,9.35613239,,4.20934484
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2013/2014,Crack cocaine,2013,0.34326438,,0.11734852
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2013/2014,Powder Cocaine,2013,9.31650967,,4.20481268
Europe,Western and Central Europe,Belgium,Cocaine,ARQ,"Cocaine salts, Flemish part",2014,1.2,,0.6
Europe,Western and Central Europe,France,Cocaine,ARQ,Cocaine salts.  Urban areas (excluding overseas departments),2014,3.2,,1.6
Europe,Western and Central Europe,France,Cocaine,ARQ,Crack.  Urban areas (excluding overseas departments),2014,1.1,,0.4
Europe,Western and Central Europe,Germany,Cocaine,ARQ, Region Frankfurt am Main,2014,3,1,
Europe,Western and Central Europe,Germany,Cocaine,ARQ,Crack.   Region Frankfurt am Main,2014,0,,
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Female,2014,1.9,0.8,1.3
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Male,2014,3.3,1.7,2.5
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Cocaine salts,2014,2.3,1.2,1.8
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Crack,2014,2.7,1.4,2.1
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Powder and or crack,2014,3.5,1.8,2.8
Europe,Western and Central Europe,Sweden,Cocaine,ARQ,Female,2014,0.5,,
Europe,Western and Central Europe,Sweden,Cocaine,ARQ,Male,2014,0.9,,
Europe,Western and Central Europe,Switzerland,Cocaine,ARQ,Cocaine salts. Female,2014,2.4,,
Europe,Western and Central Europe,Switzerland,Cocaine,ARQ,Cocaine salts. Male,2014,1.2,,
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,-,2014,2.3,0.9,2
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Cocaine salts,2014,2.3,0.9,2
Europe,Western and Central Europe,United Kingdom (England),Cocaine,ARQ,Crack,2014,0.3,0.2,0.2
Europe,Western and Central Europe,Belgium,Cocaine,ESPAD,"Cocaine salts, Flemish part",2014,3,,
Europe,Western and Central Europe,Belgium,Cocaine,ESPAD,"Crack, Flemish part",2014,1,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2014/2015,Any Cocaine,2014,10.10644831,1.6987349,4.82308784
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2014/2015,Crack cocaine,2014,0.71869896,0.08745075,0.14586988
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2014/2015,Powder Cocaine,2014,10.10644831,1.6987349,4.76441686
Europe,Western and Central Europe,Greece,Cocaine,ARQ,-,2015,1.34,,1.05
Europe,Western and Central Europe,Greece,Cocaine,ARQ,Cocaine salts,2015,1,,0.76
Europe,Western and Central Europe,Ireland,Cocaine,ARQ,-,2015,2.1,,1.8
Europe,Western and Central Europe,Italy,Cocaine,ARQ,-,2015,3.8,1.5,2.5
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Cocaine salts,2015,3.2,1.3,2.2
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Crack,2015,1.7,0.7,1.1
Europe,Western and Central Europe,Latvia,Cocaine,ARQ,Cocaine salts,2015,2.3,,2.1
Europe,Western and Central Europe,Latvia,Cocaine,ARQ,Crack,2015,2.2,,
Europe,Western and Central Europe,Liechtenstein,Cocaine,ARQ,-,2015,1.8,,
Europe,Western and Central Europe,Liechtenstein,Cocaine,ARQ,Cocaine salts,2015,1.8,,
Europe,Western and Central Europe,Lithuania,Cocaine,ARQ,Cocaine salts,2015,2.2,,1.3
Europe,Western and Central Europe,Lithuania,Cocaine,ARQ,Crack,2015,0.9,,0.6
Europe,Western and Central Europe,Portugal,Cocaine,ARQ,Cocaine salts,2015,2,,
Europe,Western and Central Europe,Portugal,Cocaine,ARQ,Crack,2015,1,,
Europe,Western and Central Europe,Slovakia,Cocaine,ARQ,-,2015,1.9,,1.1
Europe,Western and Central Europe,Sweden,Cocaine,ARQ,Female,2015,0.5,,
Europe,Western and Central Europe,Sweden,Cocaine,ARQ,Male,2015,1.2,,
Europe,Western and Central Europe,Finland,Cocaine,ARQ (ESPAD),-,2015,1,,
Europe,Western and Central Europe,Germany,Cocaine,ARQ / DAS Data,-,2015,4,2,0.3
Europe,Western and Central Europe,Germany,Cocaine,ARQ / DAS Data,Crack,2015,0.5,0.5,
Europe,Western and Central Europe,Austria,Cocaine,ARQ / ESPAD,-,2015,2,,1.5
Europe,Western and Central Europe,Austria,Cocaine,ARQ / ESPAD,Cocaine salts,2015,1.8,,1.4
Europe,Western and Central Europe,Austria,Cocaine,ARQ / ESPAD,Crack,2015,0.6,,0.4
Europe,Western and Central Europe,Czechia,Cocaine,ARQ / ESPAD,Cocaine salts,2015,1.5,0.3,0.7
Europe,Western and Central Europe,Czechia,Cocaine,ARQ / ESPAD,Cocaine salts,2015,1.4,0.3,0.8
Europe,Western and Central Europe,Denmark,Cocaine,ARQ / ESPAD,-,2015,1.8,,
Europe,Western and Central Europe,Malta,Cocaine,ARQ / ESPAD,-,2015,2.8,,2
Europe,Western and Central Europe,Netherlands,Cocaine,ARQ / ESPAD,-,2015,1.3,0.5,0.9
Europe,Western and Central Europe,Belgium,Cocaine,ESPAD,"Crack, Flemish par",2015,1,,
Europe,Western and Central Europe,Belgium,Cocaine,ESPAD,Flemish part,2015,3,,
Europe,Western and Central Europe,Cyprus,Cocaine,ESPAD,-,2015,3,,
Europe,Western and Central Europe,Cyprus,Cocaine,ESPAD,Crack,2015,2,,
Europe,Western and Central Europe,Czechia,Cocaine,ESPAD,-,2015,1,,
Europe,Western and Central Europe,Czechia,Cocaine,ESPAD,Crack,2015,1,,
Europe,Western and Central Europe,Denmark,Cocaine,ESPAD,-,2015,2,,
Europe,Western and Central Europe,Estonia,Cocaine,ESPAD,-,2015,1,,
Europe,Western and Central Europe,Faroe Islands,Cocaine,ESPAD,-,2015,0,,
Europe,Western and Central Europe,Faroe Islands,Cocaine,ESPAD,Crack,2015,0,,
Europe,Western and Central Europe,France,Cocaine,ESPAD,-,2015,4,,
Europe,Western and Central Europe,France,Cocaine,ESPAD,Crack,2015,3,,
Europe,Western and Central Europe,Greece,Cocaine,ESPAD,-,2015,1.34,,1.05
Europe,Western and Central Europe,Greece,Cocaine,ESPAD,Crack,2015,1,,0.76
Europe,Western and Central Europe,Hungary,Cocaine,ESPAD,Cocaine salts,2015,3.2,,1.9
Europe,Western and Central Europe,Hungary,Cocaine,ESPAD,Crack,2015,1.6,,0.9
Europe,Western and Central Europe,Iceland,Cocaine,ESPAD,-,2015,2,,
Europe,Western and Central Europe,Iceland,Cocaine,ESPAD,Crack,2015,1,,
Europe,Western and Central Europe,Ireland,Cocaine,ESPAD,-,2015,3,,
Europe,Western and Central Europe,Ireland,Cocaine,ESPAD,Crack,2015,2,,
Europe,Western and Central Europe,Malta,Cocaine,ESPAD,-,2015,3,,
Europe,Western and Central Europe,Malta,Cocaine,ESPAD,Crack,2015,1,,
Europe,Western and Central Europe,Malta,Cocaine,ESPAD,Crack,2015,1.4,,0.9
Europe,Western and Central Europe,Monaco,Cocaine,ESPAD,-,2015,3,,
Europe,Western and Central Europe,Monaco,Cocaine,ESPAD,Crack,2015,2,,
Europe,Western and Central Europe,Netherlands,Cocaine,ESPAD,-,2015,2,,
Europe,Western and Central Europe,Netherlands,Cocaine,ESPAD,Crack,2015,1,,
Europe,Western and Central Europe,Norway,Cocaine,ESPAD,-,2015,1,,
Europe,Western and Central Europe,Norway,Cocaine,ESPAD,Crack,2015,1,,
Europe,Western and Central Europe,Poland,Cocaine,ESPAD,-,2015,4,,
Europe,Western and Central Europe,Poland,Cocaine,ESPAD,Crack,2015,2,,
Europe,Western and Central Europe,Slovenia,Cocaine,ESPAD,-,2015,2,,
Europe,Western and Central Europe,Slovenia,Cocaine,ESPAD,Crack,2015,1,,
Europe,Western and Central Europe,United Kingdom (Scotland),Cocaine,Government,Cocaine,2015,3.9,1.9,3.5
Europe,Western and Central Europe,United Kingdom (Scotland),Cocaine,Government,Crack,2015,1.5,0.9,1.3
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2015/2016,Any Cocaine,2015,8.58644741,1.96255469,4.44181162
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2015/2016,Crack cocaine,2015,0.59062508,0.01841315,0.01841315
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2015/2016,Powder Cocaine,2015,8.58644741,1.96160289,4.44181162
Europe,Western and Central Europe,Italy,Cocaine,ARQ,-,2016,3.56,1.55,2.46
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Cocaine salts,2016,3.1,1.4,2.21
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Crack,2016,1.56,0.86,1.12
Europe,Western and Central Europe,Poland,Cocaine,ARQ,-,2016,3.4,1,1.6
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Cocaine salts,2016,2.6,0.8,2.1
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Crack,2016,1.7,0.5,1.2
Europe,Western and Central Europe,Spain,Cocaine,ARQ,Powder and or crack,2016,3.2,1,2.5
Europe,Western and Central Europe,Sweden,Cocaine,ARQ,-,2016,0.9,,
Europe,Western and Central Europe,Belgium,Cocaine,ARQ / ESPAD,Flemish part /Cocaine salts,2016,2,,1.1
Europe,Western and Central Europe,Belgium,Cocaine,ARQ / ESPAD,Flemish part /Cocaine salts,2016,2.2,,1.3
Europe,Western and Central Europe,Czechia,Cocaine,ARQ / ESPAD,Cocaine salts,2016,1.5,0.3,0.7
Europe,Western and Central Europe,Switzerland,Cocaine,"Addiction Monitoring in Switzerland, July 2017",Cocaine,2016,0.8,0.1,0.6
Europe,Western and Central Europe,Switzerland,Cocaine,"Addiction Monitoring in Switzerland, July 2017",crack,2016,,,0
Europe,Western and Central Europe,Cyprus,Cocaine,ESPAD,-,2016,2.1,0.2,0.3
Europe,Western and Central Europe,United Kingdom (England),Cocaine,Government,-,2016,4.1,1.4,3.2
Europe,Western and Central Europe,United Kingdom (England),Cocaine,Government,Cocaine salts,2016,3.6,1.3,2.9
Europe,Western and Central Europe,United Kingdom (England),Cocaine,Government,Crack,2016,1.3,0.2,0.7
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2016/2017,Any Cocaine,2016,10.04214541,1.62538293,4.83627051
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2016/2017,Crack cocaine,2016,0.50533235,0,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2016/2017,Powder Cocaine,2016,9.94574884,1.62538293,4.83627051
Europe,Western and Central Europe,United Kingdom (Scotland),Cocaine,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Cocaine,2016,2.4,1.2,2.1
Europe,Western and Central Europe,United Kingdom (Scotland),Cocaine,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),Crack cocaine,2016,1,0.6,0.9
Europe,Western and Central Europe,France,Cocaine,ARQ,Cocaine salts,2017,2.8,,1.5
Europe,Western and Central Europe,France,Cocaine,ARQ,Crack,2017,0.6,,0.2
Europe,Western and Central Europe,Italy,Cocaine,ARQ,-,2017,3.37,1.26,1.91
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Cocaine salts,2017,2.6,1.16,1.79
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Crack,2017,1.18,0.61,0.86
Europe,Western and Central Europe,Belgium,Cocaine,ARQ / ESPAD,-,2017,2,,1.1
Europe,Western and Central Europe,Belgium,Cocaine,ARQ / ESPAD,Other coca/cocaine type,2017,2.2,,1.3
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2017/2018,Any Cocaine,2017,10.8,2.1,6
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2017/2018,Crack cocaine,2017,0.2,0,0.1
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2017/2018,Powder Cocaine,2017,10.8,2.1,6
Europe,Western and Central Europe,Italy,Cocaine,ARQ,-,2018,2.85,0.94,1.81
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Cocaine salts,2018,2.7,0.87,1.71
Europe,Western and Central Europe,Italy,Cocaine,ARQ,Crack,2018,0.88,0.4,0.59
Europe,Western and Central Europe,Poland,Cocaine,ARQ,-,2018,3.7,1.2,2.1
Europe,Western and Central Europe,Slovakia,Cocaine,ARQ,-,2018,1.35,,
Europe,Western and Central Europe,Sweden,Cocaine,ARQ,-,2018,1.01,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2018/2019,Cocaine,2018,11.3,2.6,6.2
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2018/2019,Crack,2018,0.2,0,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Cocaine,Government 2018/2019,Powder Cocaine,2018,11.2,2.6,6.2
Europe,Eastern Europe,Russian Federation,Ecstasy,ARQ/ ESPAD,-,2007,3.2,,
Europe,Eastern Europe,Ukraine,Ecstasy,ESPAD,-,2007,3,,
Europe,Eastern Europe,Republic of Moldova,Ecstasy,ESPAD,-,2008,1.6,0.8,1.3
Europe,Eastern Europe,Belarus,Ecstasy,ARQ,-,2010,1.1,0.2,0.7
Europe,Eastern Europe,Ukraine,Ecstasy,ARQ,-,2010,2,0.2,1
Europe,Eastern Europe,Republic of Moldova,Ecstasy,Govt.,-,2010,1.2,0.2,0.6
Europe,Eastern Europe,Republic of Moldova,Ecstasy,ARQ,-,2011,1.2,0.1,0.6
Europe,Eastern Europe,Russian Federation,Ecstasy,ARQ,-,2011,2.6,0.7,1.2
Europe,Eastern Europe,Ukraine,Ecstasy,ARQ,-,2011,3.1,,
Europe,Eastern Europe,Republic of Moldova,Ecstasy,ESPAD,-,2015,1,,
Europe,South-Eastern Europe,Turkey,Ecstasy,ARQ,-,2003,1.8,,0.8
Europe,South-Eastern Europe,Albania,Ecstasy,ARQ,-,2004,4.9,,
Europe,South-Eastern Europe,Croatia,Ecstasy,ARQ,-,2007,1.9,,0.3
Europe,South-Eastern Europe,Romania,Ecstasy,ESPAD,-,2007,1.2,,0.6
Europe,South-Eastern Europe,Bosnia and Herzegovina,Ecstasy,ARQ,-,2008,,,3
Europe,South-Eastern Europe,Bulgaria,Ecstasy,ARQ,-,2008,7.1,2.6,4.6
Europe,South-Eastern Europe,Serbia,Ecstasy,ARQ,-,2008,1.5,,
Europe,South-Eastern Europe,Montenegro,Ecstasy,ESPAD,-,2008,,,1
Europe,South-Eastern Europe,North Macedonia,Ecstasy,ESPAD,-,2008,3.1,1.6,2.1
Europe,South-Eastern Europe,Bosnia and Herzegovina,Ecstasy,ARQ,-,2011,1.4,0.4,0.7
Europe,South-Eastern Europe,Romania,Ecstasy,ARQ,-,2011,2,0.6,1.4
Europe,South-Eastern Europe,Serbia,Ecstasy,ARQ,-,2011,1.5,1,1
Europe,South-Eastern Europe,Bulgaria,Ecstasy,ESPAD,-,2011,4.4,2.2,3.2
Europe,South-Eastern Europe,Montenegro,Ecstasy,ESPAD,-,2011,3.3,1.2,2.4
Europe,South-Eastern Europe,Serbia,Ecstasy,ESPAD,-,2011,1.5,,
Europe,South-Eastern Europe,Bulgaria,Ecstasy,ARQ,-,2013,4.1,1.9,3.1
Europe,South-Eastern Europe,Montenegro,Ecstasy,ARQ,-,2015,3,,
Europe,South-Eastern Europe,North Macedonia,Ecstasy,ARQ,-,2015,2.1,,1.7
Europe,South-Eastern Europe,Romania,Ecstasy,ARQ,-,2015,2.1,1,1.4
Europe,South-Eastern Europe,Albania,Ecstasy,ARQ / ESPAD,-,2015,2.4,,
Europe,South-Eastern Europe,Bulgaria,Ecstasy,ARQ / ESPAD,-,2015,5.2,,4.2
Europe,South-Eastern Europe,Croatia,Ecstasy,ESPAD,-,2015,2,,
Europe,South-Eastern Europe,North Macedonia,Ecstasy,ESPAD,-,2015,2,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 1996,-,1996,11.6844989,2.9,6.59559135
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 1998,-,1998,10.77560427,2.2,5.08679618
Europe,Western and Central Europe,Luxembourg,Ecstasy,ARQ,-,1999,3.1,,1.7
Europe,Western and Central Europe,Luxembourg,Ecstasy,National Drug Report 2017,-,1999,2.1,,1.3
Europe,Western and Central Europe,Luxembourg,Ecstasy,National Drug Report 2017,-,1999,1.7,,
Europe,Western and Central Europe,Luxembourg,Ecstasy,National Drug Report 2017,-,1999,1.8,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2000,-,2000,11.72203678,3.2,5.60794573
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2001/2002,-,2001,12.10786651,3.5,6.75231751
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2002/2003,-,2002,12.53104651,2.7,5.82349971
Europe,Western and Central Europe,Greenland,Ecstasy,ESPAD,-,2003,2,,1
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2003/2004,-,2003,11.27445851,2.6,5.52759504
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2004/2005,-,2004,10.84872659,1.9,4.85572494
Europe,Western and Central Europe,Liechtenstein,Ecstasy,ARQ,-,2005,0.7,,0.6
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2005/2006,-,2005,10.41767769,2,4.30544614
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2006/2007,-,2006,10.50900579,2.47805577,4.84355135
Europe,Western and Central Europe,Cyprus,Ecstasy,ARQ,-,2007,3,2,3
Europe,Western and Central Europe,Czechia,Ecstasy,ARQ,-,2007,4.5,1.2,3
Europe,Western and Central Europe,Denmark,Ecstasy,ARQ,-,2007,5.2,,
Europe,Western and Central Europe,Estonia,Ecstasy,ARQ,-,2007,5.7,1.6,3.9
Europe,Western and Central Europe,Finland,Ecstasy,ARQ,-,2007,2,,
Europe,Western and Central Europe,Germany,Ecstasy,ARQ,-,2007,3.6,,2
Europe,Western and Central Europe,Latvia,Ecstasy,ARQ,-,2007,6.5,,4.1
Europe,Western and Central Europe,Malta,Ecstasy,ARQ,-,2007,3.9,1.7,3.1
Europe,Western and Central Europe,Netherlands,Ecstasy,ARQ,-,2007,2.4,0.8,
Europe,Western and Central Europe,Slovenia,Ecstasy,ARQ,-,2007,3.3,1.3,2.5
Europe,Western and Central Europe,Czechia,Ecstasy,ARQ./ ESPAD,-,2007,4.6,,3
Europe,Western and Central Europe,Austria,Ecstasy,ESPAD,-,2007,3.4,1.4,
Europe,Western and Central Europe,Cyprus,Ecstasy,ESPAD,-,2007,3,,
Europe,Western and Central Europe,Faroe Islands,Ecstasy,ESPAD,-,2007,1,,
Europe,Western and Central Europe,France,Ecstasy,ESPAD,-,2007,4,,
Europe,Western and Central Europe,Hungary,Ecstasy,ESPAD,-,2007,1.2,,
Europe,Western and Central Europe,Iceland,Ecstasy,ESPAD,-,2007,2,,
Europe,Western and Central Europe,Ireland,Ecstasy,ESPAD,-,2007,4,,
Europe,Western and Central Europe,Lithuania,Ecstasy,ESPAD,-,2007,3.4,,
Europe,Western and Central Europe,Monoco,Ecstasy,ESPAD,-,2007,4,,
Europe,Western and Central Europe,Netherlands,Ecstasy,ESPAD,-,2007,4,,
Europe,Western and Central Europe,Norway,Ecstasy,ESPAD,-,2007,1,,
Europe,Western and Central Europe,Portugal,Ecstasy,ESPAD,-,2007,2.2,,
Europe,Western and Central Europe,Slovenia,Ecstasy,ESPAD,-,2007,3.1,,2.5
Europe,Western and Central Europe,Switzerland,Ecstasy,ESPAD,-,2007,2,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2007/2008,-,2007,9.189764,1.36530309,3.92445015
Europe,Western and Central Europe,Gibraltar,Ecstasy,ARQ,-,2008,,,0.4
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2008/2009,-,2008,9.76211829,1.49288312,4.33180629
Europe,Western and Central Europe,Germany,Ecstasy,Govt.,-,2008,3.2,0.3,0.9
Europe,Western and Central Europe,Sweden,Ecstasy,ARQ,-,2009,1,,1
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2009/2010,-,2009,9.89112494,1.87089894,4.20980628
Europe,Western and Central Europe,Belgium,Ecstasy,ARQ,-,2010,2.82,,1.53
Europe,Western and Central Europe,Greece,Ecstasy,ARQ,-,2010,1.2,,
Europe,Western and Central Europe,Italy,Ecstasy,ARQ,-,2010,1.1,0.3,0.6
Europe,Western and Central Europe,Latvia,Ecstasy,ARQ,-,2010,4.7,1.7,3
Europe,Western and Central Europe,Luxembourg,Ecstasy,ARQ,-,2010,1,,0.7
Europe,Western and Central Europe,Netherlands,Ecstasy,ARQ,-,2010,2.6,0.9,
Europe,Western and Central Europe,Poland,Ecstasy,ARQ,-,2010,3.5,0.8,1.4
Europe,Western and Central Europe,Slovakia,Ecstasy,ARQ,-,2010,1.9,0.6,1.4
Europe,Western and Central Europe,Spain,Ecstasy,ARQ,-,2010,2.5,1,1.7
Europe,Western and Central Europe,United Kingdom (England),Ecstasy,ARQ,-,2010,2.6,0.8,2.3
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2010/2011,-,2010,9.42913129,1.298698,3.72076641
Europe,Western and Central Europe,Luxembourg,Ecstasy,National Drug Report 2017,-,2010,0.3,,
Europe,Western and Central Europe,Luxembourg,Ecstasy,National Drug Report 2017,-,2010,1.4,,
Europe,Western and Central Europe,Belgium,Ecstasy,ARQ,-,2011,2.3,,0.6
Europe,Western and Central Europe,Czechia,Ecstasy,ARQ,-,2011,3.3,0.4,1.5
Europe,Western and Central Europe,Denmark,Ecstasy,ARQ,-,2011,1.5,,
Europe,Western and Central Europe,Estonia,Ecstasy,ARQ,-,2011,2.9,,
Europe,Western and Central Europe,Finland,Ecstasy,ARQ,-,2011,1,,
Europe,Western and Central Europe,France,Ecstasy,ARQ,-,2011,1.9,,1.4
Europe,Western and Central Europe,Germany,Ecstasy,ARQ,-,2011,3,,
Europe,Western and Central Europe,Germany,Ecstasy,ARQ,-,2011,,,0.2
Europe,Western and Central Europe,Ireland,Ecstasy,ARQ,-,2011,2,1,2
Europe,Western and Central Europe,Liechtenstein,Ecstasy,ARQ,-,2011,3,,
Europe,Western and Central Europe,Lithuania,Ecstasy,ARQ,-,2011,2.1,,
Europe,Western and Central Europe,Netherlands,Ecstasy,ARQ,-,2011,2.6,0.9,
Europe,Western and Central Europe,Slovenia,Ecstasy,ARQ,-,2011,2,,
Europe,Western and Central Europe,United Kingdom (England),Ecstasy,ARQ,-,2011,2.7,0.8,2.3
Europe,Western and Central Europe,Cyprus,Ecstasy,ESPAD,-,2011,3,3,3
Europe,Western and Central Europe,Iceland,Ecstasy,ESPAD,-,2011,2,1,1
Europe,Western and Central Europe,Latvia,Ecstasy,ESPAD,-,2011,4.3,1.5,2.3
Europe,Western and Central Europe,Malta,Ecstasy,ESPAD,-,2011,3,2,2
Europe,Western and Central Europe,Norway,Ecstasy,ESPAD,-,2011,1,1,1
Europe,Western and Central Europe,Portugal,Ecstasy,ESPAD,-,2011,3,1,3
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2011/2012,-,2011,8.74046778,1.52348527,3.29713263
Europe,Western and Central Europe,Belgium,Ecstasy,ARQ,-,2012,1.8,,1
Europe,Western and Central Europe,Belgium,Ecstasy,ARQ,-,2012,2.9,,1.5
Europe,Western and Central Europe,Cyprus,Ecstasy,ARQ,-,2012,0.8,0.1,0.1
Europe,Western and Central Europe,Italy,Ecstasy,ARQ,-,2012,0.78,0.25,0.5
Europe,Western and Central Europe,Poland,Ecstasy,ARQ,-,2012,3,1.5,2.2
Europe,Western and Central Europe,Spain,Ecstasy,ARQ,-,2012,3,1.2,2.2
Europe,Western and Central Europe,United Kingdom (England),Ecstasy,ARQ,-,2012,3,1.2,2.4
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2012/2013,-,2012,7.90371503,,2.88003175
Europe,Western and Central Europe,Belgium,Ecstasy,ARQ,-,2013,2,,1.1
Europe,Western and Central Europe,Denmark,Ecstasy,ARQ,-,2013,1.5,,
Europe,Western and Central Europe,Estonia,Ecstasy,ARQ,-,2013,0.8,,
Europe,Western and Central Europe,Finland,Ecstasy,ARQ,-,2013,2,,
Europe,Western and Central Europe,Germany,Ecstasy,ARQ,-,2013,4,1,
Europe,Western and Central Europe,Italy,Ecstasy,ARQ,-,2013,0.81,0.29,0.53
Europe,Western and Central Europe,Latvia,Ecstasy,ARQ,-,2013,2.43,,
Europe,Western and Central Europe,Poland,Ecstasy,ARQ,-,2013,2.6,1,1.4
Europe,Western and Central Europe,United Kingdom (England),Ecstasy,ARQ,-,2013,2.1,1.2,1.8
Europe,Western and Central Europe,United Kingdom (Scotland),Ecstasy,Government,-,2013,2,1,2
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2013/2014,-,2013,9.02304445,,3.86048482
Europe,Western and Central Europe,Belgium,Ecstasy,ARQ,-,2014,1.6,,0.9
Europe,Western and Central Europe,France,Ecstasy,ARQ,-,2014,3.8,,2.1
Europe,Western and Central Europe,Germany,Ecstasy,ARQ,-,2014,5,1,
Europe,Western and Central Europe,Netherlands,Ecstasy,ARQ,-,2014,2.6,0.9,
Europe,Western and Central Europe,Spain,Ecstasy,ARQ,-,2014,1.2,0.4,0.9
Europe,Western and Central Europe,Sweden,Ecstasy,ARQ,-,2014,0.5,,
Europe,Western and Central Europe,Sweden,Ecstasy,ARQ,-,2014,0.7,,
Europe,Western and Central Europe,Switzerland,Ecstasy,ARQ,-,2014,0.9,,
Europe,Western and Central Europe,Switzerland,Ecstasy,ARQ,-,2014,1.9,,
Europe,Western and Central Europe,United Kingdom (England),Ecstasy,ARQ,-,2014,2.7,1.3,2.4
Europe,Western and Central Europe,Belgium,Ecstasy,ESPAD,-,2014,3,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2014/2015,-,2014,10.16546066,2.14000026,5.38468578
Europe,Western and Central Europe,Ireland,Ecstasy,ARQ,-,2015,3.1,,2.1
Europe,Western and Central Europe,Italy,Ecstasy,ARQ,-,2015,3.3,1.4,2.4
Europe,Western and Central Europe,Latvia,Ecstasy,ARQ,-,2015,2.7,,1.2
Europe,Western and Central Europe,Liechtenstein,Ecstasy,ARQ,-,2015,1.8,,
Europe,Western and Central Europe,Lithuania,Ecstasy,ARQ,-,2015,1.5,,
Europe,Western and Central Europe,Portugal,Ecstasy,ARQ,-,2015,2,0.8,1.6
Europe,Western and Central Europe,Slovakia,Ecstasy,ARQ,-,2015,3.9,,2.2
Europe,Western and Central Europe,Sweden,Ecstasy,ARQ,-,2015,0.4,,
Europe,Western and Central Europe,Sweden,Ecstasy,ARQ,-,2015,0.9,,
Europe,Western and Central Europe,Finland,Ecstasy,ARQ (ESPAD),-,2015,1,,
Europe,Western and Central Europe,Germany,Ecstasy,ARQ / DAS Data,-,2015,4,2,0.5
Europe,Western and Central Europe,Austria,Ecstasy,ARQ / ESPAD,-,2015,2,,1.4
Europe,Western and Central Europe,Czechia,Ecstasy,ARQ / ESPAD,-,2015,2.7,0.6,1.7
Europe,Western and Central Europe,Denmark,Ecstasy,ARQ / ESPAD,-,2015,0.5,,
Europe,Western and Central Europe,Malta,Ecstasy,ARQ / ESPAD,-,2015,2,,1.5
Europe,Western and Central Europe,Netherlands,Ecstasy,ARQ / ESPAD,-,2015,1.9,0.6,1.5
Europe,Western and Central Europe,Slovenia,Ecstasy,ARQ/ESPAD,-,2015,2.18,,
Europe,Western and Central Europe,Belgium,Ecstasy,ESPAD,-,2015,3,,
Europe,Western and Central Europe,Cyprus,Ecstasy,ESPAD,-,2015,3,,
Europe,Western and Central Europe,Estonia,Ecstasy,ESPAD,-,2015,3,,
Europe,Western and Central Europe,Faroe Islands,Ecstasy,ESPAD,-,2015,0,,
Europe,Western and Central Europe,France,Ecstasy,ESPAD,-,2015,2,,
Europe,Western and Central Europe,Greece,Ecstasy,ESPAD,-,2015,1.25,,1.11
Europe,Western and Central Europe,Hungary,Ecstasy,ESPAD,-,2015,3.6,,2.1
Europe,Western and Central Europe,Iceland,Ecstasy,ESPAD,-,2015,2,,
Europe,Western and Central Europe,Monaco,Ecstasy,ESPAD,-,2015,2,,
Europe,Western and Central Europe,Norway,Ecstasy,ESPAD,-,2015,1,,
Europe,Western and Central Europe,Poland,Ecstasy,ESPAD,-,2015,3,,
Europe,Western and Central Europe,United Kingdom (Scotland),Ecstasy,Government,-,2015,5,3,
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2015/2016,-,2015,9.22087144,1.44129089,4.52408088
Europe,Western and Central Europe,Luxembourg,Ecstasy,National Drug Report 2017,-,2015,0,0,0
Europe,Western and Central Europe,Czechia,Ecstasy,ARQ,-,2016,3.3,0.8,2.3
Europe,Western and Central Europe,Italy,Ecstasy,ARQ,-,2016,3.04,1.32,2.1
Europe,Western and Central Europe,Poland,Ecstasy,ARQ,-,2016,3.9,0.9,1.9
Europe,Western and Central Europe,Spain,Ecstasy,ARQ,-,2016,2.3,0.6,1.6
Europe,Western and Central Europe,Sweden,Ecstasy,ARQ,-,2016,0.6,,
Europe,Western and Central Europe,United Kingdom (England),Ecstasy,ARQ,-,2016,4,1.5,3.7
Europe,Western and Central Europe,Switzerland,Ecstasy,"Addiction Monitoring in Switzerland, July 2017",-,2016,2.5,0.6,0.8
Europe,Western and Central Europe,Cyprus,Ecstasy,ESPAD,-,2016,1.5,0.1,0.1
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2016/2017,-,2016,9.7115705,1.11271064,4.27406387
Europe,Western and Central Europe,United Kingdom (Scotland),Ecstasy,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),-,2016,2.1,1.3,2
Europe,Western and Central Europe,United Kingdom (Scotland),Ecstasy,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),-,2016,3,1.6,2.7
Europe,Western and Central Europe,Belgium,Ecstasy,ARQ,-,2017,2.2,,1.1
Europe,Western and Central Europe,France,Ecstasy,ARQ,-,2017,3.4,,2
Europe,Western and Central Europe,Iceland,Ecstasy,ARQ,-,2017,0.7,,
Europe,Western and Central Europe,Ireland,Ecstasy,ARQ,-,2017,3.1,,2.1
Europe,Western and Central Europe,Italy,Ecstasy,ARQ,-,2017,2.36,0.76,1.39
Europe,Western and Central Europe,Sweden,Ecstasy,ARQ,-,2017,0.8,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2017/2018,-,2017,11.3,1.9,5.1
Europe,Western and Central Europe,Italy,Ecstasy,ARQ,-,2018,2.24,0.59,1.24
Europe,Western and Central Europe,Poland,Ecstasy,ARQ,-,2018,4.2,0.7,2.2
Europe,Western and Central Europe,Slovakia,Ecstasy,ARQ,-,2018,2.4,,
Europe,Western and Central Europe,Sweden,Ecstasy,ARQ,-,2018,0.8,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Ecstasy,Government 2018/2019,-,2018,10.6,1.1,4.7
Europe,Western and Central Europe,Gibraltar,Ecstasy,ARQ,-,2019,,0.15,0.88
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 1998,All Opiates,1998,1.7,0.7,0.83833565
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2000,All Opiates,2000,1.7,0.3,0.81423346
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2001/2002,All Opiates,2001,1.1,0.2,0.29222675
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2002/2003,All Opiates,2002,1,0.2,0.2426493
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2003/2004,All Opiates,2003,1.3,0.3,0.46102012
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2004/2005,All Opiates,2004,0.7,0.1,0.16254988
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2005/2006,All Opiates,2005,0.8,0.1,0.1748828
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2006/2007,All Opiates,2006,0.7,0.14183395,0.19899566
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2007/2008,All Opiates,2007,0.6,0.04752603,0.18485554
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2008/2009,All Opiates,2008,0.6,0.01924041,0.0277015
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2009/2010,All Opiates,2009,0.7,0.1698482,0.26917083
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2010/2011,All Opiates,2010,0.9,0.17254602,0.36209359
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2011/2012,All Opiates,2011,1,0.31920752,0.46419549
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2012/2013,All Opiates,2012,0.5,,0.00791285
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2013/2014,All Opiates,2013,0.8,,0.15866263
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2014/2015,All Opiates,2014,0.4,0.01885501,0.01885501
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2015/2016,All Opiates,2015,0.6,0.05108779,0.05108779
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2016/2017,All Opiates,2016,0.4,0,0.05321913
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2017/2018,All Opiates,2017,0.7,0,0.1
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2017/2018,Heroin,2017,0.2,0,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2017/2018,Methadone,2017,0.5,0,0.1
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2018/2019,All Opiates,2018,0.1,0,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2018/2019,Heroin,2018,0,0,0
Europe,Western and Central Europe,United Kingdom (England and Wales),Opioids,Government 2018/2019,Methadone,2018,0.1,0,0
Europe,Eastern Europe,Republic of Moldova,Tranquillizers and sedatives,,-,2010,1.6,,
Europe,Eastern Europe,Republic of Moldova,Tranquillizers and sedatives,ARQ,-,2011,2.4,,
Europe,Eastern Europe,Republic of Moldova,Tranquillizers and sedatives,ESPAD,-,2011,5,,
Europe,Eastern Europe,Republic of Moldova,Tranquillizers and sedatives,ARQ,-,2013,,,0.35
Europe,Eastern Europe,Republic of Moldova,Tranquillizers and sedatives,ARQ,-,2014,,,0.1
Europe,Eastern Europe,Republic of Moldova,Tranquillizers and sedatives,ARQ,-,2015,,,0
Europe,Eastern Europe,Republic of Moldova,Tranquillizers and sedatives,ESPAD,GHB,2015,0,,
Europe,Eastern Europe,Republic of Moldova,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,South-Eastern Europe,Bulgaria,Tranquillizers and sedatives,,-,2008,15.9,6.4,10.5
Europe,South-Eastern Europe,Bulgaria,Tranquillizers and sedatives,,Barbiturates,2008,12.7,5.3,8.4
Europe,South-Eastern Europe,Bulgaria,Tranquillizers and sedatives,,Benzodiazepines,2008,11.8,4.2,7.4
Europe,South-Eastern Europe,Romania,Tranquillizers and sedatives,,-,2011,3.1,,
Europe,South-Eastern Europe,Turkey,Tranquillizers and sedatives,,-,2011,4.3,0.7,0.8
Europe,South-Eastern Europe,Bosnia and Herzegovina,Tranquillizers and sedatives,ARQ,-,2011,4.2,,
Europe,South-Eastern Europe,Romania,Tranquillizers and sedatives,ARQ,GHB,2011,0.9,,
Europe,South-Eastern Europe,Bulgaria,Tranquillizers and sedatives,ESPAD,-,2011,4.2,,
Europe,South-Eastern Europe,Montenegro,Tranquillizers and sedatives,ESPAD,Benzodiazepines,2011,4.9,,
Europe,South-Eastern Europe,Serbia,Tranquillizers and sedatives,ESPAD,-,2011,7.5,,
Europe,South-Eastern Europe,Bulgaria,Tranquillizers and sedatives,ARQ,-,2013,12.2,4.7,9
Europe,South-Eastern Europe,Bulgaria,Tranquillizers and sedatives,ARQ,Barbiturates,2013,10.4,3.3,7.1
Europe,South-Eastern Europe,Bulgaria,Tranquillizers and sedatives,ARQ,Benzodiazepines,2013,5.4,2.3,4.1
Europe,South-Eastern Europe,Montenegro,Tranquillizers and sedatives,ARQ,-,2015,10,,
Europe,South-Eastern Europe,North Macedonia,Tranquillizers and sedatives,ARQ,-,2015,11.1,,
Europe,South-Eastern Europe,Romania,Tranquillizers and sedatives,ARQ,-,2015,2,,
Europe,South-Eastern Europe,Romania,Tranquillizers and sedatives,ARQ,GHB,2015,1.1,,
Europe,South-Eastern Europe,Albania,Tranquillizers and sedatives,ARQ / ESPAD,-,2015,7.2,,
Europe,South-Eastern Europe,Bulgaria,Tranquillizers and sedatives,ARQ / ESPAD,-,2015,3.6,,
Europe,South-Eastern Europe,Albania,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,South-Eastern Europe,Bulgaria,Tranquillizers and sedatives,ESPAD,GHB,2015,3,,
Europe,South-Eastern Europe,Croatia,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,South-Eastern Europe,Montenegro,Tranquillizers and sedatives,ESPAD,GHB,2015,2,,
Europe,South-Eastern Europe,North Macedonia,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 1996,Tranquillizers,1996,3.85414025,0.4,0.94905434
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 1998,Tranquillizers,1998,3.4487699,0.5,1.49648954
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2000,Tranquillizers,2000,4.50219741,0.5,1.51257318
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2001/2002,Tranquillizers,2001,3.31133445,0.4,1.02032844
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2002/2003,Tranquillizers,2002,2.74509356,0.4,0.89871286
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2003/2004,Tranquillizers,2003,2.90268196,0.3,0.87157066
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2004/2005,Tranquillizers,2004,2.22076904,0.4,0.784027
Europe,Western and Central Europe,Liechtenstein,Tranquillizers and sedatives,,Barbiturates,2005,1.1,,1.8
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2005/2006,Tranquillizers,2005,2.57541718,0.4,0.71686272
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2006/2007,Tranquillizers,2006,2.27925395,0.27776983,0.59800158
Europe,Western and Central Europe,Austria,Tranquillizers and sedatives,,-,2007,2.6,,
Europe,Western and Central Europe,Cyprus,Tranquillizers and sedatives,,-,2007,7,,
Europe,Western and Central Europe,Czechia,Tranquillizers and sedatives,,-,2007,9.1,,
Europe,Western and Central Europe,Estonia,Tranquillizers and sedatives,,-,2007,7.1,,
Europe,Western and Central Europe,Finland,Tranquillizers and sedatives,,-,2007,5,,
Europe,Western and Central Europe,Malta,Tranquillizers and sedatives,,-,2007,4.7,,11.1
Europe,Western and Central Europe,Netherlands,Tranquillizers and sedatives,,GHB,2007,0.6,,
Europe,Western and Central Europe,Slovenia,Tranquillizers and sedatives,,-,2007,5.2,,
Europe,Western and Central Europe,Slovenia,Tranquillizers and sedatives,,GHB,2007,0.6,,
Europe,Western and Central Europe,Germany,Tranquillizers and sedatives,ESPAD,GHB. Select regions,2007,2.2,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2007/2008,Tranquillizers,2007,2.00895639,0.21222391,0.67518772
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2008/2009,Tranquillizers,2008,2.58218412,0.33429448,0.96851534
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2009/2010,Tranquillizers,2009,2.47388369,0.37232093,0.83753756
Europe,Western and Central Europe,Greece,Tranquillizers and sedatives,,-,2010,3,,
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,,-,2010,4,1.2,2.2
Europe,Western and Central Europe,Netherlands,Tranquillizers and sedatives,,GHB,2010,0.5,0.1,
Europe,Western and Central Europe,Poland,Tranquillizers and sedatives,,-,2010,20,4,10
Europe,Western and Central Europe,Poland,Tranquillizers and sedatives,,Other sedatives and tranquillizers,2010,11,1,7
Europe,Western and Central Europe,Slovakia,Tranquillizers and sedatives,,Benzodiazepines,2010,9.5,2.7,3.7
Europe,Western and Central Europe,Spain,Tranquillizers and sedatives,ARQ,-,2010,10.4,3,5.6
Europe,Western and Central Europe,Spain,Tranquillizers and sedatives,ARQ,GHB,2010,1.2,0.5,0.7
Europe,Western and Central Europe,United Kingdom (England),Tranquillizers and sedatives,ARQ,-,2010,0.4,0.1,0.2
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2010/2011,Tranquillizers,2010,2.29000436,0.31552173,0.71204219
Europe,Western and Central Europe,Latvia,Tranquillizers and sedatives,,GHB,2011,2.1,,
Europe,Western and Central Europe,Czechia,Tranquillizers and sedatives,ARQ,-,2011,10.1,,
Europe,Western and Central Europe,Estonia,Tranquillizers and sedatives,ARQ,-,2011,8.1,,
Europe,Western and Central Europe,Finland,Tranquillizers and sedatives,ARQ,-,2011,7,,
Europe,Western and Central Europe,Iceland,Tranquillizers and sedatives,ARQ,-,2011,8,,
Europe,Western and Central Europe,Ireland,Tranquillizers and sedatives,ARQ,-,2011,3,,
Europe,Western and Central Europe,Liechtenstein,Tranquillizers and sedatives,ARQ,-,2011,2,,
Europe,Western and Central Europe,Lithuania,Tranquillizers and sedatives,ARQ,-,2011,13.1,,
Europe,Western and Central Europe,Slovenia,Tranquillizers and sedatives,ARQ,-,2011,5,,
Europe,Western and Central Europe,Slovenia,Tranquillizers and sedatives,ARQ,GHB,2011,1,,
Europe,Western and Central Europe,United Kingdom (England),Tranquillizers and sedatives,ARQ,-,2011,1.4,0.6,1.1
Europe,Western and Central Europe,Cyprus,Tranquillizers and sedatives,ESPAD,-,2011,10,,
Europe,Western and Central Europe,Latvia,Tranquillizers and sedatives,ESPAD,-,2011,4.2,,
Europe,Western and Central Europe,Malta,Tranquillizers and sedatives,ESPAD,-,2011,3,,
Europe,Western and Central Europe,Norway,Tranquillizers and sedatives,ESPAD,-,2011,4,,
Europe,Western and Central Europe,Portugal,Tranquillizers and sedatives,ESPAD,-,2011,7,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2011/2012,Tranquillizers,2011,2.08071698,0.25324111,0.51895978
Europe,Western and Central Europe,Belgium,Tranquillizers and sedatives,,"GHB, Flemish part",2012,0.6,,0.4
Europe,Western and Central Europe,Poland,Tranquillizers and sedatives,,GHB,2012,1.2,,
Europe,Western and Central Europe,Cyprus,Tranquillizers and sedatives,ARQ,-,2012,,0.7,1.2
Europe,Western and Central Europe,Germany,Tranquillizers and sedatives,ARQ,GHB.  Region Frankfurt am Main,2012,2,,
Europe,Western and Central Europe,Greece,Tranquillizers and sedatives,ARQ,-,2012,9.3,,
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,-,2012,1.57,0.67,1.05
Europe,Western and Central Europe,Poland,Tranquillizers and sedatives,ARQ,-,2012,15.5,,
Europe,Western and Central Europe,Spain,Tranquillizers and sedatives,ARQ,-,2012,8.9,3.4,5.8
Europe,Western and Central Europe,Spain,Tranquillizers and sedatives,ARQ,GHB,2012,1.3,0.7,1
Europe,Western and Central Europe,United Kingdom (England),Tranquillizers and sedatives,ARQ,-,2012,0.7,0.3,0.6
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2012/2013,Tranquillizers,2012,1.82292094,,0.4102797
Europe,Western and Central Europe,Estonia,Tranquillizers and sedatives,ARQ,Barbiturates,2013,1,,
Europe,Western and Central Europe,Estonia,Tranquillizers and sedatives,ARQ,Benzodiazepines,2013,1,,
Europe,Western and Central Europe,Finland,Tranquillizers and sedatives,ARQ,-,2013,6,,
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,-,2013,2.45,0.78,1.35
Europe,Western and Central Europe,Poland,Tranquillizers and sedatives,ARQ,-,2013,19.7,5.1,11
Europe,Western and Central Europe,Poland,Tranquillizers and sedatives,ARQ,GHB,2013,1.3,0.7,0.7
Europe,Western and Central Europe,United Kingdom (England),Tranquillizers and sedatives,ARQ,-,2013,0.8,0.4,0.6
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2013/2014,Tranquillizers,2013,1.78421579,,0.51214604
Europe,Western and Central Europe,United Kingdom (Scotland),Tranquillizers and sedatives,Govt.,-,2013,1,1,1
Europe,Western and Central Europe,France,Tranquillizers and sedatives,ARQ,Urban areas (excluding overseas departments),2014,15.8,,
Europe,Western and Central Europe,Germany,Tranquillizers and sedatives,ARQ,GHB.  Region Frankfurt am Main,2014,1,,
Europe,Western and Central Europe,Spain,Tranquillizers and sedatives,ARQ,-,2014,7.8,3,5.3
Europe,Western and Central Europe,Spain,Tranquillizers and sedatives,ARQ,GHB,2014,1,0.4,0.7
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,Female,2014,4.8,1.5,3.5
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,GBL. Female,2014,0.3,,
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,GBL. Male,2014,0.3,,
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,Male,2014,3.1,1.2,2.4
Europe,Western and Central Europe,Switzerland,Tranquillizers and sedatives,ARQ,Female,2014,2.8,,
Europe,Western and Central Europe,Switzerland,Tranquillizers and sedatives,ARQ,MAle,2014,2.9,,
Europe,Western and Central Europe,United Kingdom (England),Tranquillizers and sedatives,ARQ,-,2014,0.5,0,0.4
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2014/2015,Tranquillizers,2014,2.5003993,0.10735012,0.75113302
Europe,Western and Central Europe,Finland,Tranquillizers and sedatives,ARQ,-,2015,6,,
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,-,2015,14,4.2,7.2
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,GHB,2015,0.8,0.5,0.7
Europe,Western and Central Europe,Latvia,Tranquillizers and sedatives,ARQ,-,2015,5.1,,
Europe,Western and Central Europe,Latvia,Tranquillizers and sedatives,ARQ,GHB,2015,0.9,,
Europe,Western and Central Europe,Liechtenstein,Tranquillizers and sedatives,ARQ,-,2015,2.7,,
Europe,Western and Central Europe,Liechtenstein,Tranquillizers and sedatives,ARQ,Benzodiazepines,2015,2.7,,
Europe,Western and Central Europe,Lithuania,Tranquillizers and sedatives,ARQ,-,2015,5.1,,
Europe,Western and Central Europe,Portugal,Tranquillizers and sedatives,ARQ,-,2015,5,,
Europe,Western and Central Europe,Slovakia,Tranquillizers and sedatives,ARQ,-,2015,9.7,,
Europe,Western and Central Europe,Slovenia,Tranquillizers and sedatives,ARQ,Benzodiazepines,2015,1.49,,
Europe,Western and Central Europe,Slovenia,Tranquillizers and sedatives,ARQ,GHB,2015,0.32,,
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,Female,2015,3.6,1,2.7
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,Male,2015,2.4,0.8,1.8
Europe,Western and Central Europe,Germany,Tranquillizers and sedatives,ARQ / DAS Data,GHB/GBL,2015,0.5,0.5,
Europe,Western and Central Europe,Austria,Tranquillizers and sedatives,ARQ / ESPAD,-,2015,4.3,,
Europe,Western and Central Europe,Hungary,Tranquillizers and sedatives,ARQ / ESPAD,-,2015,9,,
Europe,Western and Central Europe,Hungary,Tranquillizers and sedatives,ARQ / ESPAD,GHB,2015,1.1,,
Europe,Western and Central Europe,Malta,Tranquillizers and sedatives,ARQ / ESPAD,-,2015,2.9,,
Europe,Western and Central Europe,Netherlands,Tranquillizers and sedatives,ARQ / ESPAD,GHB,2015,0.4,,0.2
Europe,Western and Central Europe,Norway,Tranquillizers and sedatives,ARQ / ESPAD,-,2015,6,,
Europe,Western and Central Europe,Austria,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,Belgium,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,Cyprus,Tranquillizers and sedatives,ESPAD,GHB,2015,2,,
Europe,Western and Central Europe,Czechia,Tranquillizers and sedatives,ESPAD,GHB,2015,0,,
Europe,Western and Central Europe,Denmark,Tranquillizers and sedatives,ESPAD,GHB,2015,0,,
Europe,Western and Central Europe,Estonia,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,Faroe Islands,Tranquillizers and sedatives,ESPAD,GHB,2015,0,,
Europe,Western and Central Europe,France,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,Greece,Tranquillizers and sedatives,ESPAD,GHB,2015,0,,
Europe,Western and Central Europe,Iceland,Tranquillizers and sedatives,ESPAD,GHB,2015,0,,
Europe,Western and Central Europe,Ireland,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,Liechtenstein,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,Lithuania,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,Malta,Tranquillizers and sedatives,ESPAD,GHB,2015,0,,
Europe,Western and Central Europe,Monaco,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,Poland,Tranquillizers and sedatives,ESPAD,GHB,2015,2,,
Europe,Western and Central Europe,Portugal,Tranquillizers and sedatives,ESPAD,GHB,2015,1,,
Europe,Western and Central Europe,Slovakia,Tranquillizers and sedatives,ESPAD,GHB,2015,2,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2015/2016,Tranquillizers,2015,2.36469602,0.11080377,0.49765242
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,-,2016,3.14,4.12,6.88
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,GHB,2016,0.88,0.63,0.7
Europe,Western and Central Europe,Spain,Tranquillizers and sedatives,ARQ,-,2016,8,2.6,5.4
Europe,Western and Central Europe,Spain,Tranquillizers and sedatives,ARQ,GHB,2016,0.6,0.2,0.4
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,-,2016,0.4,,
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,-,2016,0.6,,
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,GHB,2016,0.1,,
Europe,Western and Central Europe,United Kingdom (England),Tranquillizers and sedatives,ARQ,-,2016,1.4,0.6,1.2
Europe,Western and Central Europe,Switzerland,Tranquillizers and sedatives,"Addiction Monitoring in Switzerland, July 2017",GHB/GBL,2016,,,0
Europe,Western and Central Europe,Cyprus,Tranquillizers and sedatives,ESPAD,-,2016,,1.2,4
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2016/2017,Tranquillizers,2016,2.20053906,0.18957519,0.58266092
Europe,Western and Central Europe,United Kingdom (Scotland),Tranquillizers and sedatives,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),-,2016,1.2,0.7,1
Europe,Western and Central Europe,United Kingdom (Scotland),Tranquillizers and sedatives,Government/Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS),GHB/GBL,2016,0.9,0.6,0.7
Europe,Western and Central Europe,France,Tranquillizers and sedatives,ARQ,-,2017,12.9,,9.6
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,-,2017,21.6,6.5,11.3
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,GHB,2017,0.59,0.36,0.5
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2017/2018,Tranquillizers,2017,2.7,,1.3
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,-,2018,14.7,4.59,8.67
Europe,Western and Central Europe,Italy,Tranquillizers and sedatives,ARQ,GHB,2018,0.45,0.23,0.33
Europe,Western and Central Europe,Poland,Tranquillizers and sedatives,ARQ,-,2018,21.9,6.3,13.7
Europe,Western and Central Europe,Slovakia,Tranquillizers and sedatives,ARQ,-,2018,8.5,,
Europe,Western and Central Europe,Sweden,Tranquillizers and sedatives,ARQ,-,2018,0.63,,
Europe,Western and Central Europe,United Kingdom (England and Wales),Tranquillizers and sedatives,Government 2017/2018,Tranquillizers,2018,2.9,0.3,0.6
Oceania,Australia and New Zealand,Australia,Amphetamines,ARQ,Methamphetamine,2007,1,,0.6
Oceania,Australia and New Zealand,New Zealand,Amphetamines,ARQ,Methamphetamine,2007,1.2,,
Oceania,Australia and New Zealand,New Zealand,Amphetamines,Govt.,Household survey,2008,2.15,,1.4
Oceania,Australia and New Zealand,Australia,Amphetamines,ARQ,Non-specified ATS,2010,2.4,0.6,1.6
Oceania,Australia and New Zealand,New Zealand,Amphetamines,New Zealand Health Survey,Amphetamine,2011,,,1
Oceania,Australia and New Zealand,New Zealand,Amphetamines,New Zealand Health Survey,Amphetamine,2012,,,1.9
Oceania,Australia and New Zealand,Australia,Amphetamines,ARQ,Amphetamines,2013,2.3,0.8,2
Oceania,Australia and New Zealand,New Zealand,Amphetamines,New Zealand Health Survey,Amphetamine,2013,,,1.5
Oceania,Australia and New Zealand,New Zealand,Amphetamines,Govt.,Household survey,2014,,,1.8
Oceania,Australia and New Zealand,New Zealand,Amphetamines,New Zealand Health Survey,Amphetamine,2014,,,1.3
Oceania,Australia and New Zealand,New Zealand,Amphetamines,Govt.,Household survey,2015,,,1.3
Oceania,Australia and New Zealand,New Zealand,Amphetamines,New Zealand Health Survey,Amphetamine,2015,,,1.4
Oceania,Australia and New Zealand,Australia,Amphetamines,ARQ,-,2016,1.4,,0.8
Oceania,Australia and New Zealand,Australia,Amphetamines,ARQ,"Meth-amphetamines / 2016 annual prevalence, 2013 lifetime and past 30 day prevalence",2016,2.3,0.8,0.8
Oceania,Australia and New Zealand,New Zealand,Amphetamines,New Zealand Health Survey,Amphetamine,2016,,,0.7
Oceania,Australia and New Zealand,Australia,Amphetamines,ARQ,Amphetamine,2017,2,1,
Oceania,Australia and New Zealand,Australia,Amphetamines,ARQ,Amphetamine type stimulants,2017,1.4,,0.8
Oceania,Australia and New Zealand,Australia,Amphetamines,ARQ,Methamphetamines,2017,2,1,1
Oceania,Australia and New Zealand,New Zealand,Amphetamines,ARQ,-,2017,,,0.7
Oceania,Australia and New Zealand,New Zealand,Amphetamines,New Zealand Health Survey,-,2017,,,1.1
Oceania,Micronesia,Guam,Amphetamines,Govt.,Youth Risk Behavior Survey/ methamphetamine,2007,5.9,,
Oceania,Micronesia,Marshall Islands,Amphetamines,Govt.,Youth Risk Behavior Survey/ methamphetamine,2007,13.1,,
Oceania,Micronesia,Northern Mariana Islands,Amphetamines,Govt.,Youth Risk Behavior Survey/ methamphetamine,2007,4.9,,
Oceania,Micronesia,Palau,Amphetamines,Govt.,Youth Risk Behavior Survey/ methamphetamine,2007,7.1,,
Oceania,Micronesia,Palau,Amphetamines,Youth Risk Behavior Survey,Methamphetamines,2011,8.5,,
Oceania,Polynesia,American Samoa,Amphetamines,Govt.,Youth Risk Behavior Survey/ methamphetamine,2007,5.7,,
Oceania,Australia and New Zealand,Australia,Cocaine,ARQ,"Cocaine, any (HCl and/ or Crack)",2007,0.8,,0.4
Oceania,Australia and New Zealand,New Zealand,Cocaine,Govt.,Household survey,2008,0.1,,0.1
Oceania,Australia and New Zealand,Australia,Cocaine,ARQ,-,2010,2.1,0.7,1.3
Oceania,Australia and New Zealand,Australia,Cocaine,ARQ,-,2013,1.5,,1
Oceania,Australia and New Zealand,Australia,Cocaine,ARQ,-,2013,2.1,0.3,1.1
Oceania,Australia and New Zealand,Australia,Cocaine,ARQ,"2016 annual prevalence, 2013 lifetime and past 30 day prevalence",2016,2.1,0.3,1
Oceania,Australia and New Zealand,Australia,Cocaine,ARQ,-,2017,2,1,2
Oceania,Micronesia,Guam,Cocaine,Govt.,Youth Risk Behavior Survey,2007,4.6,2,
Oceania,Micronesia,Marshall Islands,Cocaine,Govt.,Youth Risk Behavior Survey,2007,7.7,5.3,
Oceania,Micronesia,Northern Mariana Islands,Cocaine,Govt.,Youth Risk Behavior Survey,2007,4.7,2.9,
Oceania,Micronesia,Palau,Cocaine,Govt.,Youth Risk Behavior Survey,2007,5.9,3.5,
Oceania,Micronesia,Palau,Cocaine,Youth Risk Behavior Survey,-,2011,7.1,,
Oceania,Polynesia,American Samoa,Cocaine,Govt.,Youth Risk Behavior Survey,2007,5.4,3,
Oceania,Australia and New Zealand,Australia,Ecstasy,ARQ,-,2007,2.2,,2
Oceania,Australia and New Zealand,New Zealand,Ecstasy,Govt.,-,2008,3.6,,2.35
Oceania,Australia and New Zealand,Australia,Ecstasy,ARQ,-,2010,4.7,1.2,2.8
Oceania,Australia and New Zealand,Australia,Ecstasy,ARQ,-,2013,3.9,,3
Oceania,Australia and New Zealand,Australia,Ecstasy,ARQ,"2016 annual prevalence, 2013 lifetime",2016,3.9,,1
Oceania,Australia and New Zealand,Australia,Ecstasy,ARQ,-,2016,3.7,,3.2
Oceania,Australia and New Zealand,Australia,Ecstasy,ARQ,-,2017,6,2,5
Oceania,Micronesia,Guam,Ecstasy,Govt.,-,2007,5.8,,
Oceania,Micronesia,Marshall Islands,Ecstasy,Govt.,-,2007,13.1,,
Oceania,Micronesia,Northern Mariana Islands,Ecstasy,Govt.,-,2007,4.7,,
Oceania,Micronesia,Palau,Ecstasy,Govt.,-,2007,6.9,,
Oceania,Micronesia,Palau,Ecstasy,Youth Risk Behavior Survey,-,2011,7.3,,
Oceania,Polynesia,American Samoa,Ecstasy,Govt.,-,2007,5,,
Oceania,Australia and New Zealand,Australia,Opioids,ARQ,-,2007,0.1,,0.1
Oceania,Australia and New Zealand,New Zealand,Opioids,Govt.,Household survey,2008,1,,1
Oceania,Australia and New Zealand,Australia,Opioids,ARQ,Pharmaceutical opioids,2016,,0.3,
Oceania,Australia and New Zealand,Australia,Opioids,ARQ,Heroin,2017,1,1,1
Oceania,Australia and New Zealand,Australia,Opioids,ARQ,Non - Heroin Opioids,2017,6,2,4
Oceania,Micronesia,Guam,Opioids,Govt.,Youth Risk Behavior Survey,2007,3.6,,
Oceania,Micronesia,Marshall Islands,Opioids,Govt.,Youth Risk Behavior Survey,2007,9.6,,
Oceania,Micronesia,Northern Mariana Islands,Opioids,Govt.,Youth Risk Behavior Survey,2007,3.5,,
Oceania,Micronesia,Palau,Opioids,Youth Risk Behavior Survey,Heroin,2011,5.8,,
Oceania,Polynesia,American Samoa,Opioids,Govt.,Youth Risk Behavior Survey,2007,5.2,,
Oceania,Australia and New Zealand,New Zealand,Tranquillizers and sedatives,Govt. HHS,-,2008,2.9,,1.6
Oceania,Australia and New Zealand,Australia,Tranquillizers and sedatives,ARQ,-,2010,,,1
Oceania,Australia and New Zealand,Australia,Tranquillizers and sedatives,ARQ,Other sedatives and tranquillizers,2010,4.5,1.6,3.2
Oceania,Australia and New Zealand,Australia,Tranquillizers and sedatives,ARQ,Tranquillizers,2017,20,6,13
